Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39482,0.150443937513654,0.00426219479509432,0.142090035715269,0.158797839312039,2.86635063517087e-262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39581,-0.0711240371910146,0.00286181683726841,-0.0767331981920606,-0.0655148761899685,1.14037563988035e-133
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39355,0.0594898612198169,0.00245194796320422,0.0546840432119366,0.0642956792276972,1.44229702868224e-127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39545,0.0837514519665759,0.00386464413854105,0.0761767494550354,0.0913261544781163,1.39667987886797e-102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39438,0.0923908778312801,0.00444221244395416,0.08368414144113,0.10109761422143,9.70885948226848e-95
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39498,0.055581816816582,0.00283672268165117,0.0500218403605457,0.0611417932726183,1.97036339223906e-84
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39636,0.0815882621158159,0.00443038710207598,0.0729047033957469,0.0902718208358848,6.43425320249186e-75
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,39403,0.115840598633052,0.00648640389204991,0.103127247004634,0.12855395026147,1.33049255125154e-70
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39462,0.0721419412541153,0.00404784872111036,0.064208157760739,0.0800757247474916,2.51448686871219e-70
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39498,0.026705065369501,0.0015197349863397,0.0237263847962752,0.0296837459427268,1.93992337318998e-68
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39513,0.0340803178692833,0.00194970357802967,0.0302588988563452,0.0379017368822215,9.52576480464814e-68
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39582,0.0290913748011521,0.00168600363241525,0.0257868076816182,0.032395941920686,4.42660842039561e-66
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39601,0.0490975788790839,0.0028584934894169,0.0434949316398268,0.054700226118341,1.67340811062934e-65
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39187,0.0967755246113926,0.00566533194084892,0.0856714740073287,0.107879575215457,8.48311684931214e-65
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39204,0.0609942385543388,0.0035834482818919,0.0539706799218307,0.0680177971868469,2.35522360321815e-64
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39608,0.0298962122330543,0.00176137337356734,0.0264439204208623,0.0333485040452463,5.05547962830988e-64
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39432,0.0428642866690729,0.00252895748823094,0.0379075299921402,0.0478210433460055,7.64868537060146e-64
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39498,-0.0381973371286898,0.00225563253571825,-0.0426183768986976,-0.033776297358682,9.79594899221071e-64
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39470,0.0458134810895537,0.00271351827832597,0.0404949852640348,0.0511319769150726,2.28727013601885e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39485,-0.0651771815273334,0.00386148406536808,-0.0727456902954548,-0.057608672759212,2.46716390690902e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,37269,-0.0945678563054104,0.00559982722584435,-0.105543517668065,-0.0835921949427555,2.67820410926718e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39541,-0.0383166562678664,0.00227762878503083,-0.0427808086865269,-0.033852503849206,6.19259928141812e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,37146,0.0499820508600195,0.00301371026026669,0.0440751787498968,0.0558889229701423,3.93561321544864e-61
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39433,0.0768224392726485,0.00463740300140349,0.0677331293898977,0.0859117491553994,4.29834315904715e-61
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39601,0.04820625972646,0.00293422204677704,0.042455184514777,0.053957334938143,3.9273786612353e-60
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39455,-0.0520276415870568,0.00316988139580797,-0.0582406091228404,-0.0458146740512732,5.13556216535803e-60
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37203,0.10351826252717,0.00633620165371499,0.0910993072858883,0.115937217768451,2.13639786185567e-59
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39541,0.0563373206966175,0.00345674403671667,0.0495621023846529,0.0631125390085822,3.27708799674183e-59
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39636,0.0468287795432647,0.00288386568954857,0.0411764027917495,0.0524811562947799,8.46828343552861e-59
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39541,0.0367397436673489,0.00228924210020002,0.0322528291509568,0.0412266581837409,1.74062540152728e-57
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39455,0.0320439766122373,0.00200265721115683,0.0281187684783699,0.0359691847461047,3.7501812153131e-57
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39601,0.0885169971967385,0.00557586368358154,0.0775883043769187,0.0994456900165583,2.68291923331154e-56
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39414,0.0542774956517861,0.00342359630431263,0.0475672468953333,0.0609877444082388,3.78150963015114e-56
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39355,0.0429061807736528,0.00270700188387905,0.0376004570812498,0.0482119044660557,4.03404315607321e-56
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,37241,-0.048121163022501,0.00304377171652121,-0.0540869555868826,-0.0421553704581195,8.989504462857e-56
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39433,0.0520458504316754,0.00329483032977292,0.0455879829853205,0.0585037178780304,9.30786130635734e-56
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39589,-0.0289529421572847,0.00183820348616511,-0.0325558209901683,-0.0253500633244011,1.87250878437255e-55
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39636,0.0350095631589871,0.00222370495186133,0.0306511014533389,0.0393680248646354,2.07739366155651e-55
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39561,0.0492899978920762,0.00314229236118964,0.0431311048641445,0.0554488909200079,5.1210065834186e-55
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39654,0.0697672628592888,0.00447045581547872,0.0610051694609505,0.0785293562576271,1.74537079702259e-54
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39499,0.0391393102176633,0.00251819511524073,0.0342036477917915,0.0440749726435352,4.69793916447973e-54
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39636,0.0500732824802532,0.00323167819151409,0.0437391932248856,0.0564073717356208,9.73916807900645e-54
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39589,0.0819846945921192,0.00531015490711882,0.0715767909741663,0.092392598210072,2.27449624201497e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39485,0.038779290160431,0.00252208383822409,0.0338360058375117,0.0437225744833502,6.00662569856201e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39499,0.0388463648810142,0.00252852414555613,0.0338904575557242,0.0438022722063042,7.27192932720151e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39439,0.0263719776650997,0.00171728923712688,0.023006090760331,0.0297378645698684,8.05682295411352e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39464,-0.0582166966350963,0.0038465292181151,-0.0657558939026019,-0.0506774993675908,2.28244804377365e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39654,-0.0442946846975411,0.00292904513155657,-0.050035613155392,-0.0385537562396902,2.71422260020711e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37255,0.0537889463302856,0.00356080036192927,0.0468097776209042,0.060768115039667,4.08279866135712e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39654,0.0549533827565102,0.0036485049735108,0.047802313008429,0.0621044525045914,6.71721429278525e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39589,0.167686888719822,0.0111553717980963,0.145822359995553,0.18955141744409,1.05299391250925e-50
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36955,0.0524601100161387,0.00351851569700883,0.0455638192500013,0.059356400782276,7.63205466105788e-50
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39654,0.0271570451272959,0.00182985688994115,0.0235705256230112,0.0307435646315805,1.7640058741122e-49
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,37247,0.0980689007899801,0.00675655552577991,0.0848260519594514,0.111311749620509,2.32698937096042e-47
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39392,-0.0747578928979853,0.00522146371442737,-0.084991961778263,-0.0645238240177077,3.44229882227572e-46
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36882,0.0463705064157336,0.00326586632191989,0.0399694084247706,0.0527716044066966,2.11711848393129e-45
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39455,0.050539780837181,0.00356523658426436,0.0435519171320229,0.0575276445423392,2.54010590831461e-45
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36668,0.0384506224643258,0.00271376485825341,0.0331316433421491,0.0437696015865024,3.26087197829329e-45
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39526,-0.0406888392198859,0.00288216213775057,-0.046337877009877,-0.0350398014298948,5.73312349709889e-45
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39497,0.0333219188591454,0.00237505040947444,0.0286668200565755,0.0379770176617153,1.94697214308066e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36637,-0.0527346191664407,0.00376228651820828,-0.0601087007421289,-0.0453605375907524,2.72119891081227e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,39344,0.0271754474171301,0.00194972955308738,0.0233539774930788,0.0309969173411813,7.01512816985439e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39428,0.0794100061881233,0.00572931666609023,0.0681805455225865,0.0906394668536602,2.04328072891586e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39601,0.0378147765083666,0.00276552122350548,0.0323943549102959,0.0432351981064373,2.60114278260065e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39531,0.0388500486031099,0.00284172600840891,0.0332802656266284,0.0444198315795913,2.6932425362564e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,37269,0.0749774549167669,0.00548814670124879,0.0642206873823193,0.0857342224512145,3.39373727273011e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39104,0.0628520815625095,0.00460380083908737,0.0538286319178983,0.0718755312071208,3.54714621655491e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36955,-0.0351036996383945,0.00257894228842888,-0.0401584265237151,-0.0300489727530739,6.78578574174917e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39390,0.0829549372528254,0.00612376375904955,0.0709523602850883,0.0949575142205625,1.46424217883219e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,37241,0.0312498828561886,0.00231755068802335,0.0267074835076629,0.0357922822047144,3.71049881596722e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37249,0.0220172810938299,0.00164366303078142,0.0187957015534983,0.0252388606341615,1.21036817140686e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,39123,0.140000753568422,0.0105350870446066,0.119351982960993,0.160649524175851,4.57006517471576e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39428,0.0345886878241667,0.00260760169347521,0.0294777885049553,0.0396995871433781,6.24165687932028e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36595,0.0259168452663324,0.00196340465007946,0.0220685721521767,0.0297651183804882,1.64217741713051e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39455,0.0322567331065344,0.00245078330308793,0.0274531978324821,0.0370602683805868,2.40469907369321e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39531,0.0386635799878264,0.00294198406209332,0.0328972912261235,0.0444298687495293,3.10743751095815e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39355,0.063971930319881,0.00487166985139413,0.0544234574111485,0.0735204032286134,3.58926095979254e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39541,0.0753497810233384,0.00573872966439643,0.0641018708811214,0.0865976911655554,3.63182325424075e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39485,0.064991584995489,0.00501303282022565,0.0551660406678468,0.0748171293231313,3.11677190071824e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39636,0.0354973477065651,0.00275713471815056,0.03009336365899,0.0409013317541402,9.84049597760346e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39475,0.0553288481331832,0.00430297177955062,0.0468950234452639,0.0637626728211024,1.22039813727966e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39016,0.0412361234652896,0.00321000621664425,0.0349445112806669,0.0475277356499123,1.44633136142655e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39194,0.0477176281622892,0.00371865845509325,0.0404290575903064,0.0550061987342719,1.72362581265154e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36955,0.0312335481433792,0.00243609106601656,0.0264588096539868,0.0360082866327717,2.14606355202583e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37203,0.0417412407020712,0.00327776122561918,0.0353168286998576,0.0481656527042848,6.36635096178647e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39455,0.0293839779376914,0.00231491086096545,0.0248467526501991,0.0339212032251837,9.94340262556649e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39462,0.0353174328026315,0.00278300092841925,0.0298627509829298,0.0407721146223332,1.03173775321609e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37247,0.0772626155372629,0.00612264998717853,0.065262221562393,0.0892630095121329,2.7237572803162e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39458,0.0308273276197574,0.00244667354497199,0.0260318474716123,0.0356228077679025,3.23323602667227e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39455,0.0809486892695647,0.00642737250458648,0.0683510391605752,0.0935463393785542,3.45674493020654e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39520,0.0363063870071379,0.00288474253709151,0.0306522916344386,0.0419604823798373,3.84851460491763e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39477,0.0298413378943673,0.00237476617929427,0.0251867961829505,0.034495879605784,4.92796056986603e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39541,0.0352701139510951,0.0028198359112421,0.0297432355650606,0.0407969923371296,1.01676947733746e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39289,0.0486424429261001,0.00389412566952587,0.0410099566138293,0.0562749292383708,1.2591554875243e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39530,0.0628113235142076,0.00505510518326414,0.0529033173550099,0.0727193296734053,2.83441978483052e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39541,-0.0465360448960577,0.00375177663406978,-0.0538895270988344,-0.0391825626932809,3.70083975904284e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39531,0.0347745226637174,0.00280598693389963,0.0292747882732741,0.0402742570541607,4.22807996549757e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36955,0.0391739734318083,0.00318278810684765,0.0329357087423869,0.0454122381212297,1.29988199590866e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39123,0.0644281441715231,0.00523839874641404,0.0541608826285516,0.0746954057144947,1.35420636775699e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39462,0.0632857564209833,0.00515065799304848,0.0531904667546083,0.0733810460873584,1.56023036188781e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39455,0.0379981723506363,0.0030957005824941,0.0319305992089479,0.0440657454923248,1.81685138689646e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39428,0.108898707086063,0.00889229910074053,0.0914698008486119,0.126327613323515,2.56261400788287e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,37269,0.0207165092334331,0.00169725030784269,0.0173898986300614,0.0240431198368048,4.46675643440693e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39496,0.048294061535,0.00397396778989023,0.0405050846668151,0.0560830384031849,8.00415571771462e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39455,-0.025972135710097,0.00216501301526491,-0.0302155612200162,-0.0217287102001777,5.26039305089636e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39455,-0.027358122524577,0.00228122383633003,-0.0318293212437839,-0.0228869238053702,5.48899613308736e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39531,0.0348680344993624,0.00292848676248782,0.0291282004448862,0.0406078685538385,1.53158483420974e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39541,0.0591637752403703,0.00497378763500589,0.0494151514757587,0.0689123990049818,1.75290913198101e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39499,0.0330094861663231,0.00278577228840324,0.0275493724810527,0.0384695998515934,3.01832904638687e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39187,0.0921373207000886,0.00779795590191962,0.0768533271323261,0.107421314267851,4.52624239595612e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37269,0.0267980140101575,0.00228217180740819,0.0223249572676375,0.0312710707526776,1.12342965380436e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39462,0.037425112526584,0.00318940282591019,0.0311738829878,0.0436763420653679,1.17034931922874e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39568,0.0416830155159148,0.00356331911698114,0.0346989100466318,0.0486671209851979,1.78738525587818e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39462,0.0662652393348728,0.0056672435619321,0.0551574419534859,0.0773730367162598,1.90186649205159e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39123,0.0798572132638203,0.00684053539336953,0.066449763892816,0.0932646626348246,2.37837833080877e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39423,-0.0630517423689486,0.00541041833195629,-0.0736561622995829,-0.0524473224383143,2.99522847824736e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39455,-0.0519593597765132,0.0044643338822287,-0.0607094541856815,-0.043209265367345,3.56326002201364e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,39194,0.075567087139756,0.00649392686613054,0.0628389904821401,0.0882951837973718,3.67508144233813e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39549,0.0712701122763309,0.00613920355463253,0.0592372733092512,0.0833029512434107,5.02320697019705e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39428,0.0591517690493402,0.00509884605254847,0.0491580307863452,0.0691455073123352,5.52481419308474e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36853,0.0269130170619295,0.00231971850367091,0.0223663687947345,0.0314596653291244,5.82685968876545e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39455,-0.0309450022855478,0.00267433078270929,-0.036186690619658,-0.0257033139514376,7.80271793451936e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39411,0.0403733091238294,0.00348941424724682,0.0335340571992256,0.0472125610484332,7.89072824756432e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39401,0.102397083694728,0.0088615494553722,0.0850284467621988,0.119765720627258,9.38593513288032e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39194,0.0828831763716299,0.00717669905344522,0.0688168462268773,0.0969495065163825,1.01339637390357e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39636,-0.0381436013371716,0.00331466001727008,-0.044640334971021,-0.0316468677033223,1.61757001758908e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39654,0.0431468453201273,0.00377189802347694,0.0357539251941125,0.0505397654461421,3.54590731359963e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39636,0.0431033678224828,0.00377726248388572,0.0356999333540668,0.0505068022908989,4.86913078041568e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39636,0.0251882888545533,0.0022105182485311,0.0208556730874324,0.0295209046216743,5.87789032303599e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39541,0.0654171635477944,0.00574779998969956,0.0541514755679833,0.0766828515276056,6.86500354407002e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39589,0.0763724281363485,0.00672932694359499,0.0631829473269023,0.0895619089457947,9.87090486964612e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37269,0.0168842049359056,0.00148721712091595,0.0139692593789103,0.0197991504929009,9.94958266307635e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39579,0.0562766723325655,0.00496962666321675,0.0465362040726607,0.0660171405924704,1.31145893468832e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39541,0.0274343002053115,0.00242276066228247,0.0226856893072379,0.0321829111033851,1.32062251270132e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39636,0.072068151113931,0.00638836448429659,0.0595469567247097,0.0845893455031524,2.12848537182513e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39541,0.0451603098630523,0.00401605210189808,0.037288847743332,0.0530317719827725,3.20476570475762e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39455,0.0539737749787899,0.00480035422698101,0.0445650806939071,0.0633824692636726,3.25485915958992e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37269,0.0178113801370964,0.00158798493236449,0.014698929669662,0.0209238306045308,4.62942876246804e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37243,0.0245922848329647,0.00219280802764427,0.0202943810987819,0.0288901885671475,4.70376094564226e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39427,0.0260466707251776,0.0023237813159526,0.0214920593459105,0.0306012821044447,4.82065311759858e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39462,0.0274184178541104,0.00244654278108204,0.0226231940031896,0.0322136417050312,4.91245251750231e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39589,0.0491973537086779,0.00442131158775852,0.0405315829966712,0.0578631244206846,1.1930531893545e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39455,0.0316725847519633,0.00285091525587438,0.0260847908504495,0.0372603786534771,1.45578498054904e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39601,0.0593169594418364,0.00535632133242302,0.0488185696302872,0.0698153492533855,2.151020205938e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36955,0.0397186240599433,0.00358782379525569,0.0326864894212421,0.0467507586986444,2.36488264252714e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37164,0.13071988382688,0.0118108258023923,0.107570665254191,0.153869102399569,2.42158215662918e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39588,0.0247465843627903,0.0022423519483627,0.0203515745439994,0.0291415941815812,3.2820902739607e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39571,0.0399630538949258,0.00362263021824152,0.0328626986671725,0.0470634091226792,3.44983644974796e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39436,0.0571945996201143,0.00519896393576923,0.0470046303060066,0.067384568934222,4.83017699793347e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39601,-0.01529659206579,0.00139142035915636,-0.0180237759697365,-0.0125694081618435,5.23982415346759e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39355,0.051023612625755,0.00465159154995836,0.0419064931878366,0.0601407320636734,6.88074434008013e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39462,0.0495676745044225,0.00452148991053398,0.0407055542797759,0.0584297947290691,7.36658272149838e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39123,0.101469208717999,0.00925608611876546,0.0833272799252189,0.11961113751078,7.42859588409093e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39554,0.0370034940916116,0.00338523713045252,0.0303684293159247,0.0436385588672986,1.04244976070892e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39396,0.0358834711203505,0.00328490526639072,0.0294450567982246,0.0423218854424763,1.12936028372498e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39429,0.0333008800609332,0.00304870757373435,0.0273254132164139,0.0392763469054526,1.13862692140432e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39462,0.056681069497125,0.00519123170741548,0.0465062553505907,0.0668558836436594,1.19319310124727e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39355,0.0319528070489929,0.00294650710446369,0.0261776531242441,0.0377279609737417,2.68399929694525e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39470,0.0456117443895672,0.00420756078551792,0.037364925249952,0.0538585635291823,2.79425065318232e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39460,0.0762256888728894,0.00704248173978389,0.062422424662913,0.0900289530828659,3.35016839784714e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39516,0.0477038093996743,0.00440979226840483,0.0390606165536009,0.0563470022457478,3.57186854707359e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37164,0.0944306367701875,0.0087326478962003,0.0773146468936349,0.11154662664674,3.89846009912009e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39654,0.0449747864849707,0.00416119400250998,0.0368188462400511,0.0531307267298902,3.95273065666924e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39589,0.0317511482950334,0.00294018728137553,0.0259883812235374,0.0375139153665295,4.36666350786026e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39498,0.0219989369890445,0.00204222679678113,0.0179961724673534,0.0260017015107355,5.8512591805076e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39477,0.0852460835120602,0.00792005172329915,0.0697227821343939,0.100769384889727,6.42907707822689e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39582,0.0304359237250422,0.0028318410184225,0.0248855153289341,0.0359863321211503,7.59054542754882e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39187,0.076722174371174,0.00714939464104212,0.0627093608747315,0.0907349878676166,9.11430862298684e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39485,0.0307807701743574,0.00287041731251147,0.0251547522418349,0.0364067881068798,9.86975909341712e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39415,0.0430873785539482,0.00402625214700544,0.0351959243458176,0.0509788327620789,1.24866774254857e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39477,0.034536358034147,0.00323011346095228,0.0282053356506805,0.0408673804176135,1.38279647829501e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39601,0.09997678899366,0.00935190367321498,0.0816470577941586,0.118306520193161,1.40216573392115e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,37040,0.0297460788974972,0.00278214606063405,0.0242930726186545,0.0351990851763399,1.44603698601789e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36648,0.0428100989180525,0.00401259370613819,0.0349454152540216,0.0506747825820833,1.8607432372693e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39485,-0.0242719188771315,0.00227925163820152,-0.0287392520880065,-0.0198045856662566,2.18686446242494e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36928,0.0326568740707112,0.00307095770750146,0.0266377969640084,0.0386759511774141,2.68010522051886e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39455,0.0310945759511552,0.00292913408317357,0.025353473148135,0.0368356787541754,3.12362925034532e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39531,0.036538908662339,0.00344999388827515,0.0297769206413197,0.0433008966833583,4.05212465197181e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,39187,-0.02120565862313,0.00200249025076516,-0.0251305395146297,-0.0172807777316303,4.131327345449e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39589,0.0266871466799932,0.00252997339972904,0.0217283988165243,0.0316458945434622,6.35672355111027e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39462,0.0540817727450025,0.00513468812889674,0.0440177840123649,0.0641457614776401,7.52033383170662e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39549,0.0426840691038658,0.00405986714526035,0.0347267294991555,0.0506414087085761,9.17367048953322e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39365,0.026491214545727,0.00252151835187063,0.0215490385760606,0.0314333905153934,9.96320868241964e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39516,0.0462669476712414,0.00440459099991275,0.0376339493114124,0.0548999460310704,1.01329196001936e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36955,0.03187775918304,0.00303385011255647,0.0259314129624293,0.0378241054036507,1.02250477814669e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39485,0.0532103668019873,0.00507975177708517,0.0432540533189004,0.0631666802850743,1.37858648428506e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39531,0.0260590373026507,0.00248779138061988,0.0211829661966357,0.0309351084086656,1.38100255028439e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39479,0.068091275333725,0.00650077267973086,0.0553497608814525,0.0808327897859975,1.38824559010458e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39552,0.0611737363232428,0.00585084508448037,0.0497060799576613,0.0726413926888243,1.6889567094297e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36975,0.0200117585919629,0.00191404362605276,0.0162602330848995,0.0237632840990263,1.76544259486321e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39485,0.0274964272552557,0.00263429655883031,0.0223332059999483,0.0326596485105631,2.03392633718581e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,37221,0.0405110549503772,0.00389235320181216,0.0328820426748254,0.0481400672259291,2.8810513348237e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,39330,0.0260124524383623,0.00250333298592375,0.0211059197859518,0.0309189850907729,3.31886823918706e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37162,0.0477988340415574,0.00461193429273042,0.0387594428278058,0.0568382252553091,4.54179605277111e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,36360,0.0215828101215489,0.00208376168407159,0.0174986372207686,0.0256669830223292,4.93577484643404e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39455,0.0344840086786129,0.00333270215704387,0.0279519124508069,0.0410161049064189,5.23179671417504e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39623,0.0332078047897097,0.00320947493571494,0.0269172339157084,0.039498375663711,5.24010607156447e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39455,-0.0357179641570589,0.00346106466197557,-0.042501650894531,-0.0289342774195868,6.93568744207085e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39428,0.0766191813044904,0.00743262493188341,0.0620512364379989,0.0911871261709818,7.8089238142549e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39516,0.0502461181694192,0.00488185411707214,0.0406776840999578,0.0598145522388806,9.20780885332023e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38700,0.0334162615573192,0.00324861811058568,0.0270489700605713,0.0397835530540672,9.91403021701222e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39194,0.0482838685116991,0.00470080427120816,0.0390702921401311,0.057497444883267,1.14814219880627e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36992,0.112465184178681,0.0109502725722465,0.0910026499370783,0.133927718420285,1.19781348689483e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39149,0.0267990072050163,0.00261506402640037,0.0216734817132716,0.031924532696761,1.46235052689646e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39432,0.0164435812853884,0.00160988849148994,0.0132881998420681,0.0195989627287087,2.0613005752009e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,39162,0.03455634140922,0.00338924056258756,0.0279134299065484,0.0411992529118916,2.49188368145532e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,37247,0.0788734854491853,0.00774149380865796,0.0637001575842157,0.094046813314155,2.76544309874839e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39462,-0.0294145868968172,0.00288983817329485,-0.0350786697164751,-0.0237505040771593,2.96146608026415e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39477,0.0457400643528548,0.00450244873069574,0.0369152648406912,0.0545648638650185,3.61943630729184e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39428,0.0356861735380898,0.00352297716742309,0.0287811382899405,0.0425912087862391,4.8828864290601e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),37006,0.152002468681797,0.0150092898410808,0.122584260593279,0.181420676770316,5.17341413100983e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39654,-0.0237363586133358,0.00234552184413597,-0.0283335814278422,-0.0191391357988293,5.37337286823623e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39636,0.0477697337340184,0.00473309020032435,0.0384928769413827,0.0570465905266542,7.07665261697912e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37057,0.0222374572899369,0.00220300075150081,0.0179195758169953,0.0265553387628785,7.22408702483723e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39403,0.0219068310060637,0.00217603827441179,0.0176417959882166,0.0261718660239108,9.1742921005358e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36955,0.0245236784168132,0.00243600121330766,0.0197491160387302,0.0292982407948962,9.50205764316269e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,39319,0.0468968771992216,0.00466190866860391,0.0377595362087579,0.0560342181896853,9.92669963874192e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39654,0.0243386878185176,0.00242123504488162,0.0195930671305496,0.0290843085064855,1.06559309492532e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36861,0.0672708852177813,0.00669374312616611,0.0541511486904957,0.0803906217450668,1.1336960250429e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39462,0.0753701501958386,0.00750827583416088,0.0606539295608833,0.0900863708307939,1.22846981986786e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37164,0.074389932324553,0.00741637264622378,0.0598538419379544,0.0889260227111516,1.37000169438891e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,37136,0.0216595127776132,0.00216094548926215,0.0174240596186594,0.025894965936567,1.47542569738591e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39531,0.0774796912965362,0.00773534210576893,0.0623184207692291,0.0926409618238433,1.53079980988754e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36880,0.0716603612273836,0.00715967582952802,0.0576273966015087,0.0856933258532585,1.70978117605066e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37085,0.0228597749630728,0.00228489763971887,0.0183813755892238,0.0273381743369218,1.77666722355192e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37247,0.084865838397986,0.00849882552071748,0.0682081403773797,0.101523536418592,2.14640520316032e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39304,0.0238097493406837,0.00239271965770892,0.0191200188115742,0.0284994798697932,2.95475902153081e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,39104,0.0267167219616213,0.00268519046331234,0.0214537486535292,0.0319796952697135,2.99893430375656e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36880,0.0774159484533253,0.00779129319928753,0.0621450137827217,0.0926868831239289,3.53393523391404e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39531,0.0600629918724335,0.00606606815370871,0.0481734982911644,0.0719524854537025,4.8228696110849e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39455,0.0364339961340577,0.0036816023994036,0.0292180554312266,0.0436499368368888,5.08452858463201e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39123,0.0393173877275839,0.00397500067530144,0.0315263864039931,0.0471083890511747,5.36647104148396e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39123,0.0693059658585502,0.00700779082834148,0.0555706958350009,0.0830412358820996,5.43722510092883e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39531,-0.0237773436798063,0.00240516959321358,-0.0284914760825049,-0.0190632112771077,5.62731931998003e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39485,0.0216494115140336,0.00219165965869372,0.0173537585829939,0.0259450644450733,6.08540228828363e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39428,0.066263050253916,0.00672894171738886,0.0530743244878339,0.0794517760199982,8.2447655641041e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39636,0.0648977766392977,0.00659636080597955,0.0519689094595778,0.0778266438190176,8.99615318794044e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36457,-0.0929589233332015,0.00946312578729757,-0.111506649876305,-0.0744111967900982,1.08836566842148e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39428,0.0464064406741028,0.00472993299055661,0.0371357720126118,0.0556771093355937,1.17886890814929e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39151,0.0431485525216573,0.00439899589862016,0.0345265205603617,0.0517705844829528,1.21179307846193e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39526,0.034989256223384,0.00356872395643449,0.0279945572687724,0.0419839551779956,1.25932316369167e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37083,0.0257477458469635,0.00262583736014714,0.0206011046210751,0.0308943870728519,1.28342744370105e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,39332,0.0426859319496004,0.00436115381388117,0.0341380704743933,0.0512337934248075,1.48641065766152e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39589,0.0556749212699327,0.00569481373106389,0.0445130863570475,0.066836756182818,1.65704257384634e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37221,0.0749987918924154,0.00769362469650538,0.0599192874872648,0.0900782962975659,2.24770011299426e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39268,0.122137807867521,0.0125541961112554,0.09753158348946,0.146744032245581,2.64900154316525e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39455,0.0349451590559672,0.00359331921453049,0.0279022533954874,0.0419880647164469,2.74411186764544e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,39187,0.0441208942857961,0.00453942071635342,0.0352236296817433,0.0530181588898488,2.90446268723154e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39591,0.0674810250950357,0.00694675903686691,0.0538653773827765,0.0810966728072948,3.05114130430768e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39531,-0.0201328572525986,0.00207301822927414,-0.0241959729819759,-0.0160697415232213,3.11832859833424e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39485,0.0373184997777361,0.00384509453889231,0.0297821144815071,0.044854885073965,3.31976393594361e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39456,-0.0145614371995704,0.0015026604714399,-0.0175066517235926,-0.0116162226755482,3.84470182775437e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39564,0.0602250436538599,0.00621722548565247,0.048039281701981,0.0724108056057387,3.97881653187093e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39428,0.0706965468156998,0.0073038797686391,0.0563809424691672,0.0850121511622325,4.28512149055356e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39337,0.0330663750815794,0.00341953936024364,0.0263640779355019,0.039768672227657,4.70281654190373e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39589,0.0183915101453315,0.00190383823893458,0.0146599871970197,0.0221230330936432,5.14962699140242e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39526,0.0410907760510245,0.00425506213664706,0.0327508542631963,0.0494306978388528,5.32097393661158e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39526,0.0820329316961721,0.00850824249559386,0.0653567764048081,0.0987090869875361,6.17332171335315e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39636,0.0245456924896242,0.00254820959923797,0.0195512016751178,0.0295401833041306,6.73197663660293e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39456,0.0368379118544108,0.00382522564624864,0.0293404695877635,0.0443353541210582,6.89306175033258e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39400,0.0644393283838505,0.00669203619928382,0.0513229374332542,0.0775557193344467,6.96402098761372e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,37269,-0.0612399737148264,0.0063607078984371,-0.0737069611957631,-0.0487729862338897,7.23183529749429e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39428,0.0569574609007934,0.00592368937866003,0.0453470297186197,0.0685678920829671,7.97505890223479e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39289,0.028716355172834,0.00298817209501313,0.0228595378666082,0.0345731724790597,8.39647219259483e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39458,0.0257249467160745,0.00267756721621953,0.0204769149722842,0.0309729784598648,8.5812289501407e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37221,0.0515121346667177,0.0053625745554213,0.0410014885380919,0.0620227807953435,8.94743270340252e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39589,0.0482921245538225,0.00505592884069016,0.0383825040260698,0.0582017450815752,1.46910069306924e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39498,-0.0240956236509479,0.00253134234663292,-0.0290570546503484,-0.0191341926515474,2.01071162328681e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39498,0.0203752044696676,0.00214383878225257,0.0161732804564526,0.0245771284828827,2.3170164529282e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,39330,0.041985009837866,0.00441837948517552,0.0333249860469219,0.05064503362881,2.35904336067956e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37203,0.0863628853949154,0.00909198903299916,0.0685425868902371,0.104183183899594,2.49781208130864e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,37221,0.08291437883667,0.00873257969810118,0.0657985226283917,0.100030235044948,2.59323414659146e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39541,0.0220833729187227,0.00233039570494017,0.0175157973370399,0.0266509485004054,3.02042902185351e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39589,0.0526354727853737,0.00555671903390874,0.0417443034789126,0.0635266420918348,3.13131204971446e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,39123,0.0592386383707952,0.00626711958283252,0.0469550839884435,0.071522192753147,3.80736931686707e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39455,0.0190668441151952,0.00201733499902811,0.0151128675171001,0.0230208207132903,3.82435055990413e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36916,-0.0507904032852484,0.00537387155773951,-0.0613231915384179,-0.040257615032079,3.93599843653389e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,39319,0.0644825428608362,0.00682866106566959,0.0510983671721238,0.0778667185495486,4.15383098787767e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37221,0.0909471366035014,0.00967197788581944,0.0719900599472953,0.109904213259708,6.1876053559381e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39541,0.0683520913731071,0.00727332456239708,0.0540963752308088,0.0826078075154054,6.36503752469561e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39428,0.0543512419043148,0.00579318444838208,0.0429966003854859,0.0657058834231437,7.38986074397849e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39428,0.035152283666359,0.00375633584538678,0.027789865409401,0.0425147019233171,9.24663961930041e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39428,0.0666637208765378,0.00712384131105108,0.0527009919068777,0.0806264498461979,9.27257196452894e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39355,0.0301082308938111,0.00322342953223343,0.0237903090106336,0.0364261527769886,1.09269095324888e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36955,0.0904236725738212,0.0096828570754304,0.0714452727059776,0.109402072441665,1.14035176476423e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,39099,-0.0963006241445307,0.0103163826129245,-0.116520734065863,-0.0760805142231987,1.15542584237746e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39428,0.096926972687644,0.0103904194918373,0.0765617504836429,0.117292194891645,1.22147433597785e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39194,0.0569933252842552,0.0061162607794217,0.0450054541565887,0.0689811964119217,1.34633474873611e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37243,0.0495539560611455,0.00531770905550308,0.0391312463123594,0.0599766658099315,1.36889552225929e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39418,0.0342179667791622,0.00367321289652987,0.0270184695019636,0.0414174640563607,1.37926262751654e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,39107,0.0444873111121682,0.004777995395657,0.0351224401366805,0.053852182087656,1.44478789105747e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36861,0.0942310771573941,0.0101351641681405,0.0743661553878387,0.114095998926949,1.67703386289887e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39428,0.0618911113426096,0.00667437431967966,0.0488093376760375,0.0749728850091818,2.05349529585881e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39601,0.0224694973002962,0.00242635157662634,0.0177138482101085,0.0272251463904838,2.30036770673267e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39462,0.0416898016971855,0.00450398037763359,0.0328620001570237,0.0505176032373474,2.39925075395413e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39497,0.0313437687532771,0.00338841363171678,0.0247024780351122,0.037985059471442,2.53475393788476e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36880,0.0654743288077365,0.00708052423486613,0.0515965013073989,0.0793521563080741,2.67943068422111e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36916,0.0763895091141172,0.00826158622944461,0.0601968001044057,0.0925822181238286,2.69707319529813e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,37164,0.0602992408800465,0.00652264501632305,0.0475148566480533,0.0730836251120397,2.73331922513117e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39037,0.0145429816032946,0.00157353635763194,0.011458850342336,0.0176271128642532,2.74242049633184e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,37114,0.072981140776506,0.00789630099287606,0.0575043908304689,0.088457890722543,2.79011995840144e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37243,0.0174114333300393,0.00188794918374728,0.0137110529298946,0.021111813730184,3.35523178935492e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39330,0.0694584715325429,0.00753359656219522,0.0546926222706403,0.0842243207944455,3.36789034062418e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39123,0.05280364821247,0.0057371549047459,0.041558824599168,0.0640484718257719,3.91372190199736e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,37243,0.0203760099778423,0.00221398507368334,0.0160365992334229,0.0247154207222616,4.00370701737846e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,39104,0.0816589049777152,0.00889569024292699,0.0642233521015783,0.0990944578538521,4.89581131606409e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39534,0.026725776579366,0.00291383868885231,0.0210146527492155,0.0324369004095165,5.23255730162601e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39654,0.0329943315325125,0.00359775491781635,0.0259427318935925,0.0400459311714325,5.28609292034757e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39589,0.0746968809007698,0.00816365836172887,0.0586961105117812,0.0906976512897584,6.41124280534196e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39428,0.0663846093715925,0.00725657803037943,0.0521617164320488,0.0806075023111362,6.5223822374261e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36972,0.0239450828416567,0.00261861085882208,0.0188126055583654,0.029077560124948,6.92639809698426e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36916,0.0708640271039053,0.00775099108212266,0.0556720845829449,0.0860559696248657,7.03453205126672e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39541,0.0812479676509475,0.00889076234619838,0.0638220734523987,0.0986738618494964,7.12659281841055e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39378,0.0345935749790647,0.00378977131649096,0.0271656231987424,0.042021526759387,7.84606094904166e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,37177,0.0226775643162162,0.00248616689825173,0.0178046771956428,0.0275504514367896,8.51131841490729e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,37221,0.0337813583581497,0.00370757410932272,0.0265145131038772,0.0410482036124223,9.32815577214705e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39601,0.101038826753727,0.0110981238685784,0.079286503971313,0.12279114953614,9.761940104749e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,37196,0.0582875913786749,0.00640284741487998,0.0457380104455101,0.0708371723118396,1.00451429619837e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39463,0.0399660354106637,0.0043932271539092,0.0313553101890016,0.0485767606323257,1.04137718688325e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,39187,0.0386883768965358,0.0042527253655379,0.0303530351800815,0.0470237186129901,1.042488866306e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37164,0.0691004034838829,0.00759696585437235,0.0542103504093131,0.0839904565584527,1.07716738720431e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37102,0.025459797939366,0.00279906192403774,0.019973636568252,0.03094595931048,1.07746872027374e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39654,-0.0200051298314443,0.00220122057229588,-0.0243195221531442,-0.0156907375097443,1.12906405165331e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36955,0.0831470214524433,0.00914849564275038,0.0652159699926525,0.101078072912234,1.1529491927407e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37164,0.0810594149618328,0.00892838525141368,0.063559779869062,0.0985590500546036,1.25752254053149e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39636,0.031096036605416,0.00342636020044724,0.0243803706125394,0.0378117025982925,1.26783181711806e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39428,0.0698077449481334,0.00769183657749432,0.0547317452562446,0.0848837446400223,1.26946049469434e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37164,0.0207977392819589,0.00229138065909491,0.0163066331901328,0.0252888453737849,1.28459402669615e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39329,-0.0260820553104991,0.00287742375146677,-0.0317218058633739,-0.0204423047576242,1.4069820583499e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39485,0.0299549869500554,0.00330758042465,0.0234721293177414,0.0364378445823694,1.51043656887733e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37164,0.089649630461366,0.00989894241162941,0.0702477033345724,0.10905155758816,1.5418291359733e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39549,0.0260278843225639,0.00287646806969217,0.0203900069059673,0.0316657617391606,1.62250403968444e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37164,0.0731380922996583,0.00808456107090068,0.057292352600693,0.0889838319986236,1.68640226775843e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39480,0.0442863111685355,0.00490055182093662,0.0346812295994997,0.0538913927375712,1.80331053553182e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39187,0.0416395207604257,0.00460893649841265,0.0326060052235369,0.0506730362973145,1.84869692822128e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39608,0.0374450371019419,0.00415002291990595,0.0293109921789263,0.0455790820249576,2.04893938337094e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39654,0.029815934957636,0.00330811954871255,0.0233320206421594,0.0362998492731126,2.24074594505402e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39455,0.0321768689509394,0.00358657419501991,0.0251471835287004,0.0392065543731785,3.26655787331157e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39420,0.0221412174008623,0.00246897431528938,0.0173020277428951,0.0269804070588295,3.3783383058496e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39526,0.0442002250313229,0.00493493540092023,0.0345277516455193,0.0538726984171266,3.73413663016183e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39462,0.0255675186820483,0.00286019361344739,0.0199615391996915,0.0311734981644052,4.37419977739195e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39636,0.0554433262011794,0.00621046588113543,0.043270813074154,0.0676158393282049,4.85296131015681e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37164,0.077223472470729,0.00865829165598624,0.060253220824996,0.094193724116462,5.34157573383037e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37247,0.0466399564197236,0.00523239257950579,0.0363844669638922,0.0568954458755549,5.59824619186712e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,37247,0.0734209612826415,0.00824313972299896,0.0572644074255635,0.0895775151397194,5.94898901561946e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39461,0.0709639095442756,0.00798221953701918,0.055318759251718,0.0866090598368332,6.78110472764811e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39428,0.0564217820176879,0.0063509402000858,0.0439739392255198,0.0688696248098561,7.17245707698914e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39582,0.0455083216976622,0.00512334986700174,0.0354665559583388,0.0555500874369856,7.25971735697542e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39418,0.0308414658575123,0.00347219513125653,0.0240359634002495,0.0376469683147751,7.27592620355896e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39531,0.018961545926086,0.00213597956632942,0.0147750259760803,0.0231480658760917,7.61611198650242e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39428,0.0331903905541911,0.00373917492562053,0.0258616076999749,0.0405191734084073,7.67761123583013e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37203,-0.0306662450568206,0.00345558669031444,-0.0374391949698369,-0.0238932951438043,7.96097639834019e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,39079,0.0673244845543971,0.00760399605874469,0.0524206522792575,0.0822283168295367,9.41463992377831e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37164,0.0850624344189187,0.00961488303276228,0.0662172636747046,0.103907605163133,1.01715212728907e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38992,0.0907815221443433,0.0102704401840815,0.0706514593835435,0.110911584905143,1.07409517270648e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39516,-0.0639549903521671,0.00723663270212055,-0.0781387904483234,-0.0497711902560108,1.08386471797205e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39455,0.0171918798488098,0.00194715814566979,0.013375449883297,0.0210083098143226,1.16905506598634e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37162,0.0598038491312669,0.00677223118278756,0.0465302760130032,0.0730774222495305,1.17492092764105e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37221,0.0741948129840676,0.0084063688063272,0.0577183301236663,0.0906712958444689,1.22456572130318e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39455,0.0363808036543435,0.0041302480864286,0.0282855174049435,0.0444760899037436,1.40673385143097e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36955,0.0231425069330809,0.00262806620801378,0.0179914971653739,0.0282935167007879,1.46759370969782e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36916,0.0394634181687158,0.00448597095760896,0.0306709150918022,0.0482559212456293,1.58763400591187e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39589,0.0401858047896341,0.00457340421432138,0.0312219325295642,0.0491496770497039,1.70102850226127e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,37255,0.0184999580646067,0.00210634189266929,0.0143715279549749,0.0226283881742385,1.79267533149595e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,37269,0.0234093843263582,0.00267028815769039,0.018175619537285,0.0286431491154313,2.07122540847386e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39541,-0.0466089421192992,0.0053218752968301,-0.0570398177010862,-0.0361780665375122,2.1958955737444e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37243,0.0201092417088134,0.00229741670308166,0.0156063049707733,0.0246121784468534,2.33638637436028e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36847,0.0503704463998587,0.0057647385375046,0.0390715588663497,0.0616693339333678,2.68318048346297e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36955,-0.0161717437799756,0.001851274361454,-0.0198002415284254,-0.0125432460315257,2.73314054593427e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37243,0.0209883966880337,0.00240484425990507,0.0162749019386198,0.0257018914374477,2.92231265347132e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38417,0.0296650427877005,0.00339954903469053,0.023001926679707,0.0363281588956939,2.9293816277022e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,39294,0.0287768670851737,0.00330429089941168,0.0223004569223268,0.0352532772480206,3.38687735374298e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39526,0.0426891049776253,0.00490743461616324,0.0330705331299454,0.0523076768253053,3.69420280289267e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39434,0.0648281159401774,0.00746573916188168,0.0501952671828893,0.0794609646974655,4.23198807015323e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37221,0.0566665808095601,0.00652684380456016,0.0438739669526222,0.069459194666498,4.35403358721896e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,37247,0.0508920655482666,0.00586267995006459,0.03940121284614,0.0623829182503932,4.40652872592605e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39381,0.0211841256884756,0.00244154307517515,0.0163987012611323,0.0259695501158189,4.49622150813989e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,37255,-0.0294910818439269,0.00340125586475889,-0.0361575433388544,-0.0228246203489995,4.8100873101362e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39654,0.0414115529379581,0.00477766910262117,0.0320473214968206,0.0507757843790956,4.84731109766712e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39354,0.0430099030694674,0.00496722582276829,0.0332741404568416,0.0527456656820933,5.25334903425832e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39455,-0.019836541572352,0.00229674191389613,-0.0243381557235884,-0.0153349274211156,6.35530842857136e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39601,0.0542310303662831,0.00628129971889024,0.0419196829172583,0.066542377815308,6.52265250823199e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39428,0.0203151829858386,0.00235317626043046,0.015702957515395,0.0249274084562823,6.5660210118128e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37182,0.0611960898943327,0.00708896074514234,0.0473017268338538,0.0750904529548117,6.70555605825351e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39428,0.0237593520171803,0.00275370212174262,0.0183620958585648,0.0291566081757958,6.85445430997059e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39541,0.0968501100397427,0.0112353313583367,0.0748288605774027,0.118871359502083,7.34367153892173e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39428,0.0567126741084658,0.00658071092690891,0.0438144806917244,0.0696108675252073,7.48559888170006e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39413,0.0236338511687222,0.00274500924076621,0.0182536330568204,0.029014069280624,8.04326126914448e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39386,0.0195272527721027,0.00226939703291162,0.0150792345875959,0.0239752709566095,8.41251751992895e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39455,0.0381612750811046,0.00443834556861893,0.0294621177666115,0.0468604323955977,8.8975752829475e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39428,0.0235588230799959,0.00274017961785198,0.0181880710290061,0.0289295751309858,8.94070928984449e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39470,0.0680301841242183,0.0079161558367134,0.05251451868426,0.0835458495641765,9.23012925772367e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39636,0.0272039736522559,0.00316886104961801,0.0209930059950046,0.0334149413095072,9.97356126060846e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39531,0.0696401530266857,0.00811417200286847,0.0537363759010635,0.0855439301523079,1.01758041611401e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39355,0.0262735306306658,0.00306489186984777,0.0202663425657642,0.0322807186955674,1.11182680630241e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39428,0.0599003386692913,0.00698955674408613,0.0462008074508825,0.0735998698877001,1.13501093931808e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,37081,0.0728189858505857,0.00849853343499148,0.0561618603180024,0.089476111383169,1.17018898441662e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39592,0.0169378333416238,0.00197985702526601,0.0130573135721024,0.0208183531111452,1.28953418240886e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37164,0.0658179923401648,0.00770880981319193,0.0507087251063086,0.080927259574021,1.51950922105525e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39526,0.0221556201158727,0.00259656845660328,0.0170663459409303,0.0272448942908152,1.56501359250129e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,37203,0.0670134186829052,0.00785295508958369,0.0516216267073211,0.0824052106584892,1.57887286607618e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39187,0.0353377241463345,0.004146573736627,0.0272104396225455,0.0434650086701234,1.71649234019488e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39435,0.0484886776316017,0.00568986226971678,0.0373365475829568,0.0596408076802466,1.71696476928507e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36916,0.0551991333213726,0.00647888586179194,0.0425005170322604,0.0678977496104848,1.7800962107634e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39636,0.0391672278972205,0.00460270549979037,0.0301459251176314,0.0481885306768097,1.90654690033397e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39428,0.0397596813926288,0.00467477831273582,0.0305971158996666,0.048922246885591,1.98337933878637e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39455,0.019120450697137,0.00225227859654332,0.014705984647912,0.0235349167463619,2.26999218565004e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39654,0.0225500026404965,0.00265969622201222,0.0173369980453526,0.0277630072356405,2.4905038915565e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39428,0.0738139912512162,0.00870741043872869,0.0567474667913079,0.0908805157111244,2.52092676621878e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37162,0.0491391576131882,0.00579771305768922,0.0377756400201173,0.0605026752062591,2.59459864388166e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39455,0.0872023686414567,0.0102966571118826,0.0670209207021667,0.107383816580747,2.70232214460285e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39531,0.0185601271834517,0.00219232255037416,0.0142631749847183,0.022857079382185,2.77201126530614e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37255,-0.0185674534480884,0.00219319697320229,-0.0228661195155649,-0.0142687873806119,2.81602163930663e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,37247,0.0310560194863062,0.00367055170793109,0.0238617381387613,0.0382503008338511,2.9407242579372e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39428,0.0677307819648035,0.00800924768371809,0.052032656504716,0.0834289074248909,3.00521163963668e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39428,0.0552718192489527,0.00654655664384921,0.0424405682270082,0.0681030702708971,3.37714295579869e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36954,-0.0151157583876747,0.0017915408709898,-0.0186271784948147,-0.0116043382805347,3.60280679499065e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39541,0.0849922237645693,0.0100760695723334,0.0652431274027958,0.104741320126343,3.60751978037298e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37125,0.0776250148719516,0.00920514172628571,0.0595829370884317,0.0956670926554716,3.7383040665856e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39477,-0.0273994834180429,0.00325206339305532,-0.0337735276684313,-0.0210254391676545,3.9224059553754e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37269,0.0126894021808979,0.00150661281025994,0.0097364410727884,0.0156423632890073,4.07614188648706e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36916,0.0231867018794938,0.00275973297979682,0.017777625239092,0.0285957785198956,4.87118987623845e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39485,0.061808450768075,0.00736480002482449,0.047373442719419,0.0762434588167311,5.18286369444487e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39428,0.0827227684586156,0.0098610938154987,0.0633950245802381,0.102050512336993,5.34550690988252e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39485,0.086001291729742,0.010254168164465,0.0659031221273907,0.106099461332093,5.42781636179294e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37247,0.0640902760720579,0.00764961019914703,0.0490970400817297,0.0790835120623861,5.92943386412511e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39531,-0.0226161983887466,0.00270006157416649,-0.0279083190741129,-0.0173240777033803,5.94449659021184e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,37224,0.0400648761272293,0.00478830583908009,0.0306797966826323,0.0494499555718263,6.50798956456234e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39477,0.018218418584289,0.0021785065886013,0.0139485456706304,0.0224882914979475,6.65756281624049e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37709,-0.0223286897740535,0.00267070991363784,-0.0275632812047836,-0.0170940983433233,6.8589929687708e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39434,0.0648668432878417,0.0077672449018687,0.049643043280179,0.0800906432955043,7.3355117907466e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39485,0.045205340215809,0.00541460981991482,0.034592704968776,0.0558179754628421,7.49343118057677e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36916,-0.0261471490285247,0.0031342327927683,-0.0322902453023506,-0.0200040527546989,8.03912223855071e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39462,-0.0338196845505634,0.0040556244153644,-0.0417687084046776,-0.0258706606964492,8.14000716502405e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39601,-0.0321827830849549,0.00386341003189218,-0.0397550667474635,-0.0246104994224462,8.75955505022327e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39485,0.0561406137856154,0.00674599301682816,0.0429184674726322,0.0693627600985986,9.38102469866696e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39428,0.0212761579349277,0.00255759694656686,0.0162632679196567,0.0262890479501988,9.644425948347e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39428,0.0245448079478687,0.00295250364098294,0.0187579008115422,0.0303317150841953,1.01077203748529e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39636,0.0322279257161402,0.0038789805802334,0.0246251237788827,0.0398307276533977,1.05174272391343e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39568,0.082983993284729,0.00999164040331179,0.0634003780942379,0.10256760847522,1.07899037593208e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36916,0.0509447395900663,0.0061378509231054,0.0389145517807797,0.0629749273993529,1.14692435143752e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39355,0.0666806405641368,0.00803591913962273,0.0509302390504763,0.0824310420777974,1.15048222070757e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39531,0.0392693623502465,0.00473574778013899,0.0299872967011741,0.048551427999319,1.20567798255194e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37221,0.0675237776706589,0.00814217539419331,0.05156511389804,0.0834824414432778,1.21335817855404e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39601,0.0397282540022871,0.00479397981232699,0.0303320535701262,0.049124454434448,1.25674558551643e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39531,0.0151096018191868,0.00182332654049694,0.0115358817998128,0.0186833218385608,1.26016630019691e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37221,0.0591717395726844,0.00714026945371292,0.0451768114434071,0.0731666677019617,1.27624249822568e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39355,0.0558049310393852,0.00673624378811511,0.0426018932146796,0.0690079688640909,1.28857553142842e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39485,0.0248204539412345,0.00299928779843143,0.0189418498563088,0.0306990580261601,1.3863278718316e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39492,-0.0260690378398251,0.00315030677319666,-0.0322436391152905,-0.0198944365643596,1.39056965386126e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39462,0.0577336244227556,0.00698258836720542,0.044047751223033,0.0714194976224782,1.47270023451881e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37184,0.0585714151167421,0.00708936838073804,0.0446762530904955,0.0724665771429886,1.57517795176584e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39485,0.0540959792384418,0.00655291273962786,0.0412522702687712,0.0669396882081124,1.64076731156163e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39194,0.0266411799079618,0.00322950854243709,0.0203113431647851,0.0329710166511385,1.72696992358798e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,39231,0.0293048541116194,0.00355700760290135,0.0223331192099328,0.036276589013306,1.8870295926878e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,39194,0.0342097365836547,0.00415437480699523,0.0260671619619441,0.0423523112053654,1.95118965982741e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39564,0.0194804197645698,0.00236982029476873,0.0148355719868231,0.0241252675423165,2.19523628056476e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37221,0.0364246016440818,0.00443218938326102,0.0277375104528902,0.0451116928352734,2.26407270388519e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39636,0.0534005216942302,0.00649974007016283,0.040661031156711,0.0661400122317493,2.2763552035812e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36955,0.0497725914053823,0.00605781637344021,0.0378992713134395,0.0616459114973251,2.30519085578241e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39485,0.0168949169690296,0.00205775778290683,0.0128617117145322,0.020928122223527,2.38327135552818e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37164,0.0326502464813206,0.0039782259361529,0.0248529236464609,0.0404475693161803,2.48031916208559e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37164,0.0536437417621371,0.00653993491627915,0.0408254693262299,0.0664620141980442,2.57979118053378e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39623,0.0264821720919977,0.00322943655596896,0.0201524764422985,0.0328118677416968,2.58966733738642e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39428,0.0509813318970341,0.00621728015058181,0.0387954628018937,0.0631672009921744,2.59877689704962e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39462,0.0233920682054068,0.00285285751739206,0.0178004674713184,0.0289836689394953,2.60735701990375e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39497,0.0186902381271053,0.00228190670183003,0.0142177009915184,0.0231627752626921,2.80614324841856e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37190,0.075386234952655,0.00920322273529081,0.057347918391485,0.093424551513825,2.82973834471377e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39482,-0.0251476189980948,0.00307071183533212,-0.0311662141953458,-0.0191290238008439,2.83236804395806e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36916,0.0714081240681467,0.00871825325878799,0.0543203476809222,0.0884959004553711,2.85042101410523e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39601,0.040301913463259,0.00492233586611279,0.0306541351656779,0.0499496917608401,2.87667105094757e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36916,0.0447219733140157,0.00546381548080219,0.0340128949716434,0.0554310516563879,2.98362681681307e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36847,0.0588159851083127,0.0071864511279612,0.0447305408975087,0.0729014293191166,3.00568597868352e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39431,0.0471827506462181,0.00577094355829109,0.0358717012719675,0.0584938000204686,3.16991292531331e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,37203,0.0190568705305092,0.00233064489299345,0.014488806540242,0.0236249345207764,3.19303028656119e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37247,0.0207184923879831,0.00253556193050784,0.0157487910041877,0.0256881937717784,3.33986602652845e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39418,0.0198527263588689,0.00243132186738341,0.0150873354987974,0.0246181172189404,3.45741619803846e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39462,0.0213100329360831,0.00260989590748782,0.016194636957407,0.0264254289147593,3.46564404410838e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37247,0.0676233680714954,0.00829468368048609,0.0513657880577426,0.0838809480852481,3.89126126134527e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,37162,0.0263452869537409,0.00323370554648479,0.0200072240826307,0.0326833498248511,4.07465660520934e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39428,0.0785553291163393,0.00965402224706304,0.0596334455120958,0.0974772127205829,4.36614979745838e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36916,0.0207782771469131,0.00256835745902685,0.0157442965272205,0.0258122577666057,6.51124073413071e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39636,0.0684882859060734,0.00846943648141693,0.0518881904024962,0.0850883814096506,6.59980716486424e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39462,0.029637062318579,0.00366548614082993,0.0224527094825524,0.0368214151546057,6.66407892757359e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39437,0.0788938071879468,0.00976014758756431,0.0597639179163208,0.0980236964595729,6.78457167155694e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39541,0.0859408636980543,0.0106330983928769,0.0650999908480155,0.106781736548093,6.82941663309344e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,37247,0.0319508694324728,0.00395276582057683,0.0242034484241422,0.0396982904408033,6.87494687386417e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39589,0.028326141442349,0.00351108265612446,0.021444419436345,0.0352078634483529,7.70142721982719e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39526,0.0755990428002971,0.0093763241411483,0.0572214474836464,0.0939766381169478,8.01620347044827e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,37221,0.0522596292725069,0.0064886592346998,0.0395418571724953,0.0649774013725185,8.7210574939386e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,37164,0.0757616219127804,0.00940958220162098,0.0573188407976032,0.0942044030279575,8.9003227660339e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,37164,0.070179947399309,0.00872013118064608,0.0530884902852427,0.0872714045133753,9.15728916533435e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36955,-0.0366617759114192,0.00455927427140751,-0.0455979534833779,-0.0277255983394605,9.6985175851498e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36955,0.0310744720678816,0.00386633766551429,0.0234964502434736,0.0386524938922896,1.00151721367858e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39462,0.0292270207505728,0.00364051898493601,0.0220916035400983,0.0363624379610474,1.06155048343209e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39123,0.040082191350855,0.00499360033563842,0.0302947346930037,0.0498696480087063,1.07670046876257e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39589,0.0397075610150548,0.00495001011366174,0.0300055411922777,0.0494095808378318,1.11875144464711e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36880,0.0341618882076636,0.00425840882050089,0.0258154069194818,0.0425083694958453,1.13132122355104e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37164,0.100300714587604,0.0125039142967426,0.0757930425659887,0.12480838660922,1.13534769481097e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37164,0.0521352811740143,0.00650237717590208,0.0393906219092463,0.0648799404387824,1.1695573329488e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36880,0.0603751439959567,0.00753159820099752,0.0456132115220016,0.0751370764699118,1.1873904468227e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39319,0.0648974207044581,0.0080986020325191,0.0490241607207207,0.0807706806881955,1.19813889775026e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39428,0.0608389946916082,0.00760151641270194,0.0459400225227124,0.075737966860504,1.29719112740327e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36955,0.0805989490386785,0.0100723467887625,0.0608571493327039,0.100340748744653,1.33170145031093e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39524,0.0348236277702217,0.00435379313400548,0.0262901932275709,0.0433570623128724,1.35095958467626e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39623,0.0346424669551715,0.00433474484120966,0.0261463670664005,0.0431385668439424,1.42485233998336e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36916,0.0606515446663802,0.00758813655812206,0.045778797012461,0.0755242923202995,1.43318537535514e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39355,-0.0405696526285595,0.00508243936942397,-0.0505312337926305,-0.0306080714644886,1.54026758377635e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39601,0.0247142944294534,0.00309932031960442,0.0186396266030288,0.0307889622558781,1.64395641209588e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39636,0.0239151341681169,0.0029993568410181,0.0180363947597214,0.0297938735765124,1.65274052209766e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39636,0.0279571480612249,0.00351738718005192,0.0210630691883232,0.0348512269341267,2.02357570451078e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36916,0.0585339274749883,0.0073697994849865,0.0440891204844147,0.0729787344655618,2.1525675590142e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39654,0.0454590944135154,0.00572962122037481,0.0342290368215808,0.05668915200545,2.26821852678036e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39566,0.0207360546840613,0.0026138453389708,0.0156129178196786,0.0258591915484441,2.28532939798249e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39355,0.0277484767769751,0.00350393289618814,0.0208807683004464,0.0346161852535039,2.55755706199755e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39462,0.0749858623904078,0.00947339691685406,0.0564180044333739,0.0935537203474418,2.63578054185881e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39448,0.0690909925709833,0.00873630499968431,0.0519678347716021,0.0862141503703646,2.78607703094343e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37247,0.0548023596660566,0.00693329704477455,0.0412130974582984,0.0683916218738147,2.91597788758719e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39482,0.0265990580325807,0.00336792236884959,0.0199979301896355,0.0332001858755259,3.0350218719373e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37164,0.0431353695694752,0.00546367970374706,0.032426557350131,0.0538441817888195,3.14225667184506e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39455,0.0254444718236378,0.00322374605628294,0.0191259295533232,0.0317630140939524,3.15743514963607e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39462,0.035684387557939,0.004525056642423,0.0268152765387899,0.0445534985770881,3.33534787415768e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39187,0.0647964331149002,0.00822382568525138,0.0486777347718075,0.0809151314579929,3.52670296777415e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39182,0.0277487377867576,0.00352254090565472,0.0208445576116743,0.0346529179618408,3.57296952140087e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,39104,0.0264233560138653,0.00335794049729068,0.0198417926391756,0.0330049193885551,3.82637927147711e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39636,0.0294052050531003,0.00374604185717821,0.022062963013031,0.0367474470931695,4.44847882080475e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37162,0.029485775627254,0.00375876232165859,0.0221186014768032,0.0368529497777048,4.69143163564822e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36955,0.0379223114549846,0.00483656513553169,0.0284426437893425,0.0474019791206267,4.84067972545836e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39281,0.0772980394421358,0.00986076273841428,0.0579709444748438,0.0966251344094278,4.85096639318719e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39206,-0.0198826058094537,0.00254013049515379,-0.0248612615799552,-0.0149039500389523,5.31790531902402e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,39355,0.0347057364590894,0.00444078137939153,0.026001804955482,0.0434096679626968,5.85135783903152e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,37269,0.0124164107871059,0.00158859242385065,0.0093027696363586,0.0155300519378532,5.87788227725451e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36928,0.0679944621213574,0.00870448181083706,0.0509336777721168,0.0850552464705981,6.10549298781618e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36955,0.0558444378736315,0.00715257829549244,0.0418253844144664,0.0698634913327967,6.29218524111444e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37203,0.0353035446497512,0.00452394296635274,0.0264366164356998,0.0441704728638025,6.47844460096759e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39552,0.0395648943688703,0.00507143931061106,0.0296248733200726,0.049504915417668,6.51581210609643e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39433,0.0443789373749212,0.00568976516120868,0.0332269976589522,0.0555308770908902,6.60860980320774e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39601,-0.0229106555684115,0.00293799527281239,-0.0286691263031238,-0.0171521848336992,6.69454653850878e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,39355,0.0638027033208946,0.0081955906968564,0.047739345555056,0.0798660610867331,7.42788389294604e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37243,0.0310623678817188,0.00399248017129706,0.0232371067459765,0.038887629017461,7.79393789375377e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,39355,0.0588597211557271,0.00756905076846579,0.0440243816495341,0.07369506066192,7.95050045968567e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37221,0.0495158497523579,0.00636760811533356,0.0370353378463041,0.0619963616584116,8.04468493585556e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36775,0.0362095904241952,0.00465739460766923,0.0270810969931635,0.0453380838552269,8.16586550127229e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36880,0.0524450294910812,0.00674647461358767,0.0392219392484494,0.065668119733713,8.22185979607391e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39654,0.0376847473067682,0.00485065312306869,0.0281774671855535,0.0471920274279828,8.4141274720025e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37221,0.0562518933993907,0.00724428391517891,0.04205309692564,0.0704506898731414,8.7851291392215e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39462,0.0350313001428047,0.00451743261253501,0.0261771322222361,0.0438854680633733,9.42274272872669e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39541,0.0285892520942515,0.00368734088342304,0.0213620639627423,0.0358164402257607,9.51929040839295e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37255,0.0399348984846311,0.00515187083295553,0.0298372316520382,0.0500325653172239,9.76262179882776e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39541,0.072795183634223,0.00940452457224594,0.054362315472621,0.0912280517958251,1.0533283242699e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37144,0.0576666461000127,0.00745380371100988,0.0430571908264333,0.0722761013735921,1.09860774203608e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39460,0.0402079570823683,0.00520348195204704,0.0300091324563561,0.0504067817083805,1.1694479463007e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39355,0.0268314009759155,0.0034750794596922,0.0200202452349188,0.0336425567169122,1.2264796608187e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39428,0.0500342485714592,0.00649183801494179,0.0373102460621733,0.0627582510807451,1.36599805499919e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39455,-0.0300506061561448,0.0039049367478997,-0.0377042821820282,-0.0223969301302614,1.49644065276838e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39455,-0.0159149620516828,0.00207072794560776,-0.019973588825074,-0.0118563352782916,1.61581579373364e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39123,0.0495664894220489,0.00644936764115081,0.0369257288453933,0.0622072499987045,1.62057523293538e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39462,0.0318369226736389,0.00414343350214668,0.0237157930094314,0.0399580523378464,1.64084373315287e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39485,0.0827519986878993,0.0107771773909855,0.0616287310015677,0.103875266374231,1.70916161333471e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39589,0.0394088809972133,0.00514051114400012,0.0293334791549731,0.0494842828394535,1.87703676149909e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,37247,0.0421850686087411,0.00550599655728471,0.0313933153564631,0.0529768218610192,1.96735574061321e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39187,0.0223527704175165,0.00291979117640669,0.0166299797117594,0.0280755611232736,2.04319789382841e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36880,0.0500384692062276,0.0065397807148057,0.0372204990052085,0.0628564394072468,2.13446385177218e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39123,0.0498627516398503,0.00651926401321115,0.0370849941739564,0.0626405091057441,2.15898977061789e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38859,-0.024303784055034,0.00317846395939261,-0.0305335734154435,-0.0180739946946245,2.19733542055491e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36992,0.0726789226076521,0.00951007632300385,0.0540391730145645,0.0913186722007396,2.28857305751889e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39541,0.0171451938555631,0.00224486281546871,0.0127452627372444,0.0215451249738818,2.3469587898708e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39654,0.0223046283530901,0.00292339324118631,0.016574777600365,0.0280344791058153,2.49212656451062e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37221,0.0372031334420179,0.00487685472242422,0.0276444981860664,0.0467617686979693,2.54285091847267e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39194,0.0430078337080974,0.0056433467891906,0.0319468740012838,0.0540687934149109,2.67058719542874e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39520,-0.0415455152195164,0.00545179489819805,-0.0522310332199846,-0.0308599972190482,2.67666546223006e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,37243,0.0156941843713272,0.00205948547709925,0.0116575928362127,0.0197307759064418,2.70591891226916e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39617,-0.0412646321077184,0.0054170852801852,-0.0518821192568814,-0.0306471449585554,2.73883685104089e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39455,0.0501520657047774,0.00658580508797044,0.0372438877323553,0.0630602436771995,2.79003486805123e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39428,0.0890461398101842,0.0117043362701272,0.0661056407207349,0.111986638899633,2.94991105370494e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39428,0.0318767745182416,0.00419127422489951,0.0236618770374385,0.0400916719990446,3.00617476037846e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36852,0.0276884310231409,0.00364023233696552,0.0205535756426885,0.0348232864035933,3.02551819303254e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39495,0.0688140999031264,0.00905171423226603,0.051072740007885,0.0865554597983678,3.07994906965385e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39187,0.0471181920716976,0.00620671607572171,0.034953028563283,0.0592833555801121,3.35192375317041e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,39194,0.0550455965857162,0.00725419128730136,0.0408273816626056,0.0692638115088269,3.43994924762283e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,39274,0.0300668867379746,0.00396293687551995,0.0222995304619555,0.0378342430139937,3.46774912592533e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39654,0.0462121079972385,0.0060994211920671,0.034257242460787,0.05816697353369,3.75494216450064e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39485,0.0370740051085144,0.00489551107838496,0.0274788033948799,0.0466692068221489,3.85699912236183e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37162,0.0371565337301303,0.00490685862365109,0.0275390908277742,0.0467739766324865,3.91767677203153e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37162,0.0606332433766098,0.00801611643187342,0.0449216551701379,0.0763448315830817,4.17967511152289e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39531,0.0467001462714903,0.00617903665365996,0.0345892344303168,0.0588110581126638,4.33363638935642e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39440,-0.0158252956885125,0.00209390609118007,-0.0199293516272254,-0.0117212397497995,4.3367407105038e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,37197,0.0540392255877628,0.00715000467176571,0.040025216431102,0.0680532347444236,4.37494186054782e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39462,0.0668733707250421,0.00885115765921003,0.0495251017129904,0.0842216397370937,4.41888979042249e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39455,-0.0276918364687313,0.00366522248015034,-0.034875672529826,-0.0205080004076367,4.42001775526963e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39187,0.070872739177471,0.00938426798702217,0.0524795739229075,0.0892659044320344,4.52733304310304e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39462,0.0518507789876326,0.0068856585526581,0.0383548882244227,0.0653466697508425,5.35193460731137e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36916,-0.0231181802614635,0.00307332895149199,-0.0291419050063879,-0.0170944555165392,5.75547140611033e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36955,0.0405585635467257,0.005393032715984,0.0299882194233971,0.0511289076700543,5.82690534720737e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37221,0.0303149136250131,0.00403124708616416,0.0224136693361314,0.0382161579138948,5.8439846954271e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39495,0.0590955026494985,0.00787020125284102,0.0436699081939301,0.0745210971050669,6.303377015452e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39428,0.0573198882738217,0.00763508452177187,0.0423551226111488,0.0722846539364945,6.36918184757903e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37203,0.0615755994827341,0.00820126766732982,0.0455011148547676,0.0776500841107005,6.39965270644434e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39564,0.0445097237353322,0.00593011529536817,0.0328866977564106,0.0561327497142538,6.45007417785169e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39531,-0.0286311804284116,0.00381531555573294,-0.0361091989176482,-0.0211531619391751,6.52156765897843e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37243,0.0336852657298096,0.00449414363389537,0.0248767442073747,0.0424937872522445,7.04591809400512e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37247,-0.0209508975410665,0.00279530951327367,-0.0264297041870829,-0.0154720908950501,7.06453975279084e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37247,0.04906898852551,0.00655210615506754,0.0362268604615777,0.0619111165894424,7.39238516822697e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39355,0.0603185470174293,0.00805720479803828,0.0445264256132743,0.0761106684215844,7.48119430118863e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39187,0.0313712195865876,0.00419239027628404,0.0231541346450709,0.0395883045281043,7.68087121825974e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38998,0.0566067167671603,0.00756992138377684,0.0417696708549577,0.0714437626793629,7.98619554024164e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39355,0.0514930471589835,0.00689246989677175,0.0379838061613108,0.0650022881566561,8.40573172947043e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,39104,0.0318741059240811,0.00426749536223906,0.0235098150140926,0.0402383968340697,8.53349205020023e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39516,0.0554264234648264,0.00742382854579714,0.040875719515064,0.0699771274145888,8.71819217180334e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39509,-0.0245936426769507,0.00330166409878362,-0.0310649043105666,-0.0181223810433348,9.92544464179787e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39247,0.0131506154069695,0.00176594061020196,0.00968937181097369,0.0166118590029654,1.00902435263169e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36861,0.043490749458679,0.00584443476861723,0.0320356573121892,0.0549458416051688,1.06190865241351e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39462,0.0343076355795274,0.00461150107058921,0.0252690934811725,0.0433461776778822,1.06473270712308e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37203,0.0515574214014195,0.00693458954559985,0.0379656258920438,0.0651492169107952,1.11395065526146e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,39312,0.0653664006844525,0.00880655364646794,0.0481055555373753,0.0826272458315296,1.21183516010643e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39589,0.021530416835402,0.00290139922312413,0.0158436743580787,0.0272171593127253,1.22690995258862e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,37269,-0.0174504922334246,0.0023533774165264,-0.0220631119698164,-0.0128378724970329,1.29182659265333e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,39095,0.0695246845075057,0.00937920238176177,0.0511414478392527,0.0879079211757588,1.30581062791933e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39428,0.0322393147733747,0.00434977653292792,0.023713752768836,0.0407648767779135,1.31337744857621e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,37243,-0.0151114081447641,0.00203960768670217,-0.0191090392107004,-0.0111137770788279,1.35261819714259e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39476,-0.0338472075802289,0.00457171319434017,-0.0428077654411356,-0.0248866497193221,1.39554643852732e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,37247,0.0575374515914676,0.00777837556645213,0.0422918354812214,0.0727830677017137,1.47859953444561e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37164,0.0409318499730672,0.00553348855644334,0.0300862124024383,0.0517774875436962,1.47906006077683e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,37145,0.0289052017544464,0.00390881041236196,0.021243933346217,0.0365664701626759,1.50412548861416e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39194,0.0579153116362632,0.0078401532738681,0.0425486112194817,0.0732820120530447,1.58211771298942e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39622,-0.0340102231636505,0.0046131155805871,-0.0430519297016013,-0.0249685166256998,1.76095927679911e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36955,-0.0201740556847675,0.00273596076487257,-0.0255365387839177,-0.0148115725856172,1.76458494567414e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39428,0.0336285142650947,0.00456148521644625,0.0246880032408601,0.0425690252893294,1.76518016200128e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39387,0.0417523055789186,0.00567395706767217,0.0306313497262812,0.0528732614315561,1.9554508503963e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39355,0.0487255502061981,0.00662338255686332,0.0357437203947459,0.0617073800176502,1.98493019222911e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36955,-0.0204361726270153,0.00277831740587731,-0.0258816747425348,-0.0149906705114957,2.01937125066141e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39123,0.0311388311227264,0.00423422582355174,0.022839748508565,0.0394379137368878,2.02417217536598e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39389,0.0151842075271446,0.00206574647689219,0.0111353444324359,0.0192330706218532,2.07748071157461e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39485,0.044818957718303,0.00609801512504737,0.0328668480732102,0.0567710673633959,2.08780789600404e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37162,0.0319232506588382,0.00434325868828996,0.0234104636297898,0.0404360376878865,2.10217661716555e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39462,0.0517348897020357,0.00704274788204324,0.037931103853231,0.0655386755508405,2.14991267258709e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,39280,0.0224766041909408,0.00306221879062186,0.0164746553613219,0.0284785530205596,2.24728504066916e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39531,0.0439827324897396,0.0059926041864505,0.0322372282842966,0.0557282366951826,2.25328342501824e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36899,0.0353228084427974,0.00481219954565149,0.0258908973333205,0.0447547195522743,2.26420918213452e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39462,0.0448949550531618,0.00611829580969384,0.0329030952661618,0.0568868148401617,2.28219398790904e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39462,0.0760500538608161,0.010372447004421,0.055720057732151,0.0963800499894812,2.38443275502569e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37221,0.0480175941001098,0.0065531813634387,0.0351733586277699,0.0608618295724496,2.48816349544441e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39455,0.0217510676157626,0.00296920180559787,0.0159314320767907,0.0275707031547344,2.50010619402452e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39559,-0.0263802655477766,0.00360583864273023,-0.0334477092875278,-0.0193128218080253,2.68342769587284e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37269,0.0159499729101024,0.00218073992716053,0.0116757226528678,0.0202242231673371,2.74676614503872e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37221,0.0445739276187078,0.00609503447200905,0.03262766005357,0.0565201951838455,2.76502804048076e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36955,0.0183818610242738,0.00251453448212178,0.0134533734393152,0.0233103486092325,2.82879179481733e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39462,0.0518299375468597,0.00709296438440296,0.0379277273534299,0.0657321477402894,2.86435043579095e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39531,0.0382531603519396,0.00523557829053539,0.0279914269024903,0.048514893801389,2.88170877083314e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,37255,0.0514698666291592,0.00704569233577947,0.0376603096510315,0.065279423607287,2.93346197833392e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37221,0.0371970051096958,0.00509216667551009,0.0272163584256961,0.0471776517936956,2.9426963609556e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39104,0.0489520990693427,0.0067047314131854,0.0358108254994993,0.0620933726391861,3.00047599401393e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37203,0.0290455492616112,0.00398426471241523,0.0212363904252774,0.036854708097945,3.28070635275761e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36955,0.0314965086122994,0.00432594439340231,0.0230176576012308,0.0399753596233679,3.51603790214287e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,37269,0.0258382373780161,0.00355089605826817,0.0188784811038105,0.0327979936522217,3.62426311456756e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39531,0.0424022320183016,0.00583644934817479,0.030962791295879,0.0538416727407242,3.91095656784353e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36916,0.0520461858368648,0.00717488102993912,0.0379834190181841,0.0661089526555454,4.28752963919246e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39601,-0.0210740300533744,0.00290923388443986,-0.0267761284668765,-0.0153719316398722,4.57161039314971e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36880,0.0276264542080118,0.00381483631273001,0.020149375035061,0.0351035333809626,4.68704738828437e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37203,0.0647997020789862,0.00895347558052108,0.0472508899411649,0.0823485142168075,4.83627970219912e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37181,0.0366598870096888,0.00506600626887607,0.0267305147226917,0.0465892592966859,4.86996069487606e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39462,0.0329401019126305,0.00455362406586423,0.0240149987435366,0.0418652050817244,4.92299508674141e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,37164,0.0439823765579971,0.00608069168204746,0.0320642208611841,0.0559005322548101,4.99067126972822e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,37146,0.0544407099612224,0.0075328740220955,0.0396762768779152,0.0692051430445295,5.21699375502221e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,39085,0.0424594170332599,0.00587602614616831,0.03094240578677,0.0539764282797498,5.22496997388916e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39601,0.0175018754875379,0.00242432940862909,0.0127501898466249,0.0222535611284509,5.47533450904072e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39601,-0.015434139741301,0.00213945681209792,-0.019627475093013,-0.0112408043895891,5.68869480160474e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,39306,0.0355756088136686,0.00493185061787318,0.0259091816026371,0.0452420360247,5.7192307830051e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39307,0.0266469340528221,0.00369563525526663,0.0194034889524995,0.0338903791531447,5.84877279301248e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39423,0.0174326221617742,0.00241855469414566,0.0126922549612488,0.0221729893622997,5.95511682122195e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39578,0.016053120642463,0.00222743914558058,0.0116873399171251,0.020418901367801,5.99083449650197e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39355,0.0616044165404237,0.00855601070590444,0.044834635556851,0.0783741975239964,6.30297191732407e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37221,0.0378186714803527,0.00525365141574192,0.0275215147054986,0.0481158282552069,6.42611197681546e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,37203,0.028117122171542,0.00391273328139538,0.0204481649400071,0.035786079403077,7.03999955604764e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39485,0.0466090134015706,0.00649250411496994,0.0338837053362295,0.0593343214669116,7.35674480035634e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39462,0.0611531509164099,0.00852320088333511,0.044447677185073,0.0778586246477467,7.57439648215326e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39453,0.05523124873265,0.00770019159382658,0.0401388732087499,0.0703236242565501,7.6965779790984e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39462,0.0722859539940827,0.0100814835987365,0.0525262461405591,0.0920456618476062,7.84006561408563e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39043,0.0350434284176234,0.00489122310292153,0.0254566311358972,0.0446302256993496,8.17781585337377e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38827,0.0137616978625969,0.00192214408254144,0.00999429546081564,0.0175291002643781,8.48637057170675e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,37164,0.0409744987593029,0.00572709504420516,0.0297493924726607,0.052199605045945,8.8583536748244e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,37247,0.0318044676309622,0.00444904646259972,0.0230843365642668,0.0405245986976577,9.24245457088453e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39530,0.0353893478439439,0.00495208596924022,0.025683259344233,0.0450954363436547,9.31999089377669e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,37164,0.0358733501812917,0.00501929761761592,0.0260355268507645,0.0457111735118189,9.34796685125122e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39414,0.0533475679301007,0.00746729107545123,0.0387116774222163,0.0679834584379851,9.47224056658522e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36955,0.0381674456100205,0.00534174048567405,0.0276976342580994,0.0486372569619417,9.48968832734387e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39187,0.0297958653521463,0.00417393701841297,0.0216149487960569,0.0379767819082357,9.87266941269122e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39436,0.0208730574774025,0.00292816637383907,0.015133851384678,0.0266122635701271,1.06202148808305e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36847,0.0576310136830914,0.00809036369677227,0.0417739008374178,0.0734881265287651,1.11107047624511e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39582,0.0370822163841442,0.00520928725718855,0.0268720133600547,0.0472924194082338,1.14029900146368e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37164,0.0349762617591309,0.00491265943780212,0.0253474492610388,0.0446050742572231,1.14044844116133e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39608,0.0193909347095729,0.00272801905849987,0.0140440173549131,0.0247378520642326,1.22934091168114e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,37247,0.0432430795719214,0.00608295041528841,0.0313204967579561,0.0551656623858866,1.2318187551271e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37057,0.0253160657670563,0.00356580226754501,0.0183270933226681,0.0323050382114445,1.31748655483791e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37247,0.038882819173614,0.0054808905583893,0.028140273679171,0.0496253646680571,1.3689975010537e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37255,-0.0198773094822167,0.00280370715644218,-0.0253725755088434,-0.01438204345559,1.41504511301767e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39123,0.0472941142505369,0.00667995134667763,0.0342014096110487,0.060386818890025,1.50691145724039e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37019,0.0335195541602197,0.00473792093801051,0.024233229121719,0.0428058791987203,1.57671013200754e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,37193,0.0385082260169861,0.0054449663672846,0.0278360919371083,0.0491803600968639,1.60388517305464e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,37203,0.0450563315656573,0.00637281432934922,0.0325656154801328,0.0575470476511817,1.62909255026549e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36916,0.0368612769259804,0.00522005402109117,0.0266299710446417,0.0470925828073191,1.734900021684e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39499,0.0201039360349207,0.00284820120303244,0.0145214616769771,0.0256864103928642,1.7570848312603e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37221,0.0480623164078962,0.00681266081126088,0.0347095012178249,0.0614151315979676,1.81697701049018e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37162,0.0495189550556673,0.00702485832694694,0.0357502327348513,0.0632876773764834,1.89377189188706e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39636,0.0562376594310953,0.00798626595761099,0.0405845781541777,0.0718907407080128,1.97919761488595e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39541,0.0552019330178581,0.00784154644330556,0.0398325019889791,0.070571364046737,2.01000550682842e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37162,0.0420333101951238,0.00597147841422663,0.0303292125032396,0.053737407887008,2.0355232866014e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,37247,0.0384126311739628,0.00545758303022221,0.0277157684347272,0.0491094939131983,2.04383033341906e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36955,0.0351574179891382,0.00499654205733594,0.0253641955567597,0.0449506404215166,2.07633993140868e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37143,0.0420891312135068,0.00598714573250911,0.0303543255777889,0.0538239368492246,2.17234646036205e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36955,0.0497837141883074,0.00708194635693042,0.0359030993287238,0.063664329047891,2.17786277733446e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39532,0.0400270503944417,0.00569603859656085,0.0288628147451824,0.0511912860437009,2.19790796802035e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36955,0.0532409830925029,0.00758136316010648,0.0383815112986941,0.0681004548863116,2.29024900398166e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37247,0.0332054473291835,0.00473253237489218,0.0239296838743949,0.0424812107839722,2.39084742395536e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36861,0.0782001830695837,0.011152018673045,0.0563422264704155,0.100058139668752,2.46761751908285e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39390,0.05062186541804,0.00722943605149847,0.036452170757103,0.0647915600789769,2.62745484754639e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36955,0.0562283658331144,0.00803455227017555,0.0404806433835703,0.0719760882826584,2.72270909773354e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37221,0.0701419482680541,0.0100261388150877,0.0504907161904823,0.089793180345626,2.76691219243921e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37243,0.0430591736449117,0.00615762863038203,0.0309902215293629,0.0551281257604604,2.82810799309077e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37247,0.0534007004790316,0.00763865238768429,0.0384289417991704,0.0683724591588928,2.86778995644139e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37164,0.0303834036601201,0.00434660594496032,0.0218640560079978,0.0389027513122423,2.88317555544908e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39355,0.026656456007357,0.00381645207959908,0.0191762099313428,0.0341367020833712,2.97724576577746e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37229,-0.0287883478328056,0.00412204518065414,-0.0368675563868877,-0.0207091392787235,3.01103534353004e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37164,0.0502947134675572,0.00720866708491397,0.0361657259811258,0.0644237009539886,3.16545234584897e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37255,-0.029466059637991,0.00422629696942675,-0.0377496016980674,-0.0211825175779146,3.27623572171932e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37164,0.0579032723818942,0.00830500730428838,0.0416254580654889,0.0741810866982994,3.27697027014737e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39462,0.050089138109217,0.00718620459792275,0.0360041770972884,0.0641740991211456,3.29727748920932e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39104,0.0504769754643924,0.0072441903442568,0.0362783623896491,0.0646755885391358,3.35370044869248e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39428,0.054318954259247,0.00780549145571271,0.0390201910060501,0.0696177175124439,3.56745357080402e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37203,0.0537087998323004,0.00771945855860101,0.0385786610574424,0.0688389386071584,3.63065426233809e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39601,0.0210768535523298,0.0030302372902644,0.0151375884634116,0.027016118641248,3.65663697700007e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37247,0.0166389100491806,0.00239682662215759,0.0119411298697517,0.0213366902286095,4.05075346359808e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37269,0.0175278174703534,0.00252506190183487,0.0125786961427571,0.0224769387979498,4.06526922395441e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,37255,-0.0222787272051548,0.00321030002713929,-0.0285709152583478,-0.0159865391519618,4.11668855346523e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39187,0.054829383210485,0.00790577278853109,0.0393340685449641,0.0703246978760059,4.22052917371008e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39104,0.0297645564005381,0.00429325248997222,0.0213497815201926,0.0381793312808837,4.29630596295339e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37203,0.058738380272442,0.00847398644467358,0.0421293668408818,0.0753473937040022,4.36101517187634e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39485,0.0494231903156408,0.00713307797137967,0.0354423574917366,0.0634040231395449,4.41879830261943e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37243,0.0142259366281319,0.00205505458755888,0.0101980296365165,0.0182538436197473,4.65205644546841e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,37243,0.053268820107406,0.00770582335291086,0.0381654063357007,0.0683722338791112,4.97730318183215e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39495,0.0397679513633129,0.00576196663189268,0.0284744967648033,0.0510614059618226,5.33996830356086e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39319,0.0654642046125351,0.00949247255630219,0.0468589584021828,0.0840694508228874,5.54750058444349e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39123,0.0310082316412506,0.00450215529121391,0.0221840072704714,0.0398324560120299,5.91239826422598e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39436,0.022911225741564,0.00332774035175635,0.0163888546521216,0.0294335968310065,6.01181196326862e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37221,0.0399832643065325,0.00580839451533827,0.0285988110564695,0.0513677175565955,6.10424586726064e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,37195,0.0567128049676483,0.00827262828523858,0.0404984535285807,0.0729271564067159,7.43506532144026e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39187,0.043668716580543,0.00637124314467537,0.0311810800169793,0.0561563531441067,7.4647011646831e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39462,0.0546964634586654,0.00798077715505576,0.0390541402347561,0.0703387866825747,7.4858527522305e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,37162,0.0479503934651904,0.00700068964364224,0.0342290417636516,0.0616717451667292,7.75846976795825e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,37187,-0.0111485301842639,0.00162768806507396,-0.0143387987918088,-0.00795826157671893,7.76197519944564e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39410,0.016041035093586,0.00234350884994116,0.0114477577477013,0.0206343124394706,7.95177482271382e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,39355,0.0390657730407217,0.00570953650599592,0.0278750814889697,0.0502564645924737,8.10280587368711e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37247,0.0427133265134804,0.00624404008229575,0.0304750079521808,0.0549516450747801,8.24180466222964e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,39256,0.0391866151729894,0.00573164766948632,0.0279525857407962,0.0504206446051825,8.4100486831692e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37247,0.0411519582008974,0.00601843008000702,0.0293558352440836,0.0529480811577111,8.41548718482049e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37164,0.050858915830102,0.00744374440790873,0.0362691767906008,0.0654486548696031,8.72889502764537e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,37164,0.0408576108324866,0.00598153374925413,0.0291338046839485,0.0525814169810247,8.8395050809793e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39123,0.0208924535547395,0.00305921263050083,0.0148963967989579,0.0268885103105212,8.86498427826482e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37221,0.0459849341706865,0.00673606719872509,0.0327822424611853,0.0591876258801877,9.08355326746895e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36916,0.0433003437000643,0.00635032612925595,0.0308537044867227,0.055746982913406,9.61714422793423e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36955,0.0726037604025251,0.0106490578490431,0.0517316070184007,0.0934759137866496,9.66552066763453e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39589,0.0267653650172958,0.00392869811739358,0.0190651167072044,0.0344656133273872,9.93395987746615e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,39187,0.0220635641362204,0.00324164614483023,0.0157099376923531,0.0284171905800876,1.04019479172977e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37221,0.0438679092931131,0.00644622508963244,0.0312333081174336,0.0565025104687927,1.05407974558086e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36992,0.0423744566735474,0.00623201077119018,0.0301597155620147,0.0545891977850802,1.09753962344946e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36757,-0.0360090635648703,0.00529973971963313,-0.0463965534153512,-0.0256215737143893,1.13699549322088e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39589,-0.0134645131819721,0.00198239538703599,-0.0173500081405627,-0.00957901822338156,1.14676723622808e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37164,0.0306735786474705,0.00452177701276127,0.0218108957024584,0.0395362615924826,1.2247390595199e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39455,0.0257621358218106,0.00379920668189189,0.0183156907253025,0.0332085809183187,1.23869350205422e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39401,0.0193917550590246,0.00286207609143572,0.0137820859198106,0.0250014241982386,1.28684981916802e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36916,0.0351407482696956,0.00518773204572258,0.0249727934600794,0.0453087030793119,1.31063219309848e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39485,0.0231084826794484,0.00341243843002734,0.0164201033565948,0.029796862002302,1.31870888062886e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39455,0.0143190635495633,0.00211484744122068,0.0101739625647708,0.0184641645343559,1.32890975709039e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,37224,0.0256356536735761,0.00378648253688327,0.0182141479012849,0.0330571594458673,1.34128232104947e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36955,0.0597053951044071,0.00882052370419463,0.0424171686441856,0.0769936215646286,1.3554357232495e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39636,0.0397059573922825,0.00586867485486105,0.0282033546767548,0.0512085601078101,1.37475695567103e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39636,0.036245419781904,0.00536072289827168,0.0257384029012915,0.0467524366625165,1.41754384990424e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39453,0.0559806396300873,0.00828090455718134,0.0397500666980119,0.0722112125621627,1.42879110464541e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36947,0.026326409601758,0.00389448026859309,0.0186932282753155,0.0339595909282004,1.44195756959879e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39355,0.0279471372378871,0.00413643643065719,0.019839721833799,0.0360545526419752,1.4677543304223e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36955,0.0500423026782153,0.00741508679814101,0.0355087325538589,0.0645758728025717,1.55742433152606e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39462,0.0368745243860708,0.00546864755547619,0.0261559751773375,0.0475930735948041,1.60928378318765e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,39123,0.023877852694533,0.00354472033983736,0.0169302008284518,0.0308255045606142,1.68663927697721e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39428,0.0468051709090728,0.0069484490905621,0.0331862106915711,0.0604241311265745,1.68670261416369e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39545,-0.01616676912385,0.0024006098437184,-0.0208719644175381,-0.011461573830162,1.70504323954559e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36916,0.0307073334894441,0.0045625480961563,0.0217647392209777,0.0396499277579104,1.7672252409352e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36857,0.0204920340116743,0.0030450585469696,0.0145237192596139,0.0264603487637347,1.77608825377533e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36955,0.050087967743792,0.00744454691349808,0.0354966557933358,0.0646792796942482,1.79333729041323e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39520,0.0408681430255141,0.00607555931801663,0.0289600467622015,0.0527762392888267,1.79870816401685e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39506,0.0684702913820323,0.010179549960329,0.0485183734597875,0.0884222093042771,1.80355146329047e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39416,0.0178931746328087,0.00266165831172394,0.0126763243418298,0.0231100249237877,1.85012478041444e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,37164,0.0594176673576355,0.0088402911546963,0.0420906966944308,0.0767446380208402,1.87882783219763e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36916,0.0444885515258247,0.00661949476881005,0.031514341778957,0.0574627612726924,1.88549040361297e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37164,0.0336188196492577,0.00500948997886498,0.0238002192906823,0.043437420007833,2.0145907428117e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39420,0.024932809477279,0.00372180886661681,0.0176380640987101,0.032227554855848,2.17172806610323e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,37247,-0.0147145931607281,0.00219651095795364,-0.0190197546383173,-0.010409431683139,2.1851869031825e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39636,0.0386733940881353,0.00577594077484978,0.0273525501694298,0.0499942380068409,2.22323645826017e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38905,0.0530623305887218,0.00792542598859072,0.037528495651084,0.0685961655263596,2.23316916548716e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39455,0.0421104720633945,0.00629061035476609,0.029780875768053,0.0544400683587361,2.24582510087439e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39485,-0.0146432659571494,0.00218981393895356,-0.0189353012774984,-0.0103512306368005,2.35839491033001e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39355,0.0419383931149964,0.00629433975458387,0.029601487196012,0.0542752990339808,2.7794065228828e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39601,0.0344605556509496,0.00517432731685505,0.0243188741099137,0.0446022371919855,2.83428480563976e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,39355,0.0211250083355006,0.00317244032041462,0.014907025307488,0.0273429913635133,2.85508891052296e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36880,0.0218364282939658,0.00327936931367483,0.0154088644391631,0.0282639921487685,2.87829556023855e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39636,0.0308507464865269,0.00463539157450498,0.0217653790004972,0.0399361139725567,2.92054865535703e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39462,0.0543301909496599,0.00817003279636324,0.0383169266687879,0.0703434552305318,3.03351511645389e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37203,0.0352915661123262,0.00530659184444346,0.024890646097217,0.0456924861274354,3.03983968441752e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39401,0.0153209114511544,0.00230454706551053,0.0108039992027537,0.019837823699555,3.0714180525913e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39471,0.017582418980862,0.00264487646222834,0.0123984611148944,0.0227663768468295,3.07915173680241e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39485,0.0373606689349742,0.00562088595817632,0.0263437324569486,0.0483776054129998,3.09934246377577e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,39123,0.0459568312390814,0.00692105701970221,0.0323915594804651,0.0595221029976977,3.24387314448067e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39066,0.0428310544742742,0.00645861998680707,0.0301721593001323,0.055489949648416,3.43701112288438e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39541,0.0146015251585815,0.00220247031281724,0.0102846833454597,0.0189183669717033,3.47994567442183e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37203,-0.0150795178843122,0.00227772419195922,-0.0195438573005523,-0.0106151784680721,3.72498408438247e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39462,0.0350201319798229,0.00529073474852252,0.0246502918727188,0.0453899720869271,3.73539422172573e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,37255,0.0632365634825527,0.00956004363951814,0.0444988779490972,0.0819742490160083,3.87177886506885e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,37221,0.0308562239911251,0.00466681778901802,0.0217092611246498,0.0400031868576004,3.94693818995536e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36955,0.0415987922093798,0.00629177434677919,0.0292669144896926,0.053930669929067,3.95602412596697e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37162,0.0277418898962343,0.00419628332798174,0.0195171745733901,0.0359666052190785,3.96821813510474e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36847,0.0417446861966985,0.00631914246138417,0.0293591669723856,0.0541302054210115,4.10793068757054e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,39104,0.0377836913912176,0.00572038882742491,0.0265717292894648,0.0489956534929704,4.10963634970026e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39477,0.0283507444375091,0.00429780521342621,0.0199270462191937,0.0367744426558244,4.34862394346773e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37247,0.041539378100057,0.00631412624998248,0.0291636906500914,0.0539150655500227,4.92720262095517e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,37165,0.0158654247314243,0.00241195761460561,0.0111379878067973,0.0205928616560513,4.96088529158485e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36847,0.0684464626970125,0.010407678358337,0.048047413114672,0.0888455122793529,5.0087176038152e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39455,0.0256286103269137,0.00390095906104193,0.0179827305672716,0.0332744900865559,5.20343672071272e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36993,0.0214444476395279,0.00326383439277005,0.0150473322296986,0.0278415630493572,5.21905875236171e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39568,0.0327802417473023,0.00499259003507745,0.0229947652785505,0.0425657182160541,5.34494585905297e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,39123,0.0212495522893228,0.00323641201120841,0.0149061847473543,0.0275929198312913,5.35028474846331e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39516,0.0481868195937034,0.00734262857275139,0.0337952675911107,0.0625783715962961,5.46002589565311e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37221,0.0403771352861618,0.00615256423975442,0.0283181093762431,0.0524361611960805,5.49011862244417e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36847,0.0376957643742371,0.00574495848531779,0.0264356457430142,0.04895588300546,5.53744795601398e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37243,-0.0332336633538226,0.0050673838073711,-0.0431657356162699,-0.0233015910913752,5.64999155826152e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39499,0.0164579370164326,0.00251179086099427,0.0115348269288838,0.0213810471039813,5.85095011966564e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39458,0.016528270734384,0.00252731869189142,0.0115747260982768,0.0214818153704912,6.3574393605694e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39413,0.0493889480800726,0.00755650422601188,0.0345781997970893,0.0641996963630558,6.52516012282449e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,39194,0.0630339279083953,0.00965550747998509,0.0441091332476245,0.0819587225691661,6.87010248591148e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39455,-0.0163300869550853,0.00250215691833384,-0.0212343145150196,-0.011425859395151,6.95287114052033e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39123,0.0356426519838668,0.00546806958561265,0.024925235596066,0.0463600683716676,7.34188656094652e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37203,0.022392887697387,0.00343542020704054,0.0156594640915876,0.0291263113031865,7.38164444908404e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39531,0.0318832644103251,0.00489500892651009,0.0222890469143653,0.0414774819062849,7.57833276808693e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,37050,0.0605579643633938,0.00930285161354446,0.0423243752008467,0.0787915535259409,7.82014987898883e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36880,0.0232172778115975,0.00356762676703204,0.0162247293482147,0.0302098262749803,7.92060765204774e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39432,0.0380333862274292,0.00584603200724571,0.0265751634932276,0.0494916089616308,7.97086395683771e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37164,0.0165876307833936,0.00255068199261774,0.0115882940778629,0.0215869674889244,8.15642594935314e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39455,0.0147953850771884,0.00227746654189733,0.0103315506550696,0.0192592194993072,8.48434126234782e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39541,0.0481944570307122,0.00741906486578417,0.0336530898937752,0.0627358241676492,8.50501892620183e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39516,0.042184753745089,0.00650021199190627,0.0294443382409527,0.0549251692492253,8.86649531428948e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39330,0.0133876032137521,0.00206290163410769,0.00934431601090106,0.0174308904166032,8.87313348619552e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36955,0.0371056453898414,0.00572253966333203,0.0258894676497106,0.0483218231299722,9.26074016316938e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39462,0.0309871808101735,0.00478133117499774,0.0216157717071779,0.040358589913169,9.40400382697596e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39531,0.0174326497459768,0.00269055080415244,0.012159170169838,0.0227061293221156,9.50620735782964e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37221,0.0690504748294812,0.010657270998541,0.0481622236723408,0.0899387259866216,9.56021784415568e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36855,0.0272082835703311,0.00419971836891573,0.0189768355672562,0.0354397315734059,9.60786183567063e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39104,0.0617465680358668,0.00955061894201619,0.0430273549095151,0.0804657811622186,1.04374011543773e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,37052,0.013235009946052,0.00204745708425954,0.00922199406090334,0.0172480258312007,1.05645916437969e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37247,0.0297744842422774,0.00460741509082868,0.0207439506642532,0.0388050178203016,1.06864495189674e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,37203,0.045937731919139,0.00711021181565761,0.0320017167604501,0.0598737470778279,1.0792926266864e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,39104,0.0338926861447238,0.00524750262795141,0.023607580993939,0.0441777912955085,1.08848232898392e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36861,0.0227314565914304,0.00351936995291932,0.0158334914837085,0.0296294216991523,1.09362755004296e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,37247,0.0410050074433468,0.00635223804854123,0.0285546208682059,0.0534553940184876,1.11972784395236e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39541,0.023501785697594,0.00364267192322828,0.0163621487280665,0.0306414226671214,1.13898690487778e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,39104,0.0283225607880307,0.00439001275277923,0.0197181357925834,0.036926985783478,1.1415742413436e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39601,0.0223303944879338,0.00346423355708071,0.0155404967160557,0.029120292259812,1.18326222455727e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39191,0.0408319280852852,0.00633597781056509,0.0284134115765776,0.0532504445939928,1.19620288148228e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39319,0.0418501340877966,0.00649726134160925,0.0291155018582425,0.0545847663173507,1.22178714356969e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39194,0.0377613714846774,0.00586400396562859,0.0262679237120454,0.0492548192573095,1.23563182763157e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36899,0.0440295607814908,0.00683864339347039,0.0306258197302888,0.0574333018326927,1.25218971008043e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37247,0.0148464284756088,0.00230662047016748,0.0103254523540805,0.019367404597137,1.26671002950559e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39410,0.0392973457510873,0.0061070881910916,0.0273274528965478,0.0512672386056269,1.27472286962466e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39428,0.032461573694313,0.00505450844223958,0.0225547371475235,0.0423684102411026,1.38277410753942e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37221,0.0258964122684326,0.00403429741155276,0.0179891893417892,0.033803635195076,1.41965448485206e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39428,0.0180276952852643,0.00281055203895098,0.0125190132889204,0.0235363772816082,1.45726022856086e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39654,-0.0147910404140411,0.00230686153744944,-0.019312489027442,-0.0102695918006402,1.48094668466552e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,37269,0.0083931506003651,0.00130914860711199,0.0058272193304256,0.0109590818703046,1.4948891715011e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39455,0.0291796233892051,0.00455338864405231,0.0202549816468625,0.0381042651315476,1.51511016382042e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,37247,-0.0200890998111046,0.00313508752222605,-0.0262338713546677,-0.0139443282675416,1.52782580717798e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39319,0.039825785532622,0.0062186937506008,0.0276371457814445,0.0520144252837996,1.55696303693275e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39322,-0.0155378534068787,0.00242628062853261,-0.0202933634388026,-0.0107823433749548,1.55923488841337e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39104,0.0145842595030871,0.00227735138153479,0.0101206507952789,0.0190478682108953,1.55926649797358e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39485,0.0467518915915939,0.00732065790743496,0.0324034020930214,0.0611003810901664,1.74943974423501e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39428,0.0305793747312807,0.00478999719320467,0.0211909802325995,0.0399677692299618,1.77593564541274e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36823,0.0541798483583167,0.00848910989464034,0.0375411929648216,0.0708185037518118,1.80704166700541e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36880,0.0264310839496716,0.0041462615131809,0.0183044113838371,0.0345577565155062,1.89832621996096e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39194,0.0193156622193768,0.00303154275165476,0.0133738384261335,0.0252574860126202,1.92668331562541e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39530,-0.0131235233065228,0.00206244467602899,-0.0171659148715396,-0.00908113174150602,2.03441633402785e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,39299,0.0316321408920581,0.00497196786286971,0.0218870838808334,0.0413771979032827,2.0485019555408e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39123,0.0379860525187436,0.0059713271336726,0.0262822513367453,0.0496898537007419,2.0583879747935e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39455,-0.0155408935564983,0.0024448621383038,-0.0203328233475738,-0.0107489637654229,2.12294822273389e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36916,0.0333105470613867,0.00524162678279423,0.02303695856711,0.0435841355556634,2.15685470968621e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39504,-0.017185182044618,0.00270739528639445,-0.0224916768059511,-0.0118786872832848,2.25114634028852e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36955,0.0444609670489678,0.00701407919350442,0.0307133718296991,0.0582085622682364,2.39495264072104e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37203,0.0464604751836579,0.00733474836298386,0.0320843683922095,0.0608365819751063,2.46437917963213e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36916,0.0417724788403291,0.00659514354655885,0.0288459974890738,0.0546989601915845,2.47380411278626e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39104,0.0358210349102584,0.00566456567675109,0.0247184861838263,0.0469235836366905,2.62772019189489e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39455,0.0149986984275038,0.00237213586311906,0.0103493121357905,0.0196480847192172,2.64020039977023e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39104,0.0328934834170131,0.00521467428146907,0.0226727218253337,0.0431142450086924,2.91025367218818e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36861,0.0430358370826286,0.00682243853781279,0.0296638575485155,0.0564078166167417,2.92297877894704e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39485,0.0364363026835015,0.0057794566785457,0.0251085675935519,0.0477640377734511,2.97290021722631e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,37141,0.0224056559574104,0.00355437601977883,0.0154390789586439,0.0293722329561769,3.00285607900703e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36955,0.0261123435674065,0.00414586645828515,0.0179864453091676,0.0342382418256454,3.10804433348027e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37203,0.0169456027776252,0.00269767253552899,0.0116581646079884,0.0222330409472621,3.46080097466561e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39104,0.0330287473994319,0.00525870978646998,0.0227216762179507,0.043335818580913,3.46409096472247e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39123,0.035111640809343,0.00559050999739445,0.0241542412144499,0.0460690404042361,3.46821211737439e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39541,0.0189371794494308,0.0030175209396501,0.0130228384077166,0.024851520491145,3.57477080199154e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,39104,0.0244332479729519,0.00389362344848134,0.0168017460139285,0.0320647499319753,3.59017101005174e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37247,0.0347076203569109,0.00553092529817059,0.0238670067724965,0.0455482339413253,3.60469359505746e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37247,0.0424236832878162,0.00676326072494481,0.0291676922669244,0.0556796743087081,3.66348353182133e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39541,0.0204773051120988,0.00326656994744258,0.0140748280151113,0.0268797822090862,3.7385835613669e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36955,-0.0152881899588466,0.00244088167821345,-0.020072318048145,-0.0105040618695483,3.89050577104236e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39428,0.0156256053018897,0.00249595653734362,0.0107335304886961,0.0205176801150832,3.94538875011731e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39462,0.0192598370505319,0.00307705441322847,0.0132288104006041,0.0252908637004597,3.97522954502469e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,39187,0.0450833167216722,0.00720761364868508,0.0309563939702495,0.059210239473095,4.08603148401674e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39068,0.025082770420496,0.00401255033398139,0.0172181717658924,0.0329473690750995,4.18945713724838e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39462,0.0347964020687109,0.00556758523735468,0.0238839350034957,0.0457088691339261,4.22027396810349e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,37164,0.0602119457321039,0.00963414740251785,0.0413290168231689,0.0790948746410389,4.23987230636897e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36880,0.0289095396091095,0.00463134527901434,0.0198321028622414,0.0379869763559776,4.45650015533114e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36690,0.0420794707861529,0.00674116207839054,0.0288667931125074,0.0552921484597983,4.45810535158809e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39428,0.0516860230962294,0.00828622909011827,0.0354450140795976,0.0679270321128613,4.56328036078701e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39589,0.0340993016512362,0.0054681821874799,0.0233816645637756,0.0448169387386968,4.60970654094086e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39485,0.0186333014778361,0.00298926708922946,0.0127743379829463,0.0244922649727258,4.68596878842032e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,39123,0.0284062972300015,0.0045619314532317,0.0194649115816673,0.0373476828783356,4.88984698337778e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39187,0.0297881027790331,0.00478428822736611,0.0204108978533955,0.0391653077046707,4.9073138481028e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37162,0.038355124200747,0.00615988170476322,0.0262817560594111,0.0504284923420829,4.91678059045919e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39499,0.0258638000594783,0.00415710485529444,0.0177158745431012,0.0340117255758554,5.05168464086568e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37203,0.0365292088304623,0.0058778923961359,0.0250085397340359,0.0480498779268887,5.30324904592641e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36916,0.0369498752756472,0.00594620451838483,0.025295314419613,0.0486044361316815,5.32896932004949e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39472,-0.0146359677604695,0.00235587497294351,-0.0192534827074388,-0.0100184528135002,5.35092734278247e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39601,0.01647628464109,0.00265537089197552,0.0112717576928179,0.021680811589362,5.61587127840107e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36919,-0.0256101998264449,0.00412697338945482,-0.0336990676697764,-0.0175213319831134,5.62282232055471e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39355,0.0311353144905025,0.00501842456417784,0.0212992023447139,0.0409714266362911,5.64285696998811e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39455,0.063071333289344,0.0101864310447697,0.0431059284415955,0.0830367381370926,6.10685918435171e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39531,-0.0224297321792477,0.00362527241665676,-0.0295352661158949,-0.0153241982426004,6.28852837449613e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,37255,-0.0318677415256607,0.00515161530223333,-0.041964907518038,-0.0217705755332834,6.36019315910526e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39462,0.0432629057973161,0.00699965510522782,0.0295435817910695,0.0569822298035626,6.54595761894612e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37247,0.0561994366438978,0.00909259660029319,0.0383779473073231,0.0740209259804724,6.57193542250936e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37221,0.0253768432483889,0.00410658591365768,0.0173279348576198,0.033425751639158,6.62413597496493e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39601,0.0345217899015958,0.00559442782991108,0.0235567113549701,0.0454868684482215,6.96984543155689e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39531,0.0439661656750132,0.00712622926705877,0.029998756311578,0.0579335750384484,7.02008200557037e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39428,0.0148175235170024,0.00240346340903089,0.0101067352353019,0.019528311798703,7.2258554038523e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36916,0.0339293605572279,0.00550318685455244,0.0231431143223052,0.0447156067921507,7.24763767551982e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39123,0.0277551850806573,0.00450457781501798,0.0189262125632221,0.0365841575980925,7.39184033530256e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36928,0.0448364213380038,0.00727709121793874,0.0305733225508439,0.0590995201251637,7.43662435285849e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39355,0.0319695990401649,0.00519136293359737,0.021794527690314,0.0421446703900157,7.54512586876337e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36861,0.0380065633883791,0.00617141149485703,0.0259105968584593,0.0501025299182989,7.57120133449633e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,37162,0.0515670554881873,0.0083764558717897,0.0351492019794795,0.0679849089968951,7.67595819986377e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39531,0.0333723752662475,0.00542331513861101,0.0227426775945699,0.0440020729379251,7.77073747047179e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37247,0.0248609862679618,0.0040417730594479,0.0169391110714439,0.0327828614644797,7.92862311441059e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39104,0.0255372099967509,0.00415521210241228,0.0173929942760229,0.033681425717479,8.16091227856231e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36916,0.013507034767859,0.00219829872242478,0.00919836927190641,0.0178157002638115,8.27584214574213e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39654,0.0458957413765257,0.00747687941890757,0.0312410577154669,0.0605504250375845,8.54512005075799e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39438,0.0243166397470066,0.00397274226787843,0.0165300649019648,0.0321032145920483,9.53845964144425e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39123,0.0440050395152341,0.0071916943368295,0.0299093186150482,0.0581007604154199,9.66375834903713e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39589,0.0681028284038303,0.0111367030417044,0.0462748904420898,0.0899307663655709,9.88246747924319e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36880,0.0467606613169671,0.00764727043225247,0.0317720112697523,0.0617493113641819,9.96485408746986e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36955,-0.0130320277576668,0.00213151599841646,-0.017209799114563,-0.00885425640077052,1.00077329516624e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39589,0.0232648132408214,0.00380891479592831,0.0157993402408019,0.0307302862408409,1.03361726807517e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39635,0.0123601363127926,0.00202590415445678,0.00838936417005734,0.0163309084555279,1.07934226751417e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39194,0.0253256688010844,0.00415234265702656,0.0171870771933123,0.0334642604088564,1.09312875305702e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36880,0.0226470645668283,0.00371797113883675,0.0153598411347082,0.0299342879989483,1.15347063038249e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39485,0.0253118246608072,0.0041562263442781,0.0171656210260222,0.0334580282955923,1.15589378714738e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39355,0.0542847611384379,0.00891389380190873,0.0368135292866968,0.071755992990179,1.15752953309669e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,39104,0.0257164578502758,0.00422360111468579,0.0174381996654917,0.03399471603506,1.16635692831445e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39462,0.0350466898429709,0.005758148585779,0.023760718614844,0.0463326610710977,1.18249488318553e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39194,-0.0199543303755278,0.00327853443703462,-0.0263802578721157,-0.01352840287894,1.18370582251472e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,37203,0.0703201190225044,0.0115529780639373,0.0476762820171873,0.0929639560278215,1.18530533456933e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37247,0.0244667482537691,0.00401982060595053,0.0165878998661061,0.0323455966414321,1.18685274123514e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36955,0.0349859459224266,0.00576025751589527,0.0236958411912719,0.0462760506535814,1.28642495642813e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39466,0.0293070461119625,0.00482827424811476,0.0198436285856575,0.0387704636382674,1.31085894787037e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36847,0.0311615609584827,0.00514443030197388,0.0210784775666139,0.0412446443503515,1.42400890467566e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39636,0.0234869337991432,0.00388468567770577,0.0158729498708399,0.0311009177274465,1.51934148013971e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37235,0.0247387821482999,0.00409487227143575,0.0167128324962858,0.032764731800314,1.57023932946084e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39531,0.0269322901968795,0.00445954769263919,0.0181915767193067,0.0356730036744523,1.5847572549762e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39541,0.0536802241837199,0.00889321511556571,0.0362495225572111,0.0711109258102287,1.6159376037546e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39485,0.0218329366496493,0.00361928296363796,0.0147391420409189,0.0289267312583797,1.6533818248288e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36916,0.0277570377947288,0.00460335914781655,0.0187344538650084,0.0367796217244492,1.68875217753334e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39428,0.0276114675489879,0.00458072746752363,0.0186332417126416,0.0365896933853342,1.70163085319752e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,39194,0.0407137311280643,0.00675492979392828,0.0274740687319649,0.0539533935241637,1.70736203464088e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39462,-0.0270101849209133,0.00448408693546267,-0.0357989953144201,-0.0182213745274065,1.7460204993787e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39531,0.0422978221698245,0.00702267271240439,0.0285333836535119,0.0560622606861371,1.75151262733523e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39589,0.0150749000395702,0.00250504332415562,0.0101650151242252,0.0199847849549152,1.80859645574162e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39568,0.0224751258357933,0.00373741676195191,0.0151497889823676,0.0298004626892191,1.85690273848768e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39427,0.0248968827232327,0.00414069412340666,0.0167811222413557,0.0330126432051098,1.86662947548838e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36880,0.0161050818112032,0.00267947941670002,0.0108533021544711,0.0213568614679352,1.9010397234292e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39355,-0.0145191032510215,0.00241725778108279,-0.0192569285019438,-0.00978127800009924,1.94057485163615e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36916,0.0473596047468441,0.00791138531119539,0.0318532895369011,0.0628659199567871,2.20626390702409e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39123,0.0389418417383075,0.00652204382365126,0.026158635843951,0.051725047632664,2.41538050015405e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37221,0.0190778030055439,0.00319568576606223,0.0128142589040619,0.0253413471070258,2.4375773101985e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39344,0.0190757670908824,0.00319907859215735,0.012805573050254,0.0253459611315108,2.53414477495774e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37247,0.0164547203853476,0.00276348986585514,0.0110382802482715,0.0218711605224237,2.67992634420698e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39516,0.0287521256794598,0.00483148195150066,0.0192824210545185,0.0382218303044011,2.72429556858336e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36880,0.0462197995911896,0.00777208632222916,0.0309865103996204,0.0614530887827587,2.80615730885316e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37221,0.0249577911934916,0.00419788890330251,0.0167299289430186,0.0331856534439645,2.83124387776832e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39424,0.0399888121936844,0.00672782509729618,0.0268022750029839,0.0531753493843849,2.84685260126789e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39589,0.0185900814802092,0.0031293825599084,0.0124564916627888,0.0247236712976297,2.90392626431104e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,39308,0.0353736325609584,0.00596396985657437,0.0236842516420726,0.0470630134798441,3.0736421473727e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39485,0.0270018088730028,0.0045540459617863,0.0180758787879016,0.0359277389581039,3.11101291316303e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,39314,0.0170477526612696,0.00287654895794818,0.0114097167036912,0.0226857886188481,3.16383415114867e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,39123,0.0492957895472717,0.00831809695503463,0.0329923195154038,0.0655992595791396,3.16723094377374e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,37203,0.0110595910884701,0.00186672698697147,0.00740080619400606,0.0147183759829342,3.21155179640835e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39462,0.0236140879887694,0.00398682590549943,0.0157999092139905,0.0314282667635483,3.2297186863289e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36955,0.0561132234664411,0.00949550280374968,0.0375020379710917,0.0747244089617904,3.52188443780702e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,39194,0.0239888226685006,0.00406239667777011,0.0160265251800711,0.03195112015693,3.60203470707678e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39516,0.0445556084964507,0.00754650786334291,0.0297644530842986,0.0593467639086028,3.62123363936965e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36955,0.0306921818049088,0.00519962614300076,0.0205009145646274,0.0408834490451903,3.66725530022823e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39568,0.0259398175639366,0.00439553413569517,0.017324570657974,0.0345550644698991,3.68133784186742e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39606,-0.0167637617020711,0.00284226148305396,-0.0223345942088569,-0.0111929291952853,3.75684338195064e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39458,0.0193337941328016,0.00328089252403741,0.0129032447856883,0.025764343479915,3.87734174474636e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39462,0.0502927329194411,0.00853531080460842,0.0335635237424086,0.0670219420964736,3.8897920396308e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,37269,0.0104159741459069,0.00176762854642006,0.00695142219492358,0.0138805260968902,3.89654904685198e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,39355,0.0204371611564279,0.00347179484516341,0.0136324432599076,0.0272418790529482,4.02626411153074e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39462,0.0529849702801113,0.00900265535386842,0.0353397657865292,0.0706301747736934,4.05354888883766e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39589,-0.0154709717806038,0.00263114185971236,-0.02062800982564,-0.0103139337355675,4.19042858167114e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39428,0.0343401462986457,0.00584645366999787,0.0228810971054498,0.0457991954918415,4.35283852283966e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39455,0.029208260975649,0.00497285509716091,0.0194614649852136,0.0389550569660844,4.35612571854415e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,39104,0.0336549527406269,0.00573266949071432,0.0224189205388268,0.044890984942427,4.43265205090167e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39601,-0.0223363999111355,0.0038199288395741,-0.0298234604367007,-0.0148493393855703,5.0979699234873e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36992,0.0246003454930803,0.0042099277814087,0.0163488870415192,0.0328518039446413,5.2412932474654e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,39104,0.035999723241182,0.00616283516748966,0.0239205663129022,0.0480788801694617,5.28545809130553e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39462,0.0184734737770746,0.00316520307259215,0.012269675754794,0.0246772717993552,5.44324853695604e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37221,0.0326362808944912,0.00559447645500568,0.0216711070426801,0.0436014547463023,5.55384655936222e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36955,0.0382008693141067,0.00656365923251801,0.0253360972183714,0.051065641409842,6.02708968038294e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,37203,0.0347152677057622,0.00597397943717193,0.0230062680089052,0.0464242674026192,6.35552589994754e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39428,-0.0117615660779976,0.00202633506616116,-0.0157331828076735,-0.00778994934832175,6.59218790540025e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39474,0.0382649023505394,0.00659726125747027,0.0253342702858976,0.0511955344151811,6.76004880915643e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39455,-0.0195303763378615,0.00336853329894654,-0.0261327016037967,-0.0129280510719263,6.85058362252724e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,37269,-0.0181556731167699,0.00313177816479625,-0.0242939583197706,-0.0120173879137693,6.90030065788356e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39462,0.0337457486583725,0.00582761301021256,0.0223236271583559,0.0451678701583891,7.15108243843219e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37203,0.0225482171591225,0.00389518956867672,0.0149136456045162,0.0301827887137289,7.2588696893675e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37164,0.0506504069904536,0.00875272572139395,0.0334950645765214,0.0678057494043857,7.34254799010615e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37162,0.0250332046825979,0.00432606574261823,0.0165541158270661,0.0335122935381296,7.35203637621426e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39485,-0.0179894731455477,0.00311308722582479,-0.0240911241081643,-0.0118878221829311,7.67892049990252e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37243,-0.0127732853439619,0.00221215453738516,-0.0171091082372368,-0.00843746245068699,7.91456700553064e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39296,0.0158766863136341,0.00274997877265299,0.0104867279192342,0.0212666447080339,7.92476362689597e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37024,0.00665903856440091,0.00115463395913457,0.00439595600449714,0.00892212112430467,8.24823089966553e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,37269,0.0100877384611034,0.00175130089330369,0.00665518871022813,0.0135202882119786,8.59748693457823e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,37221,0.0337295324301185,0.00586021624906967,0.022243508581942,0.0452155562782951,8.82773157760875e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39635,0.0133090599489749,0.00231438982594115,0.00877285589013028,0.0178452640078196,9.06542895977969e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39601,0.0131296857962577,0.00228372844735457,0.00865357803944278,0.0176057935530727,9.13764344216972e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36955,0.0129136594116888,0.0022471329026718,0.00850927892245207,0.0173180399009255,9.31111141272131e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37247,0.0196473402388993,0.00341980448259421,0.0129445234530146,0.0263501570247839,9.3923280698653e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39428,0.026610220406354,0.00463584528486713,0.0175239636480144,0.0356964771646935,9.64525529761833e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39462,0.0133315502640393,0.00233137680005347,0.0087620517359345,0.0179010487921441,1.09632692704763e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,39104,0.0347376162238631,0.00607817153513025,0.0228244000150078,0.0466508324327184,1.11745540916145e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39654,0.019904373517367,0.00348534993987079,0.0130730876352202,0.0267356593995137,1.14503113793571e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36880,0.0577008776419026,0.0101072655516435,0.0378906371606813,0.0775111181231239,1.16343550367454e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39123,0.0308197239084268,0.00540797778652293,0.0202200874468418,0.0414193603700117,1.22874257719849e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39541,0.0203189962141642,0.0035677011193025,0.0133263020203313,0.0273116904079971,1.2547781079147e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39589,0.0318759958607479,0.00559734148996524,0.0209052065404161,0.0428467851810798,1.25777115854635e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37164,0.0404597947701731,0.00711666992966293,0.0265111217080337,0.0544084678323124,1.33523284088285e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39477,0.0192356781716751,0.00338762945107421,0.0125959244475697,0.0258754318957806,1.38627984628613e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37203,0.0176782715842878,0.00311414544497087,0.0115745465121449,0.0237819966564307,1.4025934450539e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37255,0.0398539882035963,0.00702274767390082,0.0260894027627507,0.0536185736444419,1.41709372464154e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36916,0.0351708025866858,0.00619994336155575,0.0230189135980365,0.047322691575335,1.43640253915531e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39104,0.0161430252328557,0.0028469853101711,0.0105629340249204,0.0217231164407911,1.45307741396669e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39449,0.0175122854340744,0.00309201487459563,0.0114519362798669,0.0235726345882818,1.50850136160282e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39214,0.0164781405826483,0.00291126864410491,0.0107720540402027,0.0221842271250939,1.54077163280601e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39531,0.019804477321774,0.00350097450712221,0.0129425672878145,0.0266663873557336,1.56979376257775e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37221,0.0324746027610896,0.00574711973396671,0.0212102480825149,0.0437389574396644,1.63319913796728e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39462,0.0457435280555039,0.00809628571407183,0.0298748080559231,0.0616122480550847,1.63418635046613e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,39104,-0.0171218015454487,0.00303044196174487,-0.0230614677904686,-0.0111821353004287,1.63494649097181e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36916,-0.00985744185281088,0.0017445598891543,-0.0132767792355533,-0.00643810447006847,1.63592745397335e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39485,0.0379992199106476,0.00673433300697032,0.0247999272169858,0.0511985126043094,1.70512238071508e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39462,0.0391654753348788,0.00694162022964013,0.0255598996847842,0.0527710509849735,1.70999755726957e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39482,-0.0182784294409679,0.00324075825028351,-0.0246303156115235,-0.0119265432704122,1.72941839620832e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37210,0.00950908364644007,0.00168827978171487,0.00620005527427892,0.0128181120186012,1.81464635021955e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39194,0.0262425434804949,0.00466738184767535,0.0170944750590512,0.0353906119019386,1.91583543321571e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39531,0.0130086402332764,0.00231914588383959,0.00846311430095083,0.017554166165602,2.06790795881581e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36847,0.0318696892619692,0.0056853404586929,0.0207264219629311,0.0430129565610073,2.11978774699322e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36955,0.033064354818016,0.00590108286165514,0.0214982324091719,0.0446304772268601,2.15001824167872e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39636,0.0278500035406433,0.0049766761400593,0.018095718306127,0.0376042887751595,2.23010931932783e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,37243,0.0326666321212382,0.00584379943869652,0.021212785221393,0.0441204790210834,2.31763604768133e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39617,0.0141795892722048,0.0025382108827199,0.00920469594207381,0.0191544826023358,2.35742765638422e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39482,-0.0214744200997611,0.00384427555879533,-0.0290092001949999,-0.0139396400045222,2.36284755169677e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37247,0.0352776453042541,0.00631639387961833,0.0228975133002022,0.047657777308306,2.38337711897468e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39462,-0.0202957439411549,0.0036358649286644,-0.0274220392013372,-0.0131694486809727,2.41754461048831e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39455,0.0194102271355609,0.00347934016530213,0.0125907204115688,0.0262297338595531,2.4649895325432e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39516,0.0215508694143033,0.00386852418991773,0.0139685620020645,0.029133176826542,2.57877793226282e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39568,0.0131140586002437,0.0023647524365376,0.00847914382463006,0.0177489733758574,2.97795702829664e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,39074,0.0320144191770832,0.00577469430922635,0.0206960183309995,0.0433328200231668,3.00901898432913e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36847,0.0280490308727223,0.00506079992714927,0.0181298630155098,0.0379681987299349,3.04430315710767e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36861,0.028972499226668,0.00523163091038393,0.0187185026423155,0.0392264958110205,3.12261342513754e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39433,0.0416430142726918,0.00752247051314849,0.0268989720669208,0.0563870564784628,3.14986241185183e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36847,0.0291794049933283,0.00527089475331018,0.0188484512768403,0.0395103587098162,3.15842187596465e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37221,0.0326122260858443,0.00589556873265493,0.0210569113698407,0.044167540801848,3.23472846955467e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36880,0.0188973229880512,0.00341620437812613,0.012201562406924,0.0255930835691785,3.23605598628682e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37203,0.0357916391447561,0.0064724113779043,0.0231057128440637,0.0484775654454486,3.26761237306344e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39462,0.0187208789494034,0.00338743433729346,0.0120815076483083,0.0253602502504986,3.31999172604736e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,39104,0.0208966681901151,0.00378150109805317,0.0134849260379309,0.0283084103422993,3.33156554177335e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37209,0.0320800735315345,0.00580723658667435,0.0206978898216528,0.0434622572414163,3.37561068043845e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,37162,0.0182784723602725,0.0033137696435719,0.0117834838588715,0.0247734608616734,3.53751970578455e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39428,0.0279992813700099,0.00508123541643408,0.0180400599537991,0.0379585027862207,3.64073742839016e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39551,-0.0120370050557686,0.0021861784401432,-0.0163219147984492,-0.00775209531308791,3.7315904140071e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39123,0.0268380473546497,0.00487934613292041,0.0172745289341257,0.0364015657751737,3.8540830216148e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37221,0.0503623658558438,0.00915962380308559,0.032409503201796,0.0683152285098915,3.90836833415014e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39526,-0.0129461480091211,0.00235495869920321,-0.0175618670595593,-0.00833042895868277,3.91695377780196e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37162,0.0164660229718394,0.00299573077295047,0.0105943906568564,0.0223376552868223,3.94880501156875e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37162,0.0209445088320029,0.00381189548759674,0.0134731936763133,0.0284158239876925,3.99333294575024e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36880,0.0432079682902883,0.00786814065461071,0.0277864126072513,0.0586295239733253,4.06344251342179e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36916,0.0317602937304252,0.00579058814986897,0.020410740956682,0.0431098465041684,4.21978102152692e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39531,0.017294184706291,0.00315541540655118,0.0111095705094507,0.0234787989031313,4.30214937058792e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39531,0.0269893785967915,0.00492552644254295,0.0173353467694074,0.0366434104241757,4.33390520884084e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,39208,0.0249432263399429,0.00455345336875218,0.0160184577371886,0.0338679949426972,4.37522481270393e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36847,0.0316849277575235,0.00578428869783294,0.020347721909771,0.0430221336052761,4.39155665112452e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39462,0.042333652289262,0.00773319235393894,0.0271765952755417,0.0574907093029823,4.46347039294658e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36992,0.0162638534657245,0.00297368831541446,0.0104354243675121,0.0220922825639368,4.6059874515e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36880,0.0263529643184136,0.0048199002799004,0.0169059597698088,0.0357999688670184,4.65157316108012e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39589,-0.0137849616931815,0.00252205698039222,-0.0187281933747502,-0.00884173001161275,4.68214633352554e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,39160,0.0225221816434961,0.00412593724871027,0.014435344636024,0.0306090186509682,4.87451216029785e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,39270,0.0354325546260246,0.00649160752348398,0.022709003879996,0.0481561053720532,4.88690217634023e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36736,0.0331568755507401,0.00607887528091136,0.0212422800001538,0.0450714711013264,5.00779848933339e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39432,0.0304435948787814,0.00558357220266211,0.0194997933615637,0.0413873963959991,5.04952150369333e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39428,0.0340042909047837,0.00624165185676922,0.021770653265516,0.0462379285440513,5.17541455930068e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,37243,-0.0114581839232495,0.00210316856254859,-0.0155803943058448,-0.00733597354065428,5.18651267623826e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36847,0.026764925535376,0.00491865932893446,0.0171243532506644,0.0364054978200875,5.38357151648086e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39082,0.0268499172424574,0.00493517895019047,0.0171769665000841,0.0365228679848308,5.39807018402501e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39499,-0.0159320677916123,0.00293103168747856,-0.0216768898990703,-0.0101872456841544,5.54467073019443e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39287,-0.0175197510488719,0.00322700830004697,-0.023844687316964,-0.0111948147807799,5.75294463811411e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,39355,0.028453932097352,0.00524122931840982,0.0181811226332688,0.0387267415614353,5.76006711455031e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36992,0.0305903256513196,0.00565730157027199,0.0195020145735865,0.0416786367290527,6.51805799123263e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39194,0.0321241413118257,0.0059435309129709,0.0204748207224028,0.0437734619012487,6.58558655239399e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37164,0.043131716576488,0.00798503143871382,0.0274810549566089,0.0587823781963671,6.72492462669187e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39485,0.0494454022352536,0.00916637113006792,0.0314793148203205,0.0674114896501868,6.98639322863151e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39462,0.0252089398806953,0.00467405570534228,0.0160477906982245,0.0343700890631662,7.0193146559531e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39428,0.0253884268343973,0.00470744900326367,0.0161618267880005,0.0346150268807941,7.02465722815068e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37221,0.0280136238800079,0.00519592086082216,0.0178296189927965,0.0381976287672193,7.11293689959239e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37255,-0.024614706434904,0.00456653539565618,-0.0335651158103902,-0.0156642970594179,7.16127094729344e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39526,0.0189303009801838,0.00352082376311892,0.0120294864044707,0.0258311155558968,7.70071922296239e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39123,0.0203884728108508,0.00379240899052613,0.0129553511894196,0.027821594432282,7.72697087991907e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39104,0.034454806139489,0.00641109812590479,0.0218890538127156,0.0470205584662624,7.80814258139607e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36880,-0.0138653637349266,0.00258249262714586,-0.0189270492841324,-0.00880367818572066,8.06056937783424e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39462,0.0471814888901804,0.00879238978085806,0.0299484049196986,0.0644145728606622,8.16187017030878e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,37203,0.0168740285239832,0.00314584192971106,0.0107081783417495,0.0230398787062169,8.28598327458947e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39462,0.0287008928002177,0.00535405440591858,0.0182069461646173,0.0391948394358181,8.41770162470072e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39330,-0.0207263441195704,0.00386996768774932,-0.0283114807875591,-0.0131412074515818,8.64979825124653e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39457,-0.0099732903723998,0.00186423028145671,-0.0136271817240549,-0.00631939902074465,8.93355384331591e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37164,0.0180888305887168,0.00338195277369808,0.0114602031522686,0.0247174580251651,9.01557445959305e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39601,-0.0267980267939949,0.00501735927164535,-0.0366320509664198,-0.0169640026215701,9.37383380555341e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37162,0.039425346527819,0.00738296358103773,0.024954737908985,0.0538959551466529,9.45246885005351e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36533,0.0489816017791633,0.00917988924126954,0.030989018866275,0.0669741846920516,9.68692631585538e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39485,0.0125792595729404,0.00235859571851243,0.00795641196465599,0.0172021071812247,9.78029649743079e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39455,0.0240073183865144,0.00450841648829862,0.0151708220694491,0.0328438147035797,1.02408226073503e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36847,0.0282376764413728,0.00530971246136245,0.0178306400171024,0.0386447128656432,1.06668622506641e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37203,0.040015946833751,0.00752590615132637,0.0252651707771513,0.0547667228903506,1.0721775600641e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39355,0.0133269058931305,0.00250784061629683,0.00841153828518874,0.0182422735010723,1.08731272128275e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37221,0.030261351352738,0.00570811074881572,0.0190734542850592,0.0414492484204168,1.1679120780902e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37162,0.05149227382754,0.00971409831696829,0.0324526411262822,0.0705319065287978,1.17240134920624e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,37255,0.0125625052784091,0.00237123627485761,0.00791488217968823,0.01721012837713,1.19102358424191e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39123,0.0417493701278009,0.00789375281253024,0.0262776146152416,0.0572211256403601,1.24812224334567e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37162,0.048520439308332,0.00918198358129577,0.0305237514889923,0.0665171271276717,1.28266068588212e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37203,0.0177402052583912,0.00336166594170061,0.0111513400126581,0.0243290705041244,1.33318223953977e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,39355,0.0149716579925637,0.00283915346353409,0.00940691720403686,0.0205363987810905,1.35877327915805e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39462,0.0324857878705874,0.00616932353363473,0.0203939137446633,0.0445776619965114,1.4158491521981e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39485,0.0124435832202585,0.00236659130661933,0.00780506425928462,0.0170821021812324,1.47609183774915e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36861,0.0364023061559863,0.00694380177672418,0.0227924546736069,0.0500121576383657,1.61088595417856e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39428,0.0160326741456599,0.00306633955229532,0.0100226486231611,0.0220426996681587,1.73092249989275e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39499,-0.0118104219077134,0.00226046399562731,-0.0162409313391429,-0.00737991247628387,1.76691860794257e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,39104,0.0200774786151552,0.00384378910450924,0.0125436519703171,0.0276113052599933,1.78115576924309e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36955,0.0112388206312995,0.00216033051036189,0.00700457283099015,0.0154730684316088,1.99883710703246e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39123,0.0356075605983067,0.00685460318468683,0.0221725383563205,0.0490425828402929,2.07803001995835e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,39106,0.0263582358197671,0.00507728602965458,0.0164067552016441,0.0363097164378901,2.11506414836932e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36916,0.0421645616896352,0.00812316521565114,0.026243157866959,0.0580859655123115,2.1284916156632e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39532,0.0497988036806416,0.0096072178493876,0.0309686566958419,0.0686289506654413,2.20598226479024e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39531,0.0135115107931137,0.00260775569655703,0.00840030962786193,0.0186227119583655,2.23210461775901e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36992,0.0163371331857568,0.00316109493709308,0.0101413871090544,0.0225328792624593,2.40007082175054e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",37269,0.00719351477340238,0.00139328357662095,0.00446267896322533,0.00992435058357944,2.46670441036603e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36916,0.0203358014533158,0.00393911550563743,0.0126151350622664,0.0280564678443651,2.47385723994513e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37221,-0.0117263636420389,0.00227170625350017,-0.0161789078988993,-0.0072738193851786,2.48102447502342e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36880,0.0233398567686968,0.00452561826386009,0.0144696449715311,0.0322100685658626,2.5442397965955e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,39187,-0.00998919412904739,0.00194049405654445,-0.0137925624798745,-0.00618582577822026,2.67010113466248e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39589,0.0251579225745748,0.00489033140902374,0.0155728730128883,0.0347429721362613,2.71699742271531e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36916,0.0219793546656641,0.00427822453386592,0.0135940345792869,0.0303646747520413,2.82632356076748e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39526,-0.0133238497202604,0.00259414342907073,-0.0184083708412391,-0.0082393285992818,2.83954718830214e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39485,0.03167893542634,0.00616950513471323,0.0195867053623021,0.043771165490378,2.86030353422925e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,39104,0.0228563152387349,0.004462446674819,0.0141099197560897,0.0316027107213802,3.06270811867393e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36990,0.0183465736200985,0.00358422417903448,0.0113214942291909,0.0253716530110061,3.12201597185051e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39104,0.0213249198547842,0.00416994733865368,0.013151823071023,0.0294980166385454,3.1946322442113e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37221,0.0342007905311929,0.00668895478556257,0.0210904391514902,0.0473111419108955,3.2162993232827e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36916,0.0298574989819851,0.00584400733591639,0.018403244603589,0.0413117533603813,3.28518658388635e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36955,0.0164878618729833,0.00322942818605567,0.0101581826283142,0.0228175411176525,3.34761864109802e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39344,0.0209464913995742,0.00410529660757814,0.0129001100487211,0.0289928727504274,3.3966157370579e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36847,0.0290966020598139,0.00571973449785097,0.017885922444026,0.0403072816756018,3.68984415745626e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36861,0.0269139447672191,0.00529138775892811,0.01654282475972,0.0372850647747182,3.70313565803953e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36955,0.0342231090682221,0.00673073727981221,0.0210308639997902,0.047415354136654,3.73730761917615e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,37221,0.0286041506410684,0.00562753374427806,0.0175741845022834,0.0396341167798534,3.76987969331785e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39541,-0.0180077186236061,0.00354373589528622,-0.024953440978367,-0.0110619962688451,3.78813724292506e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39549,0.0267696855592697,0.0052690213508007,0.0164424037117003,0.037096967406839,3.80773969511777e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39568,0.0286616602556676,0.00564242776267335,0.0176025018408279,0.0397208186705074,3.82597776197677e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39654,0.0241478360471589,0.0047562134516509,0.0148256576819232,0.0334700144123947,3.87740820762793e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36880,0.0175424629451455,0.00345549065616312,0.0107697012590658,0.0243152246312252,3.89618391174893e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36880,0.0248495024785712,0.00489888914779193,0.015247679748899,0.0344513252082434,3.98333266794509e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36934,-0.0247353112899209,0.00487752473092723,-0.0342952597625382,-0.0151753628173035,4.00809650992009e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39485,0.0292188604242972,0.00577816771004463,0.0178936517126097,0.0405440691359847,4.31436690868454e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39462,0.016055333794728,0.00317651317225981,0.00982936797709879,0.0222812996123572,4.36849769357288e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36847,0.0288913956433997,0.00571590826948617,0.0176882154352069,0.0400945758515926,4.37538840306724e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39187,0.0397071450278748,0.00785815076375213,0.0243051695309206,0.055109120524829,4.40157363218627e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39531,0.0114150226991907,0.00226044191654139,0.00698455654276958,0.0158454888556118,4.47182260655817e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39440,0.0469667789133197,0.0093044843466806,0.0287299895938257,0.0652035682328137,4.52266345234124e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39123,0.0236453349087273,0.00469713378119343,0.0144389526975882,0.0328517171198664,4.86061515225426e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39123,0.0203389616248828,0.00404217468616984,0.0124162992399899,0.0282616240097757,4.91931154478255e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39194,0.0178588645473435,0.00355242029129329,0.0108961207764087,0.0248216083182783,5.03430423792354e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36916,0.0215296431943191,0.00428912836501864,0.0131229515988825,0.0299363347897556,5.24982011339009e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37044,0.00348026366849607,0.000693441279259838,0.00212111876114678,0.00483940857584535,5.26971788003316e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39123,0.0286152998466924,0.0057022141396009,0.0174389601330747,0.0397916395603102,5.27468707388698e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36916,0.0238643726442448,0.00475569034556157,0.0145432195669441,0.0331855257215454,5.29137050460776e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39636,0.0377052418409655,0.00752369561336816,0.0229587984387639,0.0524516852431671,5.46059181713716e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36861,0.0208577111902931,0.00416251543517343,0.0126991809373532,0.029016241443233,5.49385443962165e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36992,0.0298416398304529,0.00595749067164678,0.0181649581140252,0.0415183215468806,5.54307380173546e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39485,-0.0161965980751665,0.00323399502357062,-0.0225352283213649,-0.00985796782896805,5.55549211571493e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,37243,0.0275725847081341,0.00551063845371822,0.0167717333388464,0.0383734360774218,5.70409119243236e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39462,0.036222294363258,0.00724032113773504,0.0220312649332973,0.0504133237932186,5.71253491034977e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39419,0.0203616063276933,0.00408034990999726,0.0123641205040987,0.0283590921512879,6.10060675997581e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37247,0.037534536938829,0.00752176416817259,0.0227918791692107,0.0522771947084473,6.11335539611426e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39462,-0.014439443916154,0.00290020755054017,-0.0201238507152127,-0.00875503711709523,6.47022660336047e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39462,0.0387889428432364,0.00779666429362591,0.0235074808277296,0.0540704048587432,6.59460772018982e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39123,0.0259132992021652,0.00521224845053357,0.0156972922391194,0.036129306165211,6.71467080167298e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37221,0.0262415307030969,0.00528397535225472,0.0158849390126777,0.0365981223935162,6.91431627112866e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39568,0.0131663141725762,0.00265449164452597,0.00796351054930528,0.0183691177958471,7.12536988294566e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39123,0.028743468955182,0.00579626682143016,0.0173827859851789,0.0401041519251851,7.16630335429253e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36880,0.033667734595987,0.00680151828025488,0.0203367587666874,0.0469987104252866,7.51744565192078e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39455,0.0157346133394807,0.00318053937430507,0.00950075616584279,0.0219684705131187,7.61226308687946e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39123,0.0266206797233828,0.00538637100734658,0.0160633925489835,0.0371779668977821,7.80866211413009e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,39342,0.0189181676392958,0.00383232869755211,0.0114068033920937,0.0264295318864979,8.04110640100189e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39355,0.0227558069355203,0.00461385363179057,0.0137126538172108,0.0317989600538298,8.22433484154787e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,37019,0.0118130861747109,0.00240258938367795,0.00710401098270213,0.0165221613667197,8.90754297059748e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39355,0.0244546718624426,0.00497548804319243,0.0147027152977855,0.0342066284270998,8.97128123101461e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39601,0.0141103658761852,0.00287515844538696,0.00847505532322674,0.0197456764291436,9.31170533092814e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,37203,0.0446253264085641,0.00909463141065672,0.0267998488436769,0.0624508039734512,9.37292094014958e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37203,0.0149261245797884,0.00304325502640411,0.00896134472803638,0.0208909044315405,9.47447471470256e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,39356,-0.0118277124330314,0.00241298349285556,-0.0165571600790283,-0.00709826478703449,9.60122092693778e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39187,0.0170059734516872,0.00348289407990886,0.0101795010550658,0.0238324458483086,1.05732859950375e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37221,0.0163194616891004,0.00335053393582706,0.00975241517487933,0.0228865082033214,1.12534223578002e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36847,0.027858872713603,0.00572018668033169,0.0166473068201529,0.0390704386070531,1.12820276184203e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37255,-0.0115167985816394,0.00236723168842494,-0.0161565726909523,-0.00687702447232655,1.15765914154339e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39495,-0.0275916621186404,0.00568282085267038,-0.0387299909898744,-0.0164533332474065,1.21427144862368e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36916,-0.028659460761656,0.00592028086575167,-0.0402632112585293,-0.0170557102647827,1.30806028965059e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39319,0.0128432550954949,0.0026548025062559,0.00763984218323329,0.0180466680077564,1.32637554903483e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,37164,0.0280522613253292,0.00580666975442493,0.0166711886066564,0.0394333340440021,1.37405794141733e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,37247,0.0220855654886113,0.00457540247647183,0.0131177766347265,0.0310533543424961,1.40191838845008e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36880,0.0402523342795,0.00834169129267941,0.0239026193458484,0.0566020492131517,1.41354353165026e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39187,0.013518725434332,0.00280418322515383,0.00802252631303052,0.0190149245556335,1.44328276008995e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36642,0.0201885351793446,0.00419949947831646,0.0119575162018444,0.0284195541568449,1.54757497183646e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36916,0.0417378716114569,0.00869870434834578,0.0246884110886992,0.0587873321342146,1.61977238148076e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,39319,0.0263516338730186,0.00549694008933976,0.0155776312979127,0.0371256364481245,1.65174971498263e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37216,0.00602183688326247,0.00125633958868976,0.00355941128943053,0.00848426247709441,1.66025261042745e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39654,0.0100515078050445,0.00209786729557688,0.0059396879057138,0.0141633277043752,1.67270654538881e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,39104,0.0289194925865221,0.00604227367667841,0.0170766361802325,0.0407623489928118,1.71632958412581e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,39187,0.0193165219783052,0.00403822951318538,0.0114015921324619,0.0272314518241485,1.74011844180817e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39187,0.0233268354561785,0.00487798524785417,0.0137659843703843,0.0328876865419727,1.75183079821244e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39601,0.0132568398517284,0.00277307807329017,0.00782160682807967,0.0186920728753771,1.7645837941225e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39541,0.0128884402284658,0.00270340048029371,0.00758977528709018,0.0181871051698415,1.88274561730465e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36880,0.0181966645313205,0.00382235039070965,0.0107048577655296,0.0256884712971114,1.95199504293164e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39485,0.0278342673987621,0.00585077765299871,0.0163667431988846,0.0393017915986396,1.97961908892918e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36992,0.0428639948081193,0.00902918256523985,0.0251667969802492,0.0605611926359894,2.08457321519684e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36861,0.0218783001825614,0.00461194036563634,0.0128388970659142,0.0309177032992086,2.12042904677262e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39462,0.0267140673902605,0.00564402944417397,0.0156517696796795,0.0377763651008414,2.23073615703266e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39123,0.0162411383023115,0.00343477619214454,0.00950897696570823,0.0229732996389148,2.2835426445425e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,37243,0.0191334168747012,0.00405240709738497,0.0111906989638267,0.0270761347855758,2.36603166059585e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37203,0.0958108873747088,0.0203111312461097,0.0560010701323338,0.135620704617084,2.41695201507585e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39505,0.022664456878079,0.00481301390276384,0.0132309496286619,0.0320979641274961,2.51162572797562e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39541,0.0131831851549521,0.00280028144558116,0.00769463352161303,0.0186717367882912,2.52622225564671e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,39055,0.0455120123805094,0.00969037882483614,0.0265188698838306,0.0645051548771882,2.66912103551198e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38907,0.0123366109821842,0.00262823928062925,0.0071852619921509,0.0174879599722176,2.70546112963056e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39428,0.0179446394340319,0.00382353761799134,0.0104505057027689,0.025438773165295,2.71340910509951e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39123,0.0194715145053116,0.00415028669935015,0.0113369525745853,0.0276060764360379,2.73513800563061e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39462,0.040184793686086,0.00857141783112226,0.0233848147370864,0.0569847726350857,2.77999837494233e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37164,0.0434179573780938,0.00926804596051777,0.025252587295479,0.0615833274607086,2.83284281124763e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39104,0.0120971330924072,0.00258456985003356,0.00703137618634147,0.017162889998473,2.88709469680247e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36847,0.0204659638131024,0.00437421675830273,0.0118924989668291,0.0290394286593758,2.91650397946194e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39124,0.0311106879891995,0.00665075614138981,0.0180752059520755,0.0441461700263235,2.92603427032096e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36916,0.046436937942107,0.00993644862781618,0.0269614986315873,0.0659123772526267,2.99365279866643e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,39341,0.0270016112946774,0.00577994427175566,0.0156729205220363,0.0383303020673185,3.01470855492199e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37099,0.0233138109573682,0.00499277159573534,0.0135279786297269,0.0330996432850094,3.05020585919682e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,37162,0.0209531763550017,0.00448907601450465,0.0121545873665726,0.0297517653434309,3.07864296621763e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39532,-0.0133265729623938,0.00285645175249552,-0.0189252183972851,-0.00772792752750261,3.10620035587661e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39654,0.0077007576151932,0.00165251322317433,0.00446183169777151,0.0109396835326149,3.18849431850902e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37164,0.0202895558160146,0.00435536321503594,0.0117530439145441,0.028826067717485,3.21717530746447e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,37241,0.00887867863872984,0.00190844997641877,0.00513811668494905,0.0126192405925106,3.315475739064e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39033,0.0218522835060776,0.00469935594286696,0.0126415458580583,0.0310630211540968,3.34751726580733e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39428,0.0372505040238217,0.00801685516835363,0.0215374678938486,0.0529635401537948,3.40451618094275e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39601,-0.0124399150465232,0.00267957026212519,-0.0176918727602886,-0.00718795733275782,3.47101185778282e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37203,0.0188683003538863,0.00408285216340554,0.0108659101136115,0.0268706905941612,3.84983160625557e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39654,-0.0129745103603473,0.00280974047726081,-0.0184816016957785,-0.00746741902491611,3.91214431477291e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39498,0.00881854563004944,0.00191394703625511,0.00506720943898943,0.0125698818211095,4.1084843936023e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36916,0.0224101449954761,0.00486432294839381,0.0128760720166242,0.031944217974328,4.12483440601137e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37221,0.0216457981763597,0.00470365517306566,0.012426634037151,0.0308649623155684,4.22666078711883e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39601,0.0176384283463554,0.00384188487361405,0.0101083339940719,0.025168522698639,4.44488566224268e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,37269,0.0101898717058842,0.00222197255487243,0.0058348054983342,0.0145449379134341,4.56189266226576e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37247,-0.0103232044536542,0.0022511310795756,-0.0147354213696224,-0.00591098753768604,4.56571613046312e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39194,0.0258681073571079,0.00564485843397155,0.0148041848265237,0.0369320298876922,4.63006016790506e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39428,0.0222285731901912,0.00485237322364938,0.0127179216718384,0.031739224708544,4.66558321592647e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39487,0.0192844739772674,0.00421492137396889,0.0110232280842884,0.0275457198702464,4.79370339430777e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,39194,0.0231385107227667,0.00505824161807119,0.0132243571513471,0.0330526642941862,4.81437248397168e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39455,0.0140152034648503,0.00306558531504902,0.00800665624735419,0.0200237506823464,4.87445265143045e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,37162,0.00800989954899372,0.00175463416695182,0.00457081658176816,0.0114489825162193,5.04187697160282e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39654,0.0102284324527769,0.00224328759260799,0.00583158877126526,0.0146252761342886,5.16578271427484e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36847,0.0271045582225587,0.00594553210618099,0.015451315294444,0.0387578011506734,5.19363474980934e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,37243,0.0281379746497323,0.00617522544763574,0.0160345327723663,0.0402414165270984,5.24718218330633e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39636,-0.00334656498850027,0.00073792254841581,-0.00479289318339526,-0.00190023679360528,5.80121772630966e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39636,0.0102486196848155,0.00226059262936362,0.00581785813126285,0.0146793812383682,5.84303519276113e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37164,0.0179653565590233,0.0039671246356548,0.0101897922731399,0.0257409208449067,5.99275466591617e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36916,0.0196573504870844,0.00434515441721642,0.0111408478293402,0.0281738531448286,6.12510110363208e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36880,0.0216436523921305,0.00478496855894301,0.0122651140166022,0.0310221907676588,6.14586446768215e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,39187,0.028904412199436,0.00639302402560326,0.0163740851092536,0.0414347392896184,6.19568752293758e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39589,0.0252767714575463,0.00559489719148385,0.014310772962238,0.0362427699528547,6.29504475737672e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37164,0.00824847775450841,0.0018302512187806,0.00466118536569844,0.0118357701433184,6.64170239611526e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36916,0.011979213223472,0.00265861845823572,0.00676832104532995,0.017190105401614,6.67238070544104e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37162,0.0235532260103492,0.0052391581011329,0.0132844761321287,0.0338219758885697,6.99834715760437e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36880,0.0169996795224384,0.00378314112442681,0.00958472291856187,0.0244146361263149,7.06828768945482e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39401,0.0227379600721613,0.00506539584538418,0.0128097842152083,0.0326661359291143,7.21333048437968e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39485,-0.0066709025630188,0.00148651008881536,-0.00958446233709691,-0.0037573427889407,7.25555930444584e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37255,0.023762124860404,0.00530690391578483,0.0133605931854657,0.0341636565353423,7.61441293715294e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39391,0.0142546427075995,0.00318825332914524,0.00800566618247478,0.0205036192327241,7.84324440553538e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39485,0.0243875544133749,0.0054546527345095,0.0136964350537363,0.0350786737730135,7.84377850163367e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,37269,0.00996189919178133,0.0022302058550226,0.00559069571593702,0.0143331026676256,8.00750977028116e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37221,0.018064854609536,0.00404600052543787,0.0101346935796778,0.0259950156393942,8.0805507283148e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36861,0.01875493430902,0.00420388022073386,0.0105153290763817,0.0269945395416584,8.21657708091332e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37255,-0.0175599873275198,0.00394408889796177,-0.0252904015675249,-0.00982957308751474,8.57023781546932e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36880,0.0165072282959774,0.00370794856015284,0.00923964911807788,0.023774807473877,8.58756838766837e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39541,0.0099722225891005,0.00224060603471972,0.00558063476104985,0.0143638104171511,8.62117629620438e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39589,0.0106280528467245,0.00239001184284145,0.00594362963475522,0.0153124760586937,8.77540729529186e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36847,0.0151971048571793,0.00342466879978163,0.00848475400960729,0.0219094557047513,9.17780051549512e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36861,0.0227778769378416,0.00514117216599204,0.0127011794924972,0.032854574383186,9.48276589091074e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39187,0.0199126951046373,0.00449733181021734,0.0110979247566113,0.0287274654526633,9.59423075842139e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36992,0.0328408240813694,0.0074216750328369,0.0182943410170091,0.0473873071457297,9.72613036562853e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39455,-0.0118953930660842,0.00269152463220323,-0.0171707813452026,-0.0066200047869659,9.95892968735615e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39123,0.0216941490419812,0.00492728327326916,0.0120366738263736,0.0313516242575887,1.07587464273673e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,39163,0.0209867910622721,0.00477429700965858,0.0116291689233413,0.030344413201203,1.11145843427907e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37247,-0.0122162303099236,0.00277956342418221,-0.0176641746213207,-0.00676828599852648,1.11656037906266e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,39032,0.0317489043518438,0.00722757648674985,0.0175828544378141,0.0459149542658735,1.12717523869651e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37203,0.0222167820247119,0.00506078170791548,0.0122976498771976,0.0321359141722262,1.14268094057289e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39589,0.0132080229606389,0.00301619595721817,0.00729627888449131,0.0191197670367865,1.20006943530566e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39123,0.0165239877087722,0.00377438528354768,0.00912619255301872,0.0239217828645256,1.20641792312582e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36916,0.0287369161163091,0.00656721553999116,0.0158651736579264,0.0416086585746918,1.21963844437902e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37203,0.0238707494326146,0.00546846251521175,0.0131525629027995,0.0345889359624296,1.28026335926827e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39390,0.0287750006792417,0.00661166297069027,0.0158161412566887,0.0417338601017946,1.35699694519346e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39654,-0.00630701748914152,0.00145110732569435,-0.00915118784750245,-0.00346284713078059,1.39321820767331e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37173,0.0212602570701263,0.00489432754204217,0.0116673750877236,0.0308531390525289,1.41087585217049e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39589,0.0246172956162858,0.00566959190366904,0.0135048954850945,0.0357296957474771,1.42117150677132e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37235,0.00905633224288714,0.00208719304966665,0.00496543386554051,0.0131472306202338,1.44230831961474e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37221,0.0342275616120324,0.00790818992164733,0.0187275093656037,0.0497276138584612,1.51535154900723e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36955,0.0199867637892796,0.00462663065310879,0.0109185677091863,0.0290549598693728,1.57276690742218e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36847,0.0150208452086119,0.0034771846149878,0.00820556336323578,0.021836127053988,1.57365299230856e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36861,0.0163544072580518,0.00379115910766875,0.00892373540702103,0.0237850791090825,1.61693070333557e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39462,-0.0142122684111908,0.00330102373683186,-0.0206822749353813,-0.00774226188700037,1.67732319861463e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36916,0.0180629114254049,0.00420016683125406,0.00983058443614691,0.0262952384146628,1.71692714162577e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39453,0.00818067642322274,0.00190383151305121,0.00444916665764236,0.0119121861888031,1.7425205062608e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36880,0.0188786684657828,0.00439825728893451,0.0102580841794712,0.0274992527520945,1.7816637346421e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36992,0.0275930086885917,0.00643601563643613,0.0149784180411769,0.0402075993360065,1.82225372685905e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39485,0.00968543352931626,0.00225949995060118,0.00525681362613795,0.0141140534324946,1.82609130859548e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39485,-0.0130249852295474,0.00303995307134116,-0.0189832932493761,-0.00706667720971875,1.84205928660933e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39428,0.0155769957456978,0.00364126949219152,0.00844010754100237,0.0227138839503931,1.89833191677199e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37243,0.00930710503285602,0.00218315545608756,0.00502812033892441,0.0135860897267876,2.03016596933282e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37162,0.0198989985986992,0.00466840409528474,0.0107489265719411,0.0290490706254573,2.03625128006558e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36992,0.0191531879752278,0.00449503311618759,0.0103429230675001,0.0279634528829554,2.05030432438594e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39623,0.00734478517400293,0.00172543623659144,0.0039629301502837,0.0107266401977222,2.08647987834969e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,39355,0.0126122371792842,0.00296476962065176,0.00680128872280677,0.0184231856357617,2.11232734763418e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39428,-0.00959456479851344,0.00225690082617293,-0.0140180904178124,-0.00517103917921451,2.13904421026872e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,39123,0.0272901756693171,0.00643194022997914,0.014683572818558,0.0398967785200762,2.21989332481115e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39455,-0.032125902116688,0.00757474561196926,-0.0469724035161478,-0.0172794007172283,2.23674612063366e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39428,0.0140503610831102,0.0033128547846654,0.00755716570516606,0.0205435564610544,2.23698346984225e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39104,0.0244062925421928,0.00575828292273093,0.0131200580136402,0.0356925270707454,2.26428874279824e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39194,0.0144861892478476,0.00341835891005309,0.00778620578414354,0.0211861727115517,2.27132254176332e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36916,0.0170207780880563,0.00402808750358184,0.00912572658103586,0.0249158295950767,2.40082286760557e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,37269,0.00789250270446522,0.00186840003806215,0.00423043862986339,0.011554566779067,2.41444034886086e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36880,0.0155432532905125,0.00368112715569727,0.0083282440653458,0.0227582625156791,2.4341656251856e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,37162,0.0227857824766588,0.00540028730661579,0.0122012193556919,0.0333703455976258,2.46691470928069e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39498,0.00969612844534734,0.00230885131337996,0.00517077987112261,0.0142214770195721,2.68989267018272e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,39104,0.0294758076038564,0.00703385859354753,0.0156894447605033,0.0432621704472096,2.79897809481382e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39477,-0.0120440471373363,0.00287616802577222,-0.0176813364678499,-0.00640675780682275,2.83611164713902e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39393,0.0143056605554684,0.00342130328777804,0.00759990611142345,0.0210114149995134,2.91437488419772e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39485,-0.0185280049036953,0.00443797905953893,-0.0272264438603916,-0.00982956594699902,2.99829775536739e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36688,0.0123085485653175,0.00294819494289053,0.00653008647725209,0.018087010653383,3.00122972307134e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36916,0.0107132588473499,0.00256651333214502,0.00568289271634564,0.0157436249783541,3.01004731225637e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39654,-0.0104107087651164,0.00249769910306217,-0.0153061990071182,-0.0055152185231145,3.08822629108001e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39455,0.0179877360217642,0.0043163651286521,0.00952766036960608,0.0264478116739223,3.09909752378572e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36909,0.0234371543031081,0.00563674020972552,0.0123891434920461,0.0344851651141701,3.23298700610579e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,39104,0.0210538225509969,0.00506721159719884,0.0111220878204871,0.0309855572815066,3.27258030048723e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36955,0.0249132170629726,0.00599829407373171,0.0131565606784584,0.0366698734474867,3.29770766291047e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39589,0.0166561150052101,0.00401570705083241,0.00878532918557861,0.0245269008248417,3.37603125518854e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,39050,0.0149928482137898,0.00363312557627531,0.00787192208429023,0.0221137743432894,3.70035427824711e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,37247,-0.00960846937342152,0.0023285172006034,-0.0141723630866042,-0.00504457566023887,3.70766678117412e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39403,0.0265428894666242,0.00643462264591506,0.0139310290806307,0.0391547498526177,3.72722464395914e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39601,0.0188757565642209,0.00459116490498697,0.00987707335044644,0.0278744397779954,3.95474311888229e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36823,0.0137826108574829,0.00335301243984295,0.0072107064753907,0.0203545152395751,3.97323873297669e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39194,0.0237937526998444,0.00579747495189137,0.0124307017941373,0.0351568036055515,4.07974131743922e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39455,0.016359179631609,0.00398792209229758,0.00854285233070579,0.0241755069325123,4.11433582797152e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37186,0.0142380436594656,0.00347973340563837,0.00741776618441438,0.0210583211345168,4.30850721238549e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36955,0.0258159648796901,0.00631065329671018,0.0134470844181382,0.0381848453412421,4.32481311788591e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39654,-0.00569272529045921,0.00139443159077057,-0.00842581120836953,-0.00295963937254889,4.47874501206066e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39462,0.0317492235986932,0.00780723096388694,0.0164470509094748,0.0470513962879116,4.79386080176513e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,37255,0.0141761555064682,0.00348853792695934,0.00733862116962788,0.0210136898433085,4.86021201056429e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36847,0.0127137382875128,0.00313204003736386,0.00657493981427961,0.0188525367607459,4.95325824352421e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39455,0.00830456949816474,0.00205024475182598,0.00428608978458581,0.0123230492117437,5.1359706923598e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36916,0.0155743673693021,0.00384870536383872,0.00803090485617824,0.023117829882426,5.22691759703732e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37162,0.016471315271633,0.00407356996363625,0.00848711814290597,0.0244555124003601,5.29790140871814e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36880,-0.0417755699276961,0.0103384326276843,-0.0620388978779573,-0.0215122419774349,5.35891340425886e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39477,0.0102587563578398,0.00254099893136057,0.00527839845237308,0.0152391142633065,5.43398348008404e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39355,-0.0401148347223528,0.00993853448954152,-0.0595943623218542,-0.0206353071228514,5.45737889056795e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39455,-0.0114939280672979,0.00284805838959349,-0.0170761225109011,-0.00591173362369465,5.4708260841217e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37221,0.0233860759662618,0.00580104707126548,0.0120160237065814,0.0347561282259421,5.57783853823919e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39194,0.0123506990291696,0.0030641299503519,0.00634500432647984,0.0183563937318593,5.58818676093338e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,37162,0.0266727257666239,0.00661782231681632,0.0137017940256639,0.0396436575075839,5.59973893598829e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36861,0.0149103229771197,0.00369970732946091,0.00765889661137632,0.0221617493428631,5.60773499126663e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,39312,-0.0227798929068379,0.00565676383683592,-0.0338671500270362,-0.0116926357866395,5.67691966971691e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39473,0.0146335160688054,0.00363400248298435,0.00751087120215603,0.0217561609354547,5.68112668623625e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39104,0.00948458422845755,0.00235843657371112,0.00486204854398376,0.0141071199129313,5.8104810020577e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36880,0.00579034850534237,0.00144147242703394,0.00296506254835584,0.0086156344623289,5.92987217301115e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39455,0.0310409945361214,0.00773743475641989,0.0158756224135385,0.0462063666587044,6.05513262015148e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37164,0.00925806103711914,0.00231332521796644,0.00472394360990492,0.0137921784643334,6.3150230640149e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36880,0.0239807041717634,0.00599831579091878,0.0122240052215625,0.0357374031219642,6.42746560255119e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39104,0.0204145317430011,0.00511276252570311,0.010393517192623,0.0304355462933792,6.56002814278418e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36861,0.0179534134756779,0.00450690115845198,0.00911988720511199,0.0267869397462437,6.82844648815396e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39654,0.024172939635611,0.00607176705717223,0.0122722762035535,0.0360736030676686,6.88860499723518e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37117,-0.00983845517843668,0.00247306200606895,-0.0146856567103318,-0.00499125364654155,6.98112899941159e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39617,-0.0161121605872922,0.00405074457181754,-0.0240516199480546,-0.00817270122652984,6.99435790751379e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39458,0.0590519439981947,0.0148805112777459,0.0298861418938127,0.0882177461025767,7.2690981890822e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36916,-0.0130818237358139,0.00330027255086567,-0.0195503579355106,-0.00661328953611715,7.41585061639024e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37164,-0.027850103828316,0.00703127115423755,-0.0416313952906216,-0.0140688123660104,7.50777308375684e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,37162,0.0108252727412588,0.00273527909555103,0.00546412571397876,0.0161864197685388,7.61029866345343e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36916,0.0140609179281937,0.00355775530588559,0.00708771752865794,0.0210341183277294,7.78671535059349e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39589,0.0430746430513241,0.0109003557717792,0.0217099457386368,0.0644393403640114,7.7959003422341e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,39194,-0.0101721018210708,0.00257478083907313,-0.0152186722656541,-0.00512553137648745,7.82966172926864e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36916,0.0247140721483356,0.00625568392464183,0.0124529316560376,0.0369752126406336,7.83658077700465e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39485,0.0151631570370674,0.00384133894974373,0.00763413269556969,0.0226921813785651,7.93766014222842e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39123,0.0139330319562504,0.00353110433318914,0.00701206746319964,0.0208539964493011,7.99043885669537e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36847,0.0228047754403844,0.00578216845409224,0.0114717252703636,0.0341378256104052,8.05804381171885e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39123,0.0199270006617658,0.00505504432909165,0.0100191137767462,0.0298348875467854,8.11789132806487e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39168,0.0128976229713837,0.00328099411464481,0.00646687450667985,0.0193283714360875,8.49767547055589e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37247,-0.00837842593314156,0.00213190222073184,-0.012556954285776,-0.00419989758050715,8.53844452781222e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37164,0.0256938792457221,0.00653898766063713,0.0128774634308733,0.0385102950605708,8.56315836637028e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39359,0.00859157016616904,0.00218719089877813,0.0043046760045639,0.0128784643277742,8.59947501873013e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36955,0.0178949740597056,0.00455883236152611,0.00895966263111446,0.0268302854882968,8.70710138642557e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36719,0.0179351145341786,0.00457324343021728,0.00897155741095276,0.0268986716574045,8.83870524206361e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39194,0.00989635909240925,0.00252452578705075,0.00494828854978979,0.0148444296350287,8.89175196823641e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39123,0.0168341500402435,0.00430021689962585,0.00840572491697686,0.0252625751635102,9.09178871016173e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36847,0.0186729477091322,0.00477383873857325,0.00931622378152866,0.0280296716367358,9.22078522393443e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37164,0.0151262077375903,0.00387358723670677,0.00753397675364505,0.0227184387215356,9.4727670882654e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36823,0.0183081179837986,0.00469859255127179,0.00909887658330588,0.0275173593842913,9.81025003495629e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,39042,0.0101497665350422,0.00260549255724076,0.00504300112285035,0.0152565319472341,9.84226513421003e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39654,-0.010488428375366,0.002692555069321,-0.0157658363112351,-0.00521102043949681,9.84792477565751e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39654,-0.00980320490322227,0.00251793878236465,-0.014738364916657,-0.00486804488978756,9.92937633515819e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37162,0.0122574449989088,0.00315009898275408,0.00608325099271076,0.0184316390051067,0.000100287392450739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37162,0.0144475759088991,0.00372579169154341,0.00714502419347405,0.0217501276243242,0.000105970978611768
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39455,0.0185600247735196,0.00478711539047757,0.00917727860818355,0.0279427709388556,0.000106168553236258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39459,-0.0245674688398997,0.00634751407766713,-0.0370085964321273,-0.0121263412476722,0.000109113302975987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,39187,-0.0168401364975032,0.00435243923843818,-0.0253709174048421,-0.0083093555901644,0.000109696418414893
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37221,0.0193282143607283,0.00500451946053896,0.00951935621807198,0.0291370725033847,0.000112947419546893
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,39104,0.0205429275353899,0.00532159769121008,0.0101125960606182,0.0309732590101617,0.000113737218919358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,37221,-0.0117904211502202,0.00305618791148451,-0.0177805494567298,-0.00580029284371053,0.00011493468428491
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39571,0.011366512391827,0.00295145253818067,0.00558166541699293,0.0171513593666611,0.000118044949847207
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,37203,0.0312836763532107,0.00815655461682005,0.0152968293042434,0.047270523402178,0.000125962025184959
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37055,0.0201586856861589,0.00526118898419983,0.00984675527712726,0.0304706160951906,0.000127938997677661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39282,0.012016690234331,0.00314148452693368,0.00585938056154096,0.018173999907121,0.000131221091090751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,37030,-0.0205168011231593,0.00536441679644244,-0.0310310580441865,-0.0100025442021321,0.000131611938218536
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39319,0.0240433054167192,0.00629148001195404,0.0117120045932892,0.0363746062401491,0.000133147045136324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36916,0.0301664603697694,0.00789862363044796,0.0146851580540914,0.0456477626854474,0.000134531690401368
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36968,0.0209111111298771,0.00547847057345524,0.0101733088059048,0.0316489134538493,0.000135756065118445
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,39319,-0.0164973786261886,0.00432551081009561,-0.024975379813976,-0.00801937743840121,0.000137303561508996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39623,0.0172347824083563,0.00451900677601758,0.00837752912736183,0.0260920356893508,0.000137364309518683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36880,0.017009693897483,0.0044657930235932,0.00825673957124031,0.0257626482237256,0.00014026644125268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,37164,0.0114130107180332,0.00300665635357972,0.00551996426501698,0.0173060571710495,0.000147783384689441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39654,-0.00782146328428508,0.00206527107805555,-0.0118693945972739,-0.00377353197129621,0.000152980046712045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39462,0.0250895957156451,0.00662493514662507,0.01210472282826,0.0380744686030303,0.000152981745698977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39428,-0.020343901897042,0.0053777727805148,-0.030884336546851,-0.00980346724723294,0.000155577059589239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39531,0.00882462357938278,0.00233398328792799,0.00425001633504392,0.0133992308237216,0.000156847236654608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36929,0.044949591803636,0.011896748077288,0.0216319655721515,0.0682672180351205,0.000158631051968448
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39440,0.00908620262698254,0.00240511828059437,0.00437217079701758,0.0138002344569475,0.000158792997825479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36955,0.0133569225732048,0.00353778357208143,0.00642286677192516,0.0202909783744844,0.000160422211574629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39428,0.0132406219051423,0.00351105781307096,0.00635894859152324,0.0201222952187614,0.000163141156432864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,37164,0.0111797194450348,0.00296695591725029,0.0053644858472242,0.0169949530428453,0.000165252917274164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37203,0.0200596239437883,0.00532371314106148,0.00962514618730781,0.0304941017002688,0.00016531759288001
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39549,0.0193156571723252,0.0051275964248965,0.00926556817952801,0.0293657461651223,0.000165848479992012
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,39123,0.0310547028372149,0.00824508646919139,0.0148943333575997,0.04721507231683,0.000166232459041799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36880,0.0105770241891858,0.00281365535615972,0.00506225969111277,0.0160917886872589,0.000171255030592687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37221,0.0184366756564347,0.0049046320456667,0.00882359684692796,0.0280497544659414,0.000171331292119226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39526,0.00868151587976761,0.0023139757502701,0.00414612340923821,0.013216908350297,0.00017624511429771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,39068,0.0142702992795023,0.00380396378660102,0.00681453025776429,0.0217260683012403,0.000176508990491337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39485,-0.0216134673031024,0.00576154690580427,-0.0329060992384788,-0.010320835367726,0.000176559193940682
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39426,0.0183537662853551,0.00492693565647647,0.00869697239866122,0.028010560172049,0.000195885749549642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36992,0.0114586425662268,0.0030776213418627,0.00542650473617591,0.0174907803962777,0.00019756384780224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,39194,0.016336036075088,0.0043883459565932,0.00773487800016528,0.0249371941500106,0.000197919104853374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39434,0.0216872791742109,0.00583309582245498,0.0102544113621991,0.0331201469862227,0.000201561392693198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37247,0.0107105115757486,0.00288152434368458,0.00506272386212682,0.0163582992893704,0.000202493746498956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39397,0.0109117966962083,0.00293804134596021,0.00515323565812629,0.0166703577342903,0.000204775506431556
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39118,0.0154751873094735,0.00417358596695638,0.00729495881423903,0.023655415804708,0.000209765538205673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39507,0.00962326476921754,0.00259686899258803,0.00453340154374501,0.0147131279946901,0.00021154749775533
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39462,0.0252861648386341,0.00682472434000057,0.011909705132233,0.0386626245450352,0.000212080806107266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,39319,0.0108323355190198,0.00292677182954744,0.00509586273310679,0.0165688083049328,0.000215424296955717
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,37167,0.0303027893475931,0.00819554180282953,0.0142395274140472,0.046366051281139,0.000218672842904698
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37203,0.0111738767280819,0.00302325316003707,0.00524830053440919,0.0170994529217545,0.000219959400071305
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36916,0.0259475728054037,0.00702995700605547,0.012168857073535,0.0397262885372725,0.000224326160645224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,39187,0.0103875481985397,0.00282469067855562,0.00485115446857065,0.0159239419285087,0.000236451075736176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36992,0.0210269099868775,0.00571901165506297,0.00981764714295405,0.0322361728308009,0.000237286459940076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,37255,0.0147146169286473,0.0040056472332317,0.00686354835151313,0.0225656855057814,0.000240256019584253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36847,0.0135552440761643,0.0036995692451314,0.00630408835570674,0.0208063997966218,0.000249336336452116
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,39194,0.0217934369374669,0.00596150467280705,0.0101088877787651,0.0334779860961688,0.00025737858700586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39608,0.00833209361370704,0.00228223142549473,0.00385892001973737,0.0128052672076767,0.000262249032437855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,37247,0.00946695004660109,0.00259421648622261,0.00438228573360478,0.0145516143595974,0.000264051297011069
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39526,0.0131937178642094,0.00362289167171042,0.00609285018765695,0.0202945855407618,0.000271683106962168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39458,-0.0150904138107056,0.00414997932222266,-0.023224373282262,-0.00695645433914916,0.000277548335866909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39522,0.046285910483074,0.0127474580116825,0.0213008927801764,0.0712709281859716,0.000283270372679148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39654,0.0128168082400262,0.00353255511191769,0.00589300022066755,0.0197406162593849,0.000286341749181365
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36823,0.0238391971537726,0.00657895182050213,0.0109444515855884,0.0367339427219568,0.000291745329809788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37162,0.0170404790734217,0.00471776042969886,0.0077936686312119,0.0262872895156314,0.000305033460477172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39455,0.0109022828683859,0.00302045299662665,0.00498219499499765,0.0168223707417741,0.000307803244091625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36916,0.00868149261897613,0.00240508834167236,0.0039675194692983,0.013395465768654,0.000307829575671855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39395,0.0167359823704631,0.00464146641325194,0.00763870820048931,0.0258332565404369,0.000312262387624314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37164,-0.00888340976485417,0.00246427527728414,-0.0137133893083311,-0.00405343022137725,0.00031349514611285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36955,0.0174896798971155,0.00485803275960337,0.0079679356882929,0.0270114241059381,0.000319256071440219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,39123,0.0187971199672446,0.00522586685262655,0.00855442093609656,0.0290398189983926,0.000323043194533238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,37122,0.0219986556916126,0.00611579752669443,0.0100116925392916,0.0339856188439337,0.000323107050335795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39582,0.0187887161575799,0.00523951620319618,0.00851926439931535,0.0290581679158444,0.000336893408614723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39123,0.0107591950403761,0.00300399350577683,0.00487136776905354,0.0166470223116987,0.000342560808691676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,37203,0.0172784073097744,0.00482724915919144,0.00781699895775917,0.0267398156617896,0.000345730815113341
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,39123,0.020919675891989,0.00585816035253633,0.00943768160101775,0.0324016701829602,0.000356715365725751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39654,0.0121988785487165,0.0034191469419645,0.00549735054246611,0.0189004065549669,0.00036108006097009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39485,-0.0120145096777125,0.00337317170574727,-0.0186259262209772,-0.00540309313444789,0.000369481840639836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39531,0.0065095921088663,0.00182993626577643,0.00292291702794449,0.0100962671897881,0.000375866926133979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37203,-0.0184087118375733,0.00517866216362716,-0.0285588896782825,-0.00825853399686403,0.000379745994807746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37203,0.0113616894452026,0.00320794186518515,0.00507412338943967,0.0176492555009655,0.000398918950464151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36823,0.0194637184843885,0.0054969475280861,0.00868970132933972,0.0302377356394372,0.0004003470908724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39462,-0.00734881376949593,0.00208167833986615,-0.0114289033156336,-0.00326872422335827,0.000416434156318337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36992,0.0221067755792359,0.00629565216634013,0.00976729733320921,0.0344462538252625,0.00044726033346182
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39404,0.0145985855532903,0.00416132238183663,0.00644239368489051,0.0227547774216901,0.000452542448403678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36861,0.0205419766217274,0.0058644837141482,0.00904758854199696,0.0320363647014579,0.000462055752752005
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,39355,-0.0126912928197498,0.00362370880684924,-0.0197937620811743,-0.00558882355832525,0.000462621417888596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39104,0.0111454429072862,0.0031832076731519,0.00490635586790851,0.017384529946664,0.000464329289872173
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39068,0.0142503642120498,0.00408758008426997,0.0062387072468807,0.022262021177219,0.000491263593535017
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37255,-0.0105694967788816,0.00303551941132973,-0.0165191148250879,-0.00461987873267536,0.000499455517461088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37247,0.00812441988793055,0.00233681823460999,0.00354425614809496,0.0127045836277661,0.000509307126794517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,39355,0.0104651147582154,0.00301315224413814,0.00455933635970465,0.0163708931567262,0.000515857329925255
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36955,0.0152095242122581,0.00438518748808584,0.00661455673560991,0.0238044916889064,0.000525356707988622
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36880,0.0177243182236153,0.00515262313390647,0.00762517688115861,0.027823459566072,0.000583919892494041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37173,0.011999714075622,0.00348851744017432,0.00516221989288038,0.0188372082583637,0.000584066363253186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36992,0.0200357905480918,0.00583403413261977,0.00860108364815709,0.0314704974480266,0.000596020679516954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39123,0.0149757513384654,0.00438585117513185,0.00637948303520697,0.0235720196417238,0.000640580416699164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39654,-0.00881969092050965,0.00258415568640878,-0.0138846360658709,-0.00375474577514845,0.000644224219838069
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39123,0.0153503949217872,0.00449864499339078,0.00653305073474125,0.0241677391088331,0.000646085183165752
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39485,-0.00916570061829716,0.00268668885094859,-0.0144316107661564,-0.00389979047043793,0.000647711138166365
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39428,-0.00615235626777932,0.00180544791498543,-0.00969103418115075,-0.00261367835440788,0.000656943989006524
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,39123,0.0133825417507258,0.00392913458623305,0.00568143796170901,0.0210836455397426,0.000661045008086886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39194,0.0168174566613636,0.00494043481190932,0.0071342044300213,0.0265007088927058,0.000665728718866018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39654,0.0176098322544682,0.00517870037110157,0.00745957952710916,0.0277600849818273,0.000674518281992899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36916,-0.012243767238143,0.00361621164639546,-0.0193315420650781,-0.00515599241120785,0.000711903423596728
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39343,0.0271765827028313,0.00802990661048444,0.0114379657462818,0.0429151996593808,0.000715126087267778
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39104,0.0210003648238444,0.0062283460698727,0.00879280652689395,0.0332079231207949,0.00074887996290193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36861,-0.00962674313295666,0.00286801141207721,-0.015248045500628,-0.00400544076528534,0.00079146502240377
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36823,0.0177239911231148,0.00528293301115434,0.00736944242125232,0.0280785398249773,0.000796171594631993
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,39130,0.0256773694382731,0.00765411519156964,0.0106753036627967,0.0406794352137496,0.000796482267884015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36848,0.00816911592637034,0.00243512607933035,0.00339626881088284,0.0129419630418578,0.000796895917722798
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37162,0.00832019097227248,0.00248571219795108,0.00344819506428835,0.0131921868802566,0.000818673247152392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39123,-0.00883249650516496,0.00264017686189462,-0.0140072431544784,-0.00365774985585151,0.000823645632995774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39123,0.0156801287732824,0.00470510899999652,0.00645811513328923,0.0249021424132756,0.000862590193361651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,39123,0.0122353919404813,0.00367199081478855,0.00503828994349572,0.0194324939374668,0.000864103944226609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39455,-0.00552019518065993,0.00165751450141132,-0.00876892360342612,-0.00227146675789373,0.000869288022464338
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39477,0.0111464373293874,0.00334783242749581,0.00458468577149566,0.0177081888872792,0.000872273528498327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,39045,0.0132922439562045,0.00400043550622035,0.00545139036401261,0.0211330975483964,0.000893701687385698
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36847,0.0079625221392713,0.00239781286558029,0.00326280892273393,0.0126622353558087,0.000900372524594514
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39516,0.00829297880393047,0.00250507156119091,0.0033830385439963,0.0132029190638647,0.000933563134655666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36989,0.0071058447711211,0.00214824764404526,0.0028952793887924,0.0113164101534498,0.000943167896981025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,37196,0.00890294237979479,0.00269175034124594,0.00362711171095275,0.0141787730486368,0.000943960205605091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37164,-0.0489794818406269,0.014820198886127,-0.0780270716574359,-0.0199318920238179,0.000952684566979353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39103,-0.00794211098655164,0.00240469440037828,-0.0126553120112931,-0.00322890996181021,0.00095970051467034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39518,0.0180054101939446,0.00545664516708882,0.00731038566645055,0.0287004347214387,0.000970053841921437
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39428,0.0100787331933495,0.00305734401828251,0.00408633891751577,0.0160711274691832,0.000981026871327048
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36916,-0.00629873255615941,0.00191168228189624,-0.010045629828676,-0.00255183528364277,0.000987442095464067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,37164,0.0163362181816885,0.00496589566967407,0.00660306266912738,0.0260693736942497,0.00100573456844335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39589,0.00727705138139184,0.00221302550944369,0.00293952138288221,0.0116145813799015,0.00101030781088624
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36823,0.0131273486020854,0.00399483497563007,0.00529747204985048,0.0209572251543203,0.0010187485449814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39462,0.0112523454785733,0.00342897823327355,0.00453154814135713,0.0179731428157894,0.00103475778796649
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37255,0.00863655622236542,0.00263266069306782,0.00347654126395249,0.0137965711807784,0.00103884478587327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36955,0.0152445818835071,0.00464921218056835,0.00613212600959311,0.024357037757421,0.00104475006374563
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36763,-0.0140939876262155,0.00430062119810752,-0.0225232051745063,-0.00566477007792481,0.00105133149958447
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36880,0.00732655357032141,0.00224112311681321,0.00293395226136752,0.0117191548792753,0.00108166756573384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39428,-0.00555401697407121,0.0016995535133063,-0.00888514186015155,-0.00222289208799086,0.00108582316427619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,39187,0.0164540016059078,0.00504145424845221,0.00657275127894147,0.0263352519328741,0.00110202120235211
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39428,0.0114963630207323,0.0035371390816945,0.00456357042061109,0.0184291556208535,0.00115583814344344
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39104,0.0153088049319896,0.0047141361576686,0.00606909806295911,0.02454851180102,0.00116716204595873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37183,0.0106780979483143,0.00329057949479864,0.00422856213850896,0.0171276337581196,0.00117732862716215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39123,0.00819189312895179,0.0025250480260883,0.00324279899781873,0.0131409872600848,0.00118022951997232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36880,0.0172866064079198,0.00533348868139459,0.00683296859238645,0.0277402442234532,0.00119364425764775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37221,0.0104763549030466,0.00323319136115294,0.00413929983518688,0.0168134099709064,0.00119729874823355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,37140,0.0157610103916849,0.00486563549580782,0.00622436481990158,0.0252976559634682,0.00120152894392396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,37091,0.0123132099869275,0.00380176915914467,0.00486174243500398,0.0197646775388511,0.00120339268927343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36861,0.0187436465131515,0.00584088313042204,0.00729551557752429,0.0301917774487787,0.0013351604623913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,37228,0.0124705888561191,0.00390202683793109,0.00482261625377411,0.020118561458464,0.00139721887770834
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38961,0.0109193972143682,0.00341886167698608,0.00421842832747546,0.0176203661012609,0.00140679593607534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,37221,0.0146649392674674,0.00459766332867863,0.00565351914325724,0.0236763593916775,0.0014278908053199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,39104,0.0102755579220347,0.00322391148675389,0.00395669140799702,0.0165944244360723,0.00143911595266028
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39541,0.00560278096712672,0.00175922624699469,0.00215469752301712,0.00905086441123632,0.00145149345176695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,39355,0.0353659759989729,0.0111413981737294,0.0135288355784633,0.0572031164194825,0.00150511409415575
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39654,0.0134718630677384,0.00424441670169409,0.00515280633241798,0.0217909198030588,0.00150642974168296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36763,-0.0121282487223385,0.00382522352476902,-0.0196256868308857,-0.00463081061379121,0.00152498037825794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,39358,-0.0142489714733793,0.0044990992792382,-0.0230672060606862,-0.00543073688607239,0.00154292597811408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39123,0.0129608197261317,0.00410086334169714,0.00492312757640527,0.0209985118758581,0.00157813318094243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39428,-0.00885395365334426,0.00280231508071203,-0.0143464912115398,-0.00336141609514869,0.00158346843973771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36763,0.0152735204025571,0.00484928302088672,0.00576892568161915,0.0247781151234951,0.0016385995876628
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39383,0.0155921992666784,0.00495367640058599,0.00588299352152982,0.0253014050118269,0.00164939813368105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,37241,0.00393986853183787,0.00125195066787865,0.00148604522279571,0.00639369184088003,0.00165342748980068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,37221,0.00818155760132934,0.0026010608160773,0.00308347840181783,0.0132796368008408,0.00166201017454099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37269,0.00672167566480182,0.00214097339759452,0.00252536780551656,0.0109179835240871,0.00169596437756677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36847,0.016460534841418,0.00524503920951921,0.00618025799076038,0.0267408116920757,0.00170326139304618
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,37247,0.0093948618888536,0.00299551983020044,0.00352364302166074,0.0152660807560465,0.0017147922688192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,37164,-0.02858420964238,0.00912204629502722,-0.0464634203806334,-0.0107049989041266,0.00173109648785414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39589,0.019264362014415,0.00614856971298954,0.00721316537695546,0.0313155586518745,0.00173273820632484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,37255,0.00615166646570621,0.00196494505475929,0.00230037415837801,0.0100029587730344,0.0017477859729449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,39187,0.00807865263616784,0.00258574280474695,0.00301059673886381,0.0131467085334719,0.00178570536905917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,39104,0.0139630308834893,0.00447070310705978,0.00520045279365207,0.0227256089733264,0.00179226866120112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39601,-0.0119748042077297,0.00384007755315264,-0.0195013562119089,-0.00444825220355054,0.00182191621051216
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39194,0.0159873083962624,0.00512888018814923,0.0059347032274899,0.0260399135650349,0.00182981563474998
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39537,0.0275013953012478,0.00884143014437771,0.0101721922182674,0.0448305983842281,0.00187110007192257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37269,-0.00519087953179011,0.00167203653277204,-0.00846807113602332,-0.0019136879275569,0.00190999972228085
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39400,0.00884587851574849,0.00285111857077193,0.0032576861170355,0.0144340709144615,0.00192186722086087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,37269,0.00506155486347806,0.00163185501765981,0.00186311902886483,0.00825999069809129,0.00192818676880855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36847,-0.00970974939859407,0.00313234815683732,-0.0158491517859952,-0.00357034701119292,0.00194065066086244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39477,-0.00950628633827005,0.00306825625346553,-0.0155200685950625,-0.00349250408147761,0.00195013099718633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39415,-0.0473615978590372,0.0152928481729377,-0.077335580277995,-0.0173876154400794,0.0019586671429643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39458,0.0272822664120817,0.00881553621732714,0.0100038154261206,0.0445607173980429,0.00197312108179563
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,37269,0.00574929328728882,0.00185832525761368,0.002106975782366,0.00939161079221164,0.00198033427714707
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,39309,0.0182393211240262,0.00590611579208759,0.00666333417153457,0.0298153080765179,0.00201737902662025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39462,0.0223212976976077,0.00724424642490125,0.00812257470480129,0.0365200206904142,0.00206510050755843
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39104,0.0168043102086497,0.00546371465376621,0.0060954294872679,0.0275131909300314,0.00210452219717994
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36916,0.0146015998386697,0.0047501426901041,0.00529132016606567,0.0239118795112737,0.00211716407899181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37247,0.00873232652651232,0.00285192900722253,0.00314254567235616,0.0143221073806685,0.00220391919621598
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36847,0.0100669159558235,0.00328921207707568,0.0036200602847552,0.0165137716268919,0.00221376799962839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36880,0.00885570836166033,0.00289540766821797,0.00318070933195311,0.0145307073913676,0.00222894611537162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37221,0.00806129339785365,0.00263825289160579,0.0028903177303063,0.013232269065401,0.0022511739883071
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36916,0.0115933873300236,0.00379839709449334,0.00414852902481663,0.0190382456352305,0.00227664963642068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39636,0.00884813002487618,0.00290174728592637,0.00316070534446049,0.0145355547052919,0.00229814536505767
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39531,-0.00629270533218048,0.00206594981453632,-0.0103419669686717,-0.00224344369568929,0.00232374829808452
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39462,0.0230719584610364,0.00759769586125365,0.0081804745729793,0.0379634423490936,0.00239590050018498
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36916,0.0134625319958702,0.00444165673586879,0.00475688479356741,0.0221681791981731,0.00244269059556288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36992,0.0184973141936579,0.00610390420518278,0.0065336619514996,0.0304609664358161,0.00244722183805267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39566,0.0125159937298245,0.00413474422908906,0.00441189504080993,0.0206200924188391,0.00247385603549022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39123,0.0117794059653632,0.00389359064277886,0.00414796830551667,0.0194108436252098,0.00248790036933097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36955,0.0219463241181013,0.0072663944856691,0.00770419092618983,0.0361884573100127,0.0025307660340815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37162,0.0135135297621596,0.00449228227875246,0.00470865649580474,0.0223184030285144,0.00263344261782721
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39123,0.00920372348569227,0.00306594346231753,0.00319447429954991,0.0152129726718346,0.00268732332771251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,39123,0.0151044516063001,0.00504607482786759,0.00521414494367958,0.0249947582689205,0.00276431527676569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39589,0.00601985132982368,0.00201552618076019,0.0020694200155337,0.00997028264411365,0.00282421544113631
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36880,0.0161246336775033,0.00540979285408627,0.00552143968349419,0.0267278276715124,0.00288205575975761
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36763,0.013076441374276,0.00440106987644221,0.0044503444164493,0.0217025383321028,0.00297215454915099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36763,0.0155977679278936,0.00525970847514331,0.00528873931661267,0.0259067965391745,0.00302751932681559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39654,0.00589382967232875,0.00198856900196282,0.00199623442848163,0.00979142491617588,0.00304282670155766
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,37162,0.0103684191439149,0.0034984153402529,0.00351152507701919,0.0172253132108105,0.00304481242678814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39104,0.00973033322404466,0.0032873285748986,0.0032871692172434,0.0161734972308459,0.00308180016974058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37247,0.00730221548556594,0.00247387854926729,0.00245341352900206,0.0121510174421298,0.00316575095537977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36880,0.0108871398171213,0.00370020607908293,0.00363473590211876,0.0181395437321239,0.00326379125811552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39654,0.00389114496318703,0.00132340696453893,0.00129726731269072,0.00648502261368334,0.00328443258031977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39636,0.00680873671522847,0.00232077382769467,0.00226002001294692,0.01135745341751,0.00335317213561623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36847,0.0175352657642419,0.00600136596155549,0.00577258847959311,0.0292979430488906,0.00348554711117461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39654,0.00804123087707424,0.00275462446521842,0.00264216692524613,0.0134402948289023,0.00351473979532547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39462,0.0372799663567893,0.0127778472562813,0.012235385734478,0.0623245469791006,0.00353319889249438
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39455,-0.0080781574864094,0.00277124965636852,-0.0135098068128917,-0.00264650815992709,0.00356229016913543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36928,0.00792691413342174,0.00272220215663838,0.00259139790641051,0.013262430360433,0.00359817478817795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36992,0.0137737028358502,0.00474794105324602,0.00446773837148796,0.0230796673002124,0.00372639151040677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39355,0.0127314168717147,0.0043972331253981,0.0041128399459344,0.0213499937974949,0.00379316883166217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,39104,0.00876224684612166,0.00303251621733774,0.00281851506013968,0.0147059786321036,0.00386505467670429
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36823,-0.0131933720394291,0.00457586212104867,-0.0221620617966845,-0.00422468228217366,0.00394268497310593
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36847,-0.00820387811996404,0.0028557376960419,-0.0138011240042062,-0.0026066322357219,0.0040758072538233
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37162,0.0141112269362341,0.00491406396575794,0.00447966156334849,0.0237427923091196,0.00409074439675108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36955,-0.0191815494015925,0.0066814037386223,-0.0322771007292922,-0.00608599807389277,0.0041001016157863
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37243,-0.00632323863646531,0.00220551187171329,-0.0106460419050234,-0.00200043536790726,0.00415038286533331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36861,0.0188846107406936,0.00659510852389742,0.00595819803385465,0.0318110234475325,0.0041978788814838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39187,0.0143035835076243,0.00499573057756591,0.0045119515755951,0.0240952154396535,0.00420028398494494
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39618,0.0128146483420901,0.00448870838927448,0.00401677989911216,0.0216125167850681,0.0043113765948373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39654,0.0119922865545694,0.00420373715789917,0.003752961725087,0.0202316113840517,0.00433987450262371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36823,0.0176715403309709,0.00621344861102681,0.00549318105335836,0.0298498996085835,0.00446130199878118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36847,0.0152428364205799,0.00536985969152889,0.00471791142518328,0.0257677614159765,0.00453868303382939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39462,-0.0082647912329595,0.00292236741657617,-0.0139926313694488,-0.00253695109647021,0.00468849931187367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36880,0.0160070337861618,0.00566852051582918,0.00489673357513664,0.027117333997187,0.00475265487824717
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39445,0.0199074010551469,0.00706345661591751,0.00606302608794861,0.0337517760223452,0.00483320674000104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,37247,0.0134024052549031,0.00476188788187636,0.00406910500642549,0.0227357055033808,0.00489254806380512
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36847,0.0103723907731347,0.00368870437275636,0.00314253020253224,0.0176022513437372,0.00493220762484806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39123,0.0108876857492818,0.00387459632394644,0.00329347695434681,0.0184818945442169,0.0049604305400479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36847,0.00857404439860726,0.00305395538800733,0.0025882918381129,0.0145597969591016,0.00500023898891496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39187,0.00903422563239593,0.00322186089495455,0.00271937827828501,0.0153490729865069,0.00505327196416781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36861,0.0102911462413191,0.00367819951140309,0.00308187519896907,0.0175004172836692,0.00515191289656931
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37241,0.00443710380916123,0.00158624159591925,0.0013280702811595,0.00754613733716295,0.00516177002613102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39104,0.0131946151996918,0.00473070507035355,0.0039224332617988,0.0224667971375847,0.00529158474526531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39428,0.00735340143766097,0.00265030391550028,0.00215880576328042,0.0125479971120415,0.00553465766933758
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36861,0.0245956272296195,0.00889376404500425,0.00716384970141121,0.0420274047578279,0.00569211125876095
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37162,0.00949974336240617,0.00343732314679501,0.00276258999468794,0.0162368967301244,0.00572316378987718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39531,-0.00560680215679302,0.00203379240599847,-0.00959303527255002,-0.00162056904103602,0.00584364241976736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37119,0.0112868207070603,0.00409693258431721,0.0032568328417986,0.0193168085723221,0.00587859655304803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36992,0.0175818678248863,0.00638354712335536,0.00507011546310976,0.0300936201866628,0.00589120618700203
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39499,-0.00695179443968186,0.0025261158706154,-0.011902981546088,-0.00200060733327568,0.0059308921644137
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39440,0.0094724975651003,0.00344385243271046,0.0027225467969878,0.0162224483332128,0.00595662062044224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39431,0.0147625987675992,0.00539137851856225,0.00419549687121716,0.0253297006639812,0.00618520451430805
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39355,0.00810012264278059,0.00295997449227451,0.00229857263792255,0.0139016726476386,0.0062160431259187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39589,0.0112439045560456,0.00410884888337752,0.00319056074462564,0.0192972483674655,0.00621672002228716
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37221,0.00819597738238789,0.00299653823949005,0.0023227624329874,0.0140691923317884,0.00624381805273806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36847,0.0110196032166628,0.00403495543175084,0.00311109057043116,0.0189281158628945,0.00632251156523903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36916,-0.00972597878143287,0.00356357455107046,-0.016710584901531,-0.00274137266133477,0.00635626018676178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39068,0.0101777900375799,0.00373088073433804,0.00286526379827739,0.0174903162768825,0.00637984455140351
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,37162,0.00830473216456192,0.00304423066613239,0.00233804005894245,0.0142714242701814,0.00638026346448876
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39509,0.00751642812973473,0.00275546392333176,0.00211571884000448,0.012917137419465,0.00638269910847094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39485,-0.00705538817684708,0.00258704413382713,-0.0121259946791483,-0.0019847816745459,0.00639483063345736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36955,0.00494484218248845,0.00181319506558981,0.00139097985393243,0.00849870451104447,0.00639744609545415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39654,0.0123001297986415,0.00451359447855285,0.00345348462067795,0.0211467749766051,0.00643497943494734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,39123,0.0143875621670654,0.00528474631215177,0.00402945939524796,0.0247456649388829,0.00648725053583514
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39428,0.0238569572391642,0.00877301718273181,0.00666184356100983,0.0410520709173185,0.00654845481080415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36847,-0.0121545300787609,0.00447050704046193,-0.0209167238780663,-0.00339233627945555,0.00656052645560445
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39123,0.0198218816451547,0.00729090946053481,0.00553169910250651,0.034112064187803,0.00656137204279746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39428,-0.00977934891880269,0.00359949695839059,-0.0168343629572482,-0.00272433488035712,0.00659791010742316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37221,0.00920975093863057,0.00339795998885688,0.00254974936047109,0.0158697525167901,0.0067296648514225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36955,0.00518984864964772,0.0019198604440286,0.00142692217935167,0.00895277511994377,0.00687593962078513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37143,0.00957456002776317,0.00354221958380507,0.00263180964350523,0.0165173104120211,0.00688116839132781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36880,-0.00982514959422875,0.00363516931452554,-0.0169500814506988,-0.00270021773775869,0.00688507385920495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36916,0.00944144909303221,0.00349616164800369,0.00258897226294498,0.0162939259231194,0.00693250106369568
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36948,-0.00729037437595755,0.00270033345690139,-0.0125830279514843,-0.00199772080043082,0.0069473470774892
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39510,-0.00643043639128494,0.00238411718583949,-0.0111033060755303,-0.00175756670703955,0.00700034890895112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36932,-0.0085086087288962,0.00315587970146546,-0.0146941329437685,-0.00232308451402389,0.0070247923238203
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36929,0.0123920314414413,0.00460375318746683,0.00336867519400631,0.0214153876888763,0.00711786183914747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39412,-0.00798021515892795,0.00296665812198971,-0.0137948650780278,-0.00216556523982812,0.00715381858642577
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37162,-0.00884420428641802,0.00329465018481751,-0.0153017186486603,-0.0023866899241757,0.0072751328695428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36847,-0.00729139205648656,0.00271650589627055,-0.0126157436131769,-0.00196704049979628,0.0072820508983452
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,37221,0.00749224871112282,0.00279527348184006,0.00201351268671629,0.0129709847355293,0.00736445396904052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39621,-0.0139393384852311,0.00520227712290213,-0.0241358016461193,-0.00374287532434289,0.00738186833031102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36955,0.00832416854953204,0.00311874741287908,0.00221142362028904,0.014436913478775,0.00761588370141535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36916,0.00722780246391768,0.00271042144014197,0.00191537644123942,0.0125402284865959,0.00767055143136916
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,37203,-0.0164093679024952,0.00616261617721448,-0.0284880956098355,-0.00433064019515478,0.007760744770325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36916,-0.0119318953852799,0.00448299893748842,-0.0207185733027572,-0.00314521746780263,0.00778727805690719
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36847,0.0264987370595778,0.0099636391441263,0.00697000433709026,0.0460274697820653,0.00783471211086302
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39485,0.00768340061109071,0.00289160614911628,0.00201585255882281,0.0133509486633586,0.00788901340812848
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39477,-0.00600703748743646,0.00226370604835679,-0.0104439013422158,-0.00157017363265715,0.00797149757772489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39485,-0.00643552029398399,0.00242556480956054,-0.0111896273207227,-0.00168141326724533,0.00798152842446585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39636,-0.00824060484811324,0.00310623441097237,-0.0143288242936191,-0.0021523854026074,0.00798807771718745
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39123,0.022347536867813,0.00842751789302983,0.00582960179747457,0.0388654719381515,0.00801656588197502
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39104,-0.0156965359070708,0.00592243935697515,-0.0273045170467421,-0.00408855476739947,0.00804948667078568
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36880,0.0071176983764359,0.00269080195420912,0.00184372654618603,0.0123916702066858,0.00817463332244941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39123,0.00679989315765002,0.00257433805566917,0.00175419056853845,0.0118455957467616,0.00826482381810798
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39187,0.0125005785658996,0.00473311825340038,0.00322366678923482,0.0217774903425643,0.00827276124438061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39559,0.0182312628605653,0.00691138661491771,0.00468494509532654,0.031777580625804,0.00835167681254488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39462,0.0152155103869252,0.00577017216610387,0.00390597294136162,0.0265250478324888,0.00837475294682277
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36880,0.0066093416288741,0.00252046564533765,0.0016692289640123,0.0115494542937359,0.00874527011145665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,37221,-0.00977627152545103,0.00372984173192071,-0.0170867613200156,-0.00246578173088645,0.00877515594695903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39554,0.0062405279775583,0.00238458715703318,0.00156673714977326,0.0109143188053433,0.0088787811783429
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39428,-0.00475599956534312,0.00181763139177109,-0.00831855709321445,-0.00119344203747179,0.00889016377772557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36823,-0.011402009735576,0.00435881188785603,-0.0199452810357738,-0.00285873843537815,0.00891130437674706
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39541,-0.00629839601071811,0.00241203915443613,-0.0110259927534129,-0.00157079926802329,0.00903056884817516
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,39194,0.0108973018088462,0.00417432782016196,0.00271561928132877,0.0190789843363637,0.00904875610499461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37203,0.00669096065867313,0.00256336011192116,0.00166677483930765,0.0117151464780386,0.00905870379119018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,39104,-0.00970504852656199,0.00373708693793914,-0.0170297389249227,-0.00238035812820126,0.00941480842227048
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,39332,0.0100362784869817,0.00386637709994912,0.00245817937108145,0.017614377602882,0.00944681739524511
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36955,0.0155501873035104,0.00599946017307638,0.00379124536428068,0.0273091292427401,0.00955498787383823
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36763,-0.0103279017781551,0.00398609180821349,-0.0181406417222535,-0.00251516183405667,0.00958147093807596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36916,0.00827974324802976,0.00319822988641772,0.00201121267065103,0.0145482738254085,0.00964083879293805
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36880,0.0126702421105139,0.00491013692790541,0.00304637373181927,0.0222941104892085,0.00987923089759795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39462,0.0100265443014442,0.00388956067448314,0.00240300537945726,0.0176500832234312,0.00995234162469646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39654,-0.0076250169341104,0.00296805310633539,-0.0134424010225278,-0.00180763284569304,0.0102078193235078
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39636,-0.00764285970024555,0.00297629608731552,-0.013476400031384,-0.00180931936910713,0.0102408577126371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39636,0.00892227839611086,0.0034781459679452,0.00210511229893828,0.0157394444932835,0.0103199690112164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36483,0.0270144525103524,0.0105399625862948,0.00635612584121462,0.0476727791794902,0.0103877568774669
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39104,0.0182949416355471,0.00714307401988117,0.00429451655658004,0.0322953667145142,0.0104406279444917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37127,0.00947273129584041,0.00369923219494759,0.00222223619374313,0.0167232263979377,0.0104567564421454
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,37203,0.014586587733104,0.00569947099288244,0.00341562458705439,0.0257575508791536,0.0105001144801495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,37164,0.00739760690608187,0.00289093583472804,0.00173137267001491,0.0130638411421488,0.0105119616780196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39601,-0.0130098252773734,0.00508557271190165,-0.0229775477927006,-0.00304210276204612,0.0105317120784807
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39428,0.00755937820201219,0.00295615977231946,0.00176530504826604,0.0133534513557583,0.0105627841234797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37221,0.00937213590337293,0.00366559417399431,0.00218757132234409,0.0165567004844018,0.0105759118139775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36847,0.00808360013579259,0.00316748768800015,0.00187532426731229,0.0142918760042729,0.0107208762894262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,37162,-0.0176626621921826,0.00692854624427054,-0.0312426128309529,-0.00408271155341234,0.0108068372250174
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36831,-0.00880863114880627,0.00345714471343181,-0.0155846347871326,-0.00203262751047993,0.0108477836275524
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36861,0.0142286093997333,0.00558796220136638,0.00327620348505517,0.0251810153144114,0.0108992397941157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,39355,-0.00728572908624255,0.00286626004066542,-0.0129035987659468,-0.00166785940653832,0.0110353989667112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39355,-0.0151227098268632,0.00595233067290706,-0.0267892779457611,-0.0034561417079654,0.0110751382986078
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36880,0.0044059768705678,0.00173598995591717,0.00100343655697016,0.00780851718416545,0.0111602729334671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36861,0.0119075515986842,0.00469587875952365,0.00270362923001783,0.0211114739673505,0.0112330011912716
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39428,-0.00328222522484716,0.00129444808692993,-0.00581934347522983,-0.000745106974464488,0.0112350068149849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36763,-0.025361085270402,0.0100039578558798,-0.0449688426679265,-0.00575332787287761,0.0112536293517881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,37162,0.00858790863711795,0.00339362667821434,0.00193640034781784,0.0152394169264181,0.0113987561781905
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,37162,-0.00867548425853223,0.00343337559340696,-0.0154049004216099,-0.0019460680954546,0.0115224400443572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39420,0.0064445895769577,0.00255173163137895,0.00144319557945495,0.0114459835744605,0.0115611467191862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37201,0.00478503273634452,0.00189917426090258,0.00106265118497546,0.00850741428771357,0.0117631739884024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,39145,-0.0134450973415714,0.00534195874500567,-0.0239153364817825,-0.00297485820136031,0.0118502938531684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,37093,0.00629172084037844,0.00250009175216118,0.00139154100614254,0.0111919006746143,0.0118617379848243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39187,0.013373366901118,0.00533902901178092,0.00290887003802742,0.0238378637642086,0.0122616904843009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36880,-0.0100706002137974,0.00403825416307002,-0.0179855783734146,-0.00215562205418014,0.0126512519454362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37203,0.00565517998788379,0.00226770549116159,0.00121047722520708,0.0100998827505605,0.0126513191549197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37255,0.0124808949150634,0.00501439407792121,0.00265268252233784,0.022309107307789,0.0128224098753156
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39428,0.00601996683992913,0.00241929576658221,0.001278147137428,0.0107617865424303,0.012845829740882
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37269,-0.0068936245705709,0.00277622384406404,-0.0123350233049364,-0.00145222583620537,0.0130373665202432
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37203,0.00617222695658968,0.00248664538491762,0.00129840200215115,0.0110460519110282,0.0130720022758813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36955,0.00915914935961004,0.00369248127025917,0.00192188606990207,0.016396412649318,0.013133387535194
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36651,-0.00820000679010481,0.00331648853137697,-0.0147003243116037,-0.00169968926860596,0.0134308292038127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39389,0.00626658053775196,0.0025353717084488,0.00129725198919231,0.0112359090863116,0.0134597445389298
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39123,0.0161813968460471,0.00656579592220624,0.00331243683852285,0.0290503568535713,0.0137318737515288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36847,0.0168316426988043,0.00684715553276089,0.00341121785459297,0.0302520675430157,0.01397731781973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36916,-0.0131930139259756,0.00537281164078463,-0.0237237247419135,-0.00266230311003772,0.0140818833498495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39636,0.0106062756659103,0.00432289726641263,0.00213339702374153,0.019079154308079,0.0141580800084051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39428,0.00599760392584195,0.00245171892195511,0.00119223483880994,0.010802973012874,0.0144450948948509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36880,0.0097098805437217,0.00396952232017272,0.00192961679618318,0.0174901442912602,0.0144545372534245
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39123,-0.0253227965376392,0.0103564958834623,-0.0456215284692253,-0.00502406460605308,0.0144923769921316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39104,0.00973613664944766,0.00398470235643898,0.00192612003082725,0.0175461532680681,0.0145621810419414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36763,-0.00957100634586877,0.00392288732661595,-0.017259865506036,-0.00188214718570152,0.0147099712212108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36880,0.00793395394987484,0.00325382038393015,0.00155646599737175,0.0143114419023779,0.0147683768862188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,39019,0.0145140142014407,0.00595353136974684,0.0028450927167369,0.0261829356861445,0.0147854196084968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39428,0.00770363893940984,0.00316246170301373,0.00150521400150293,0.0139020638773168,0.0148637922030282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,39123,-0.01744700870594,0.00717309097048605,-0.0315062670080926,-0.00338775040378733,0.0150157319879353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39601,0.00796671288353431,0.00327571935817526,0.00154630294151079,0.0143871228255578,0.0150251451725349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39123,0.0112396243989199,0.00462361895751055,0.00217733124219926,0.0203019175556406,0.0150726482728285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36992,0.00948095586900709,0.003925453787192,0.00178706644611078,0.0171748452919034,0.0157385812930793
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36992,-0.0075747430544514,0.00313672978204355,-0.0137227334272568,-0.00142675268164605,0.0157557529169041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39507,0.00629206625043539,0.0026122518474942,0.00117205262934676,0.011412079871524,0.0160224745356757
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37203,-0.0146107535326837,0.00607572778910061,-0.0265191799993209,-0.00270232706604652,0.016196623033894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39606,0.0142529434292737,0.00593230930901537,0.00262561718360363,0.0258802696749439,0.0162911047229894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39502,0.00969980725917551,0.00404582836999843,0.00176998365397858,0.0176296308643724,0.016520229838001
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,39104,-0.00669258989139436,0.00280942510641416,-0.0121990630999661,-0.0011861166828226,0.0172226055908782
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,37203,0.0265494913973661,0.0111658294474061,0.00466446568045021,0.0484345171142819,0.0174335365537932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37162,0.00762018909343948,0.00321143263763096,0.00132578112368279,0.0139145970631962,0.0176670969227949
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,39355,0.0112769178973861,0.00476470541037607,0.00193809529304901,0.0206157405017232,0.0179572358055356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36847,-0.00748847338537502,0.00316608747316722,-0.0136940048327828,-0.00128294193796727,0.0180349803710602
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39428,0.00775554605174927,0.00328042711053096,0.00132590891510859,0.0141851831883899,0.0180823321802687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39388,0.00844727712971574,0.003577454654318,0.00143546600725246,0.015459088252179,0.0182260445466557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36880,-0.00646998076832958,0.00274070812560291,-0.0118417686945113,-0.00109819284214789,0.0182559926935781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36880,0.00714568697310919,0.00302777785509331,0.0012112423771263,0.0130801315690921,0.0182881653352963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36880,0.00756885963543281,0.00320904293217609,0.00127913548836767,0.0138585837824979,0.0183592399316696
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39194,0.0120466571815598,0.00511064048995193,0.00202980182125397,0.0220635125418655,0.0184277282109908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36880,-0.0125982551068308,0.0053453623605805,-0.0230751653335686,-0.00212134488009306,0.0184457638127871
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39601,0.0122451960277908,0.00519787872322351,0.00205735373027274,0.0224330383253089,0.0184952171205666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39589,-0.00545940583549868,0.00232859388006913,-0.0100234498404342,-0.000895361830563191,0.0190650808588697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39526,0.0074842726710972,0.00319500239425187,0.00122206797836354,0.0137464773638309,0.0191683010921025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36880,0.00653539734210252,0.00279087070957612,0.00106529075133332,0.0120055039328717,0.0192115627446501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,37221,-0.00426438428397623,0.00182688134073383,-0.00784507171181452,-0.000683696856137929,0.0195984465523516
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39428,0.00433940445439218,0.00185977090562374,0.000694253479369644,0.00798455542941472,0.0196455435317737
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36763,-0.00602093851995489,0.00258611640583526,-0.011089726675392,-0.00095215036451778,0.0199187839668112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39608,-0.00896655484752682,0.00385817714780296,-0.0165285820572206,-0.00140452763783303,0.0201365464521761
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39194,0.00805213143520043,0.00346507113141343,0.00126059201763011,0.0148436708527707,0.0201497543332301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,39187,0.00884138578842301,0.00381750117651027,0.00135908348246288,0.0163236880943831,0.0205711643897391
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36992,0.00582338222119131,0.00251710001588361,0.000889866190059429,0.0107568982523232,0.020709699594274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37203,0.00430895053818176,0.00186932280773273,0.000645077835025611,0.00797282324133792,0.0211777150567921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36861,0.00768661808139708,0.00333929774125764,0.0011415945085321,0.0142316416542621,0.0213591733463595
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39104,0.00973461430336365,0.00423644733053577,0.00143117753551355,0.0180380510712137,0.0215857756517198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39485,0.00619284661764183,0.00270264057933081,0.000895671082153442,0.0114900221531302,0.0219537119286079
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36955,-0.00547599603008853,0.00240053801169398,-0.0101810505330087,-0.000770941527168334,0.0225560967942315
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39458,0.0141421468926087,0.00623153925888757,0.00192832994518909,0.0263559638400284,0.0232552964133748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39462,0.0192158923389436,0.00846763618645821,0.00261932541348556,0.0358124592644017,0.0232621654188015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36847,0.00718490095224499,0.00316693379526251,0.000977710713530457,0.0133920911909595,0.0233021899926855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36847,0.00630446907649624,0.00278133907083566,0.000853044497658341,0.0117558936553341,0.0234255425340151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37247,0.00593684119838078,0.00262048653317371,0.000800687593360304,0.0110729948034013,0.0234956378200244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36823,-0.0178071898371611,0.00786033984666712,-0.0332134559366287,-0.00240092373769356,0.0235024244945903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36916,0.0109203005641772,0.00483218775724578,0.00144921255997543,0.0203913885683789,0.0238441376344053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36847,0.00768380637930665,0.00340294566950675,0.00101403286707342,0.0143535798915399,0.0239638007983847
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39524,0.00776700927069305,0.00344269924888469,0.00101931874287905,0.014514699798507,0.0240798132624962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,37203,0.0119584439578163,0.00530177135115223,0.00156697210955797,0.0223499158060747,0.0241153087870841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39499,-0.00633751464575802,0.00281035055331144,-0.0118458017302484,-0.000829227561267601,0.0241437497720054
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39194,0.00734023507188331,0.00325753690327949,0.000955462741455497,0.0137250074023111,0.0242543480392069
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39194,0.0107886243480033,0.00479433450430171,0.00139172871957195,0.0201855199764346,0.024445469975156
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36880,0.00685501347763575,0.00305832812008509,0.000860690362268981,0.0128493365930025,0.0250161294016068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39579,-0.00822256678378247,0.00367382601393221,-0.0154232657710896,-0.00102186779647534,0.025225889234109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,37255,-0.0173448487006812,0.00775132703115304,-0.0325374496817412,-0.00215224771962125,0.0252602467096908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37255,-0.00400723712115889,0.00179796960982274,-0.00753125755641146,-0.000483216685906314,0.0258473764134271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37162,0.00750071384128433,0.00336736350660693,0.000900681368334742,0.0141007463142339,0.0259330677988654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37247,0.0112771791690399,0.00506746472707208,0.00134494830397861,0.0212094100341012,0.0260711872202854
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39123,-0.00711698201778997,0.0032070088589983,-0.0134027193814266,-0.000831244654153298,0.0264886138629071
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38483,0.0090995999461818,0.00410152984297238,0.00106060145395593,0.0171385984384077,0.0265307911979545
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39589,0.00493423039051515,0.00222595730227967,0.000571354078046984,0.00929710670298331,0.0266599152450501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36847,0.0119770562278081,0.00540513551212473,0.00138299062404363,0.0225711218315726,0.0267187746902776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36852,0.0111569391567239,0.00503595713128171,0.0012864631794118,0.0210274151340361,0.0267469093921296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36763,0.0126137436090959,0.00569383120351507,0.00145383445020639,0.0237736527679855,0.0267553085874164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36992,0.0124885772526073,0.00564782682789349,0.00141883666993609,0.0235583178352786,0.0270387051340184
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36861,-0.00710366506186562,0.00321268691825651,-0.0134005314216484,-0.000806798702082864,0.0270450716787202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39633,0.00787537721733545,0.00356303623919393,0.000891826188515353,0.0148589282461555,0.0270992421191513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39455,0.00562358898209517,0.00254839101136413,0.000628742599821468,0.0106184353643689,0.0273486183822206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36880,0.0091940281870514,0.00417471661694309,0.00101158361784295,0.0173764727562599,0.0276615786697899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36893,-0.00642095105240981,0.00291726033389269,-0.0121387813068395,-0.00070312079798015,0.0277528427635448
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37164,0.00789450029279458,0.00359029334792041,0.000857525330870562,0.0149314752547186,0.0279068605998749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39427,0.00418556790028491,0.00190837306487163,0.000445156693136526,0.0079259791074333,0.0283036104248503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36847,0.0091223873992073,0.00416414110294194,0.000960670837441108,0.0172841039609735,0.0284920048252519
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39104,0.015872656474208,0.00724922906399197,0.00166416750878374,0.0300811454396323,0.0285715324615565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37243,0.0112726894728722,0.00514868118763947,0.00118127434509879,0.0213641046006455,0.0285834300931602
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,37162,0.00896187898321456,0.00410165541952533,0.00092263436094491,0.0170011236054842,0.0289113015124296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36955,-0.00403642477635102,0.00184905092183536,-0.00766056458314833,-0.000412284969553716,0.0290564711757446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37164,0.00492813867744177,0.00226183318078294,0.000494945643107207,0.00936133171177634,0.0293629742683475
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39187,0.00667146491473196,0.00306794278343797,0.000658297059193532,0.0126846327702704,0.0296779994022554
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37221,0.00810941480790565,0.00374001662085116,0.000778982231037373,0.0154398473847739,0.0301555595634275
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36763,-0.013772998444014,0.00635385145823008,-0.0262265473021449,-0.00131944958588301,0.0302035612432136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37162,0.00752135175437627,0.00348223395252035,0.000696173207436376,0.0143465303013162,0.0307973891023608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,37203,-0.00676714090474334,0.00313354197965191,-0.0129088831848611,-0.000625398624625598,0.030823624832846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36894,0.00760610062716686,0.00352386536812579,0.000699324505640313,0.0145128767486934,0.0309116305261413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37203,0.00998890031108698,0.00463031915474572,0.000913474767785378,0.0190643258543886,0.0310023863098566
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36955,-0.0165427902652894,0.00769416720373727,-0.0316233579846145,-0.00146222254596435,0.0315709342265781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39641,0.00620945982326927,0.00288863755315149,0.000547730219092355,0.0118711894274462,0.0316013924911587
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36823,0.00827146250786452,0.00385282893800457,0.000719917789375558,0.0158230072263535,0.0318242605416198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39415,0.00628271152901869,0.00293028606490686,0.000539350841801245,0.0120260722162361,0.0320440782503945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36847,0.00903106670561953,0.00422514145714037,0.000749789449624399,0.0173123439616147,0.032580184449377
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36823,-0.0166194150961565,0.00780023808759047,-0.0319078817478338,-0.00133094844447915,0.033139368085669
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39462,-0.0109910788018083,0.00515985260340093,-0.0211043899044741,-0.000877767699142442,0.0331783464903372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37255,0.00729413256241712,0.00342545827296743,0.000580234347400951,0.0140080307774333,0.0332411284517329
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39104,0.0116861196097248,0.00549929873700463,0.00090749408519575,0.0224647451342539,0.0336016347629842
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39531,0.00496920191586824,0.00233935165587966,0.000384072670344101,0.00955433116139238,0.0336713966495044
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39477,0.0333729252638057,0.0157192146295771,0.00256326458983449,0.0641825859377769,0.0337646490844115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,37164,0.012412217752585,0.00584771435393994,0.000950697618862748,0.0238737378863073,0.0338086796150246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39428,-0.00813728450813665,0.00383576224603109,-0.0156553785103576,-0.000619190505915722,0.0339023750859426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36861,-0.00564147519586593,0.00266935064732326,-0.0108734024646195,-0.000409547927112348,0.03458422355603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36823,0.00616112790296724,0.00291747630118387,0.000442874352646861,0.0118793814532876,0.0347235592426452
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39499,-0.00433104759125004,0.00205155615385554,-0.00835209765280691,-0.000309997529693178,0.0347798561035963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,39194,0.00917897933232809,0.00435753078192654,0.000638218999752069,0.0177197396649041,0.0351809704888902
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36763,-0.0062465928841553,0.00297164815766508,-0.0120710232731788,-0.000422162495131747,0.0355679813100245
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36880,0.0105747937011974,0.00503808293839217,0.000700151141948767,0.0204494362604461,0.0358395145710757
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36847,0.00682304420654432,0.00325335860772198,0.000446461335409249,0.0131996270776794,0.0359933459017532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37164,0.00967532695390711,0.0046144319060771,0.000631040417995995,0.0187196134898182,0.0360350980111307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39478,0.00892738077992138,0.00425823747989827,0.000581235319320772,0.017273526240522,0.03605483114651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36880,0.0155854500418899,0.00747316868553908,0.000938039418233297,0.0302328606655465,0.037042386191286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39123,0.00881566050556016,0.00423341447880726,0.000518168127097925,0.0171131528840224,0.0373232703052598
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,37269,0.00261471739368265,0.00125877140151293,0.000147525446717297,0.00508190934064799,0.037803159019628
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39516,0.0146792524350161,0.00706889506258765,0.000824218112344314,0.0285342867576879,0.0378556016291072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36992,0.0105912250172159,0.00510095907466209,0.000593345230878244,0.0205891048035536,0.0378846552468769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39123,0.0108651701763634,0.00523827876154219,0.000598143803740731,0.0211321965489861,0.0380793379027322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36763,-0.0143404421692511,0.00692057018773064,-0.0279047597372032,-0.00077612460129908,0.0382724571353968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,39123,0.0149593235691092,0.00722461471458989,0.000799078728513003,0.0291195684097054,0.0384131711465707
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39460,0.0115430811330912,0.0055763717509424,0.000613392501244123,0.0224727697649383,0.0384695512902265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39355,-0.00634277145114195,0.00306720790172249,-0.012354498938518,-0.000331043963765863,0.0386638140233053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36880,0.00734235866670212,0.00356807092407937,0.000348939655506564,0.0143357776778977,0.0396306216222874
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37203,0.0113389200122125,0.00551781088719804,0.000524010673304287,0.0221538293511206,0.0399025069738026
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36861,0.00565067120748988,0.00275205155060088,0.000256650168312155,0.0110446922466676,0.0400685006184732
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39123,0.00924609672135758,0.00450708218638246,0.000412215636047951,0.0180799778066672,0.0402399319368188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36823,-0.0132723103339608,0.00648165304844062,-0.0259763503089044,-0.000568270359017143,0.040613055521307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36847,0.00684591388799071,0.00334476706666359,0.000290170437330076,0.0134016573386513,0.0407033327935788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36847,0.00792843099760936,0.00389210542691523,0.000299904360855501,0.0155569576343632,0.0416657786381052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39258,-0.00929032009824558,0.00456430340202242,-0.0182363547662095,-0.000344285430281638,0.0418253950067352
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39455,0.0075582981382068,0.00373407893165584,0.000239503432161344,0.0148770928442523,0.0429734445792244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37162,0.00878246835802431,0.00435404771951962,0.000248534827765861,0.0173164018882828,0.0437080102178034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39458,0.00622699723998689,0.00309275144452442,0.000165204408719032,0.0122887900712547,0.0440886357224571
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39428,0.00454750473308747,0.00225967372962154,0.000118544223029244,0.00897646524314569,0.0441892559180332
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39123,0.00600891909910021,0.00300612197933662,0.00011692001960043,0.0119009181786,0.0456382426690203
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36992,-0.00927643207219666,0.00464589159767414,-0.018382379603638,-0.00017048454075534,0.0458798205770005
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39462,0.00868450043294295,0.00435641166372189,0.000145933572048045,0.0172230672938379,0.046224946715728
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39428,-0.014918381026553,0.00750759943224777,-0.0296332759137587,-0.000203486139347403,0.0469290582258927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,37162,-0.0199319422424441,0.0100390019270355,-0.0396083860194336,-0.000255498465454553,0.0471158171576648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36823,-0.00607306532681734,0.00306185870711888,-0.0120743083927703,-7.18222608643475e-05,0.0473384688564969
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39309,0.00503072728308853,0.00254018340372868,5.19678117803244e-05,0.0100094867543967,0.0476704713209713
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39104,0.00830681586835342,0.00419807557660462,7.8587738208364e-05,0.0165350439984985,0.0478662414157535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39589,0.00762956325517635,0.00385653630084113,7.07521055277379e-05,0.015188374404825,0.0479077851076688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38842,0.00793482361701625,0.00401417809956883,6.70345418613515e-05,0.0158026126921711,0.0480946749323178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36955,0.011366868688562,0.00576227784287597,7.28041165251343e-05,0.0226609332605989,0.0485592044054764
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36880,-0.00489004382461003,0.00248274780448974,-0.00975622952140993,-2.38581278101339e-05,0.048905308485159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,39104,-0.00880654571496588,0.00447736301157208,-0.0175821772176472,-3.09142122845961e-05,0.0492130563316499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39194,0.00768679204495278,0.00392911199592671,-1.42674670635745e-05,0.0153878515569691,0.0504405805672497
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39068,0.0110277601778682,0.0056396891980822,-2.60306503729549e-05,0.0220815510061093,0.0505567460290115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36849,0.00638848533515621,0.00326839616474841,-1.7571147750679e-05,0.0127945418180631,0.0506499201577096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36976,-0.016490101191288,0.00844418624874235,-0.033040706238823,6.05038562470316e-05,0.0508614096760785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,37243,-0.00425501606638438,0.00218095774085537,-0.0085296932384609,1.9661105692138e-05,0.0510806208905263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39485,0.00582871468362574,0.00299284794672008,-3.72672919456167e-05,0.0116946966591971,0.0514876761953538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,37221,-0.00425311100285417,0.00218539202605586,-0.00853647937392366,3.02573682153121e-05,0.0516580639184677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,37196,0.00774922373047894,0.00398689814352628,-6.50966308325639e-05,0.0155635440917904,0.0519569567486704
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37164,0.00494598725053892,0.0025620186074849,-7.55692201314826e-05,0.00996754372120931,0.0535666311087973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39636,0.00799774380398525,0.00415051583426788,-0.000137267231179803,0.0161327548391503,0.0540072823309283
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39123,0.00780020038720896,0.00405068726083421,-0.000139146644026093,0.015739547418444,0.0541675657272473
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36763,-0.00561214916011916,0.00291644594512515,-0.0113283832125645,0.00010408489232614,0.0543386289199887
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39079,0.0088158669301192,0.00458700996016919,-0.000174672591812419,0.0178064064520508,0.0546352086255248
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36823,0.00560522948293497,0.0029193228638849,-0.000116643330279435,0.0113271022961494,0.0548752608229295
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,39194,0.0072869855309914,0.0037980231659936,-0.000157139874356059,0.0147311109363389,0.0550509879367655
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,37221,0.00616232888609985,0.00321357638467775,-0.000136280827868542,0.0124609386000683,0.0551850284732352
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39481,-0.0102237238174663,0.00533537634641485,-0.0206810614564394,0.000233613821506811,0.0553567866970562
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36742,-0.008028602990508,0.00419476630542453,-0.0162503449491401,0.00019313896812408,0.0556488307392031
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39104,0.00647557508803342,0.00338902237129905,-0.000166908759712719,0.0131180589357796,0.0560561893162663
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36861,0.00595016705189558,0.00312206706463164,-0.00016908439478243,0.0120694184985736,0.0566937700430666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36823,-0.0104147509073926,0.00548108085194047,-0.021157669377196,0.000328167562410688,0.057439654451675
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36880,0.0053216092861262,0.00280848102608149,-0.000183013524993522,0.0108262320972459,0.0581373989146049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,37203,-0.00427717640577027,0.0022584133513015,-0.00870366657432121,0.000149313762780664,0.0582628155202598
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39104,-0.00741549563149509,0.00391783732679484,-0.015094456792013,0.000263465529022793,0.0584105074290244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39355,-0.00813249379081713,0.00430174556560447,-0.0165639150994019,0.000298927517767621,0.0587091422596608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,39194,-0.00516916607590586,0.00274213425595358,-0.0105437492175749,0.00020541706576316,0.0594375246542721
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,37216,-0.00581238735142604,0.00308644881524257,-0.0118618270293015,0.000237052326449402,0.0596965601683423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36916,0.00546972952784274,0.00290840790871063,-0.000230749973230087,0.0111702090289156,0.0600413342345556
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36861,0.0117118813063053,0.0062337835719308,-0.000506334494679107,0.0239300971072896,0.0602985434623319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37203,0.00494964408364108,0.00263486908163743,-0.000214699316368273,0.0101139874836504,0.0603333884540771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39601,-0.0072666842985334,0.00387149234074716,-0.0148548092863978,0.000321440689331042,0.0605410789659803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36823,-0.0138448874539346,0.00737805474781371,-0.0283058747596495,0.000616099851780299,0.0606107761973372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39485,-0.00451172267312242,0.0024055352405715,-0.00922657174464255,0.000203126398397712,0.0607352603205939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37164,0.00679785987816872,0.00363150732374843,-0.00031989447637819,0.0139156142327156,0.0612418090927168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36880,-0.00555866481945439,0.0029706964819921,-0.0113812299241589,0.000263900285250133,0.0613456197382923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36957,-0.0105236456175704,0.00562497658253304,-0.0215485997193351,0.000501308484194378,0.0613853121524331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36847,0.00886735441507127,0.00474709397233842,-0.000436949770712031,0.0181716586008546,0.0617920241291418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39462,-0.00413861452915917,0.00221825645622479,-0.00848639718335975,0.000209168125041408,0.0621019920922013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,37203,-0.00853990934784738,0.00458651846699412,-0.0175294855431559,0.000449666847461103,0.062631856832798
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36847,-0.00644595193891738,0.00346296534205994,-0.0132333640093549,0.000341460131520106,0.0627118436243828
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36880,0.00705023908200642,0.00379588117657405,-0.000389688024078717,0.0144901661880916,0.0632865422929709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36823,0.0105668332489017,0.00570376166615471,-0.000612539616761526,0.0217462061145649,0.0639623973405979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,39194,0.00511860959478786,0.0027645801097158,-0.000299967420255103,0.0105371866098308,0.0641181831209848
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39462,0.00547924764486062,0.00297671120389643,-0.000355106314776379,0.0113136016044976,0.0656845046407423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36861,-0.00661552539450536,0.00359912247452585,-0.013669805444576,0.000438754655565302,0.0660724455145874
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39428,0.00956439307209367,0.00521862397685023,-0.000664109922532786,0.0197928960667201,0.0668607409119736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37164,0.00863745476639454,0.00471319607953715,-0.000600409549498275,0.0178753190822874,0.066883825163796
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,37221,0.0128714715257162,0.00702537441806716,-0.000898262333695386,0.0266412053851279,0.066953799806827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38698,0.00448067544466374,0.0024478760908621,-0.000317161693425977,0.00927851258275345,0.0672059586415941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36823,-0.0122327941873097,0.00668705167844997,-0.0253394154770716,0.000873827102452264,0.0673749167431867
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36992,-0.0130281371762873,0.0071319326122077,-0.0270067250962144,0.000950450743639759,0.0677636724880164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39485,0.00540913235863858,0.00297446507094642,-0.000420819180416399,0.0112390838976936,0.0690041644021423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39496,0.008800571938757,0.00485233146648305,-0.000709997735549773,0.0183111416130638,0.0697470672348641
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37164,0.00403947824166685,0.00223221730204655,-0.000335667670344379,0.00841462415367808,0.0703774292582139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39123,-0.0051753364618315,0.00286365805672799,-0.0107881062530184,0.000437433329355364,0.0707443043769787
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39194,0.0102825648440271,0.00569677610035359,-0.000883116312665976,0.0214482460007201,0.0710982649160628
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39104,-0.00541726752085008,0.00300342090044595,-0.0113039724857241,0.000469437444023976,0.0712990253797651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37203,0.00509826707867449,0.00282818725659768,-0.000444979944256966,0.0106415141016059,0.0714648393442513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,37183,0.00488830539739751,0.00271259007237352,-0.000428371144454597,0.0102049819392496,0.0715564024658531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36823,-0.0100003894240257,0.0055505125699916,-0.0208793940612093,0.000878615213157798,0.0716160779350684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36847,0.0136110799155115,0.00756744220214952,-0.00122110680070155,0.0284432666317246,0.072100473818102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36763,0.00836697523159073,0.0046530045256422,-0.000752913638667989,0.0174868641018495,0.0721717669933386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36763,-0.00875045905163442,0.00487026713555895,-0.01829618263733,0.000795264534061119,0.0724061291019688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39104,0.00764707113161321,0.00425945570954976,-0.000701462059104326,0.0159956043223307,0.0726238868968591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,37162,0.00515544120865172,0.00287874972191354,-0.000486908246298825,0.0107977906636023,0.0733393579419977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,37203,0.00602910932238547,0.0033718177721226,-0.000579653510974824,0.0126378721557458,0.0737854317969267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39415,0.0165122989583692,0.00926561275101706,-0.00164830203362424,0.0346728999503626,0.0747523102084442
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37181,0.00580692356120257,0.00325891444364992,-0.000580548748351274,0.0121943958707564,0.0747961843457269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39428,0.0284663870155604,0.0159809217887262,-0.00285621969034293,0.0597889937214638,0.0748880985224361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36955,0.00516229311353338,0.00289813154177548,-0.000518044708346556,0.0108426309354133,0.0748960958326233
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36880,0.00832833460475002,0.00467850671624597,-0.000841538559092088,0.0174982077685921,0.0750796573324495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,37203,0.010736513260329,0.00605808664148617,-0.00113733655698387,0.0226103630776419,0.0763750452926149
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39428,0.00338864655284895,0.0019184554027003,-0.000371526036443639,0.00714881914214154,0.0773590152881752
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39370,0.0103921571405352,0.00589716869297744,-0.00116629349770058,0.021950607778771,0.0780512208854965
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36763,0.00961352855976772,0.00545553255524663,-0.00107931524851568,0.0203063723680511,0.0780668549433183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36992,-0.00680318607954539,0.0038610886228729,-0.0143709197803763,0.000764547621285495,0.0780959376080846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36847,-0.00481884893396172,0.00273780407328673,-0.0101849449176037,0.000547247049680275,0.0784130388325188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36763,0.0134636200144203,0.00766000446940552,-0.00154998874561455,0.0284772287744551,0.0788316381012196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,39354,-0.00428924552360662,0.00244120020990101,-0.0090739979350126,0.000495506887799352,0.0789343804036748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,39161,0.0108044387321407,0.00615200280918118,-0.00125348677385442,0.0228623642381358,0.0790669886756874
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37221,0.0103799160925393,0.00592767074390975,-0.00123831856552383,0.0219981507506024,0.0799535139539652
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,39194,-0.00743374654221178,0.00424995998578684,-0.015763668114354,0.000896175029930426,0.0802887894717415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,39180,0.00632411288567182,0.00363822078373614,-0.000806799850451014,0.0134550256217947,0.0821888521987059
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37203,0.00682082532956688,0.00393182192450584,-0.000885545642464576,0.0145271963015983,0.0828048773514862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39462,0.00663995661881473,0.00383246195744485,-0.000871668817777175,0.0141515820554066,0.0831950791806513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,37164,0.0153324440934828,0.00885721095853042,-0.00202768938523685,0.0326925775722024,0.083463707276606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39485,0.00502622816289035,0.00290676287078112,-0.000671027063840644,0.0107234833896213,0.0838028343146521
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,39194,0.00748856743661487,0.00433216384588565,-0.00100247370132101,0.0159796085745507,0.0839021016923214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36861,-0.00770943649851404,0.00446157593361086,-0.0164541253283913,0.00103525233136325,0.0840198026300454
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,39342,-0.0187752063146256,0.0109095891790566,-0.0401580011055766,0.00260758847632546,0.0852748685583737
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,37255,-0.00447937832431324,0.00262137463369105,-0.0096172726063477,0.000658515957721225,0.087514123404757
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39553,-0.00646767821100228,0.00378924954309938,-0.0138946073154771,0.000959250893472494,0.087870611181219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,37203,0.00547825835716463,0.0032117836221521,-0.00081683754225349,0.0117733542565827,0.0880930003971886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39355,-0.00329822382827586,0.00193453445237711,-0.007089911354935,0.000493463698383275,0.0882304429383565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36861,-0.00619546004782591,0.00363912279660078,-0.0133281407291634,0.000937220633511625,0.0886942650047487
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36880,0.00677123983137882,0.00397999895343123,-0.00102955811734639,0.014572037780104,0.0889084937435606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36823,0.0117983000516504,0.0069353244207642,-0.00179493581304741,0.0253915359163483,0.0889325668876869
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,39194,0.00636976212677076,0.00376198264220756,-0.00100372385195606,0.0137432481054976,0.0904398920478034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36992,0.00486459548031519,0.0028743215014948,-0.000769074662614611,0.010498265623245,0.0905883583808511
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36763,-0.00592748012905404,0.00350382816995952,-0.0127949833421747,0.000940023084066625,0.0907255558198388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,39194,0.0120132307021792,0.00710966854372562,-0.00192171964352298,0.0259481810478815,0.0911058677024125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38989,-0.0084738215214595,0.00502446418185673,-0.0183217713178987,0.00137412827497969,0.0917185917387208
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39104,0.00548448622800446,0.00325864528325096,-0.000902458527167423,0.0118714309831763,0.09238533408749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37162,0.00478565927269033,0.00284775851650419,-0.000795947419657887,0.0103672659650386,0.0928845731137574
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,37162,-0.00704813526803105,0.00419790776315536,-0.0152760344838156,0.00117976394775345,0.0931836751708771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39480,-0.0142743424939523,0.00851028351369204,-0.0309544981807887,0.00240581319288409,0.0935036192940265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36880,0.0153540966467607,0.00915803519286899,-0.00259565233126248,0.033303845624784,0.0936515430656332
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36823,0.00826672391995844,0.00493791708301345,-0.00141159356274792,0.0179450414026648,0.0941299817112645
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39462,0.0100934596514205,0.00604119697104356,-0.00174728641182489,0.0219342057146658,0.0947876701714595
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,39194,0.00406600878825245,0.00244301068299525,-0.000722292150418241,0.00885430972692314,0.0960650695236939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36992,0.00746244223234206,0.00448687698857312,-0.00133183666526126,0.0162567211299454,0.096303265071498
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39568,0.00321236136251404,0.00193227377588926,-0.000574895238228921,0.00699961796325699,0.0964378369023453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39441,0.0180425220219065,0.0108923693299492,-0.00330652186479398,0.0393915659086071,0.0976543130388663
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39621,-0.0165766261106204,0.0100157462018876,-0.0362074886663201,0.0030542364450794,0.097933719573211
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37221,0.00392970071431796,0.00237589237953511,-0.000727048349570852,0.00858644977820677,0.098154254491461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,37255,0.0073608807432016,0.00445107200874372,-0.00136322039393608,0.0160849818803393,0.098206469137559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37162,0.00599281996125466,0.00363934279172445,-0.00114029191052526,0.0131259318330346,0.0996492957023227
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36763,-0.0065521940178268,0.00398339142579335,-0.0143596412123818,0.00125525317672817,0.100020446403619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36992,-0.00434035869198278,0.00264503831714182,-0.00952463379358075,0.000843916409615198,0.100834202510986
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36847,-0.00505622884819482,0.0030840612681693,-0.0111009889338067,0.000988531237417017,0.1011405938736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37255,0.003099390718477,0.00189303143305067,-0.000610950890302318,0.00680973232725633,0.101600060949034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36847,0.0110605323755929,0.00677490534987514,-0.0022182821101624,0.0243393468613481,0.102584084752997
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36823,0.0081773651314902,0.00502112780302273,-0.00166404536243436,0.0180187756254148,0.103425027045513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36861,0.00726501087898301,0.00446184920034957,-0.00148021355370215,0.0160102353116682,0.103497039144656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36861,0.00435671526121137,0.00267820182603272,-0.000892560317812775,0.00960599084023551,0.103819527283346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36847,-0.00809601844832038,0.00497975816531396,-0.0178563444523357,0.00166430755569498,0.104020723558141
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37162,0.00857281833395911,0.00527395237062794,-0.00176412831247166,0.0189097649803899,0.104080503441173
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36880,0.0143273741647163,0.0088352577183597,-0.00298973096326873,0.0316444792927013,0.104911473567248
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37203,0.0051432915500144,0.00317638239462607,-0.0010824179434527,0.0113690010434815,0.105422659442696
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36955,-0.00528671642999941,0.00327448253910998,-0.011704702206655,0.00113126934665614,0.106439989982674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36823,0.0158673332134617,0.00983256669185952,-0.00340449750258296,0.0351391639295064,0.106606534950364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39104,0.00591076504014668,0.00369909675052864,-0.00133946459088946,0.0131609946711828,0.110088100862643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,39355,-0.0046414130395107,0.00290872678318101,-0.0103425175345455,0.00105969145552407,0.110580239844061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36992,0.00735257343652913,0.00461010779786628,-0.00168323784728877,0.016388384720347,0.110764044832553
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37221,0.00367609626073488,0.00230629163967239,-0.000844235353023012,0.00819642787449277,0.110973664518937
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,37247,0.003951502188407,0.00248691025260514,-0.000922841906699066,0.00882584628351307,0.112103094740116
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36763,0.012877664231148,0.00810823144629951,-0.00301446940359901,0.0287697978658951,0.112262032442266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36823,0.00618010442297613,0.00389164963599369,-0.00144752886357149,0.0138077377095238,0.11230231931325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36880,0.00386005198425124,0.00243379891895876,-0.000910193896907927,0.00863029786541042,0.112760379687241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37135,0.00365480075990734,0.0023073204070782,-0.000867547237965928,0.00817714875778061,0.113218135166504
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,39079,0.00835253175902285,0.00528002536181005,-0.00199631795012485,0.0187013814681706,0.113691442979957
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36861,0.00486928908917572,0.00309492743946777,-0.00119676869218112,0.0109353468705325,0.11567189103039
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36955,-0.00687924631518799,0.00439137654681196,-0.0154863443469394,0.00172785171656346,0.117248661477886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37162,0.00377990529484182,0.00241320944664181,-0.00094998522057612,0.00850979581025976,0.117294051658389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39123,0.00984560961129458,0.00629519875496408,-0.00249297994843502,0.0221841991710242,0.117842167512976
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39545,0.002802043307281,0.00179163980528512,-0.000709570711077848,0.00631365732563984,0.117849196984076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,37255,0.00579116201580973,0.00371206480093915,-0.001484484994031,0.0130668090256505,0.118762895467352
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39324,0.00383032526868617,0.00245558690173505,-0.000982625058714537,0.00864327559608687,0.118818724394908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39428,-0.00271996446451233,0.00174511203090287,-0.00614038404508195,0.000700455116057285,0.119107755077673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36847,0.00482323368580029,0.00309526901486557,-0.00124349358333623,0.0108899609549368,0.119197173458032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,39125,0.00659791804405785,0.00423600509334458,-0.00170465193889753,0.0149004880270132,0.119354340863221
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36763,0.00479659914394495,0.00308018944996393,-0.00124057217798435,0.0108337704658742,0.1194388401576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,37269,0.00437931084989981,0.00281440860048878,-0.00113693000705821,0.00989555170685782,0.119725088403758
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37255,0.00305847742854535,0.00196638181109787,-0.000795630921206469,0.00691258577829718,0.119879526500338
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36992,-0.00980159426727989,0.00630643730716632,-0.0221622113893259,0.0025590228547661,0.120157060275119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39462,0.0103068300313732,0.00665962341032459,-0.00274603185286296,0.0233596919156094,0.1217253587268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36823,-0.00996310407806645,0.00644132671736715,-0.0225881044441061,0.00266189628797315,0.121949795525467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37224,-0.0139028747592962,0.0090219217602863,-0.0315858414094573,0.00378009189086498,0.123339042327022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36823,0.00755677809694971,0.00490928328873246,-0.00206541714896591,0.0171789733428653,0.12376070939798
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39436,-0.00406370313271015,0.00264403550071462,-0.00924601271411082,0.00111860644869051,0.124331043327465
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36763,-0.00339671693282324,0.00221312884769888,-0.00773444947431305,0.000941015608666561,0.124857907774007
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36861,0.0109835251715421,0.00717217361744329,-0.00307393511864678,0.0250409854617309,0.125694041201988
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36763,0.00777381680473314,0.0050838348291001,-0.00219049946030306,0.0177381330697693,0.126259254706559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,37243,0.00637052969207655,0.00417146821303429,-0.00180554800547065,0.0145466073896238,0.126744150554322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36847,-0.0037314793818727,0.00244495667546642,-0.00852359446578688,0.00106063570204148,0.126986952546787
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39462,0.00636212323601265,0.00417397070461226,-0.00181885934502739,0.0145431058170527,0.127470427511813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36823,0.00714296385780361,0.00469110498748949,-0.00205160191767579,0.016337529633283,0.127869033269048
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36847,0.00866407507159198,0.00572428709457568,-0.00255552763377636,0.0198836777769603,0.130161945221956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36861,0.00894469018418223,0.00592215770532771,-0.00266273891826008,0.0205521192866245,0.13097274218141
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36955,0.00492487468244089,0.00326218391914183,-0.00146900579907711,0.0113187551639589,0.131148733741307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36847,0.00587132746408975,0.00389571818179152,-0.00176428017222164,0.0135069351004011,0.13180455186172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37247,-0.01346553621895,0.00893696663091602,-0.0309819908155455,0.00405091837764536,0.131906273383192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39485,-0.0152020819018148,0.0100905506721009,-0.0349795612191326,0.00457539741550303,0.131942915629207
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37247,0.00936908625973079,0.00624401822044208,-0.00286918945233569,0.0216073619717973,0.133512222788795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39194,0.00447878812883411,0.00298625687255103,-0.0013742753413659,0.0103318515990341,0.133687625425963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39404,0.00769696871074306,0.00514459985605006,-0.00238644700711505,0.0177803844286012,0.134641975214487
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37255,-0.00415578245967188,0.00278200267304077,-0.00960850769883178,0.00129694277948803,0.135250019998041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36847,-0.00688245623256774,0.00462156890846092,-0.0159407312931511,0.00217581882801567,0.136459252325227
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,37203,-0.00386374586228473,0.00259655805893604,-0.00895299965779937,0.00122550793322991,0.136768769874188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36823,0.015211132071522,0.0102342656287363,-0.00484802856080108,0.0352702927038452,0.137226740974874
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36992,-0.00434976107563758,0.00293755420537528,-0.0101073673181731,0.00140784516689796,0.138700353345664
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37162,0.00680496077050027,0.00459795794712651,-0.0022070368058677,0.0158169583468682,0.138899018190659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36847,-0.00589856755115377,0.00399723324654049,-0.0137331447143731,0.00193600961206559,0.140059895679006
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,39123,0.00388602704574772,0.00264727274195264,-0.00130262752847944,0.00907468161997489,0.142143037258221
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,39104,-0.00920189245110114,0.00627058785654144,-0.0214922446499224,0.00308845974772009,0.14227001688331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36926,0.0103275540770839,0.00709050896189136,-0.00356984348822314,0.024224951642391,0.145270745397268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39654,0.00279886241157988,0.00192356140145686,-0.000971317935275552,0.00656904275843532,0.145678313456112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36861,0.00581520277992258,0.0039977106382443,-0.00202031007103625,0.0136507156308814,0.145796116849171
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39499,0.00300002119111005,0.00206446486677068,-0.00104632994776048,0.00704637232998058,0.146197039476802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36825,0.00511536643860446,0.00352208847765642,-0.00178792697760211,0.012018659854811,0.146424836699383
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36880,0.00326750399416119,0.00225274134873622,-0.00114786904936181,0.0076828770376842,0.14695641607947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,37164,0.00563539730339027,0.00388767278093949,-0.00198444134725113,0.0132552359540317,0.147207193371057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36847,0.0104142099622454,0.00719298867874586,-0.0036840478480965,0.0245124677725873,0.147690469653559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38760,0.00344261745532338,0.00238052074015818,-0.00122320319538665,0.00810843810603341,0.148153812259243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36763,-0.0079036024818953,0.00546580248249039,-0.0186165753475765,0.00280937038378585,0.148199985175061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36971,-0.00692963147961263,0.00479270239050839,-0.0163233281650091,0.00246406520578382,0.148238298309543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39411,0.00443709189916956,0.00307143959031649,-0.00158292969785076,0.0104571134961899,0.148582958221314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,37243,0.00845602011580951,0.0058542348725545,-0.00301828023439732,0.0199303204660163,0.148643144724235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37247,0.00309504338342367,0.00214892846482829,-0.00111685640763978,0.00730694317448713,0.149814679187113
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,39123,0.0049949912908984,0.00347756627868991,-0.00182103861533383,0.0118110211971306,0.150924997967225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36763,-0.0056704005260988,0.00395618173089211,-0.0134245167186473,0.00208371566644975,0.151797137252692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36763,-0.00439516740197059,0.00306802686342944,-0.0104085000542923,0.00161816525035111,0.152005763316856
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39520,0.00637222396075037,0.00444881786403378,-0.00234745905275584,0.0150919069742566,0.152067015939754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36992,-0.00428446856945705,0.00299614273531282,-0.0101569083306702,0.00158797119175608,0.152743421625953
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,37243,-0.00657347408783897,0.00459969091465769,-0.015588868280568,0.0024419201048901,0.152996427523707
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36880,0.00257642620851926,0.00181022040892826,-0.000971605792980126,0.00612445821001865,0.154683993516515
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36847,-0.00638075557423211,0.00448491643197061,-0.0151711917808945,0.00240968063243028,0.154844105450198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37203,-0.00554987857957337,0.00390294550216556,-0.0131996517638179,0.00209989460467114,0.155058886465758
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37221,-0.00549498754893147,0.00386455513429314,-0.013069515612146,0.00207954051428309,0.155081465241244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39187,-0.00422659157743941,0.00297714597950175,-0.0100617976972628,0.00160861454238401,0.155722314379951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,37269,0.00240984745760355,0.00169875677558626,-0.00091971582254552,0.00573941073775263,0.156041509606123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38988,0.0122079902895323,0.00862796975682619,-0.00470283043384706,0.0291188110129116,0.157109862982192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,39194,0.00584920203210216,0.00413591471312395,-0.00225719080562079,0.0139555948698251,0.157310719799673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36763,-0.00999450378778825,0.00707948383176392,-0.0238702920980455,0.00388128452246904,0.158047091198099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36992,0.00521107883350067,0.00369206116499709,-0.00202536104989363,0.012447518716895,0.158143235628621
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36992,-0.00488527467557733,0.00346728592726223,-0.0116811550930113,0.00191060574185665,0.158871152181103
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37057,0.00670278178690062,0.0047691717880191,-0.00264479491761682,0.0160503584914181,0.159915312738926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36847,-0.0063651872933872,0.00454549502728623,-0.0152743575468682,0.00254398296009382,0.161439931058372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36847,-0.00628558976113797,0.00449409168735323,-0.0150940094683503,0.00252282994607436,0.161947762907673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,39194,0.00370674495404373,0.00265644964626019,-0.00149989635262623,0.0089133862607137,0.162923630932219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36763,-0.00605148696871957,0.004345909643828,-0.0145694698706225,0.00246649593318331,0.163809574417409
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36847,0.0130988134470878,0.00941084544885927,-0.00534644363267634,0.031544070526852,0.163982236835583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39104,0.016908582345841,0.0121726177707441,-0.00694974848481739,0.0407669131764995,0.164833470861857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36861,0.00535466170376371,0.00385761358738977,-0.00220626092752024,0.0129155843350477,0.165138755329878
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36992,0.00272395018810873,0.00196321653337351,-0.00112395421730335,0.0065718545935208,0.165315985858889
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36880,0.00352048105445695,0.00255213025743274,-0.00148169425011122,0.00852265635902513,0.167787515975992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39485,0.00751620034040322,0.00546071214638819,-0.00318679546651763,0.0182191961473241,0.168714013935172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39194,0.00342530321301419,0.00249024850664084,-0.00145558386000186,0.00830619028603024,0.169001566163937
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36847,-0.00730869252356614,0.00532067769484145,-0.0177372208054554,0.00311983575832311,0.169578500841358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39636,0.00384905461167012,0.00281222015503826,-0.00166289689220488,0.00936100611554511,0.171116778612414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36763,-0.0037224803580911,0.0027237158112921,-0.0090609633482236,0.00161600263204141,0.171746853237904
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39485,0.00326735215346875,0.0023911040643812,-0.00141921181271841,0.00795391611965591,0.171814527838958
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39462,-0.00546821083058851,0.00400362274396646,-0.0133153114087628,0.00237888974758575,0.172017279394249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36847,0.004826479873718,0.00353719182010913,-0.0021064160936959,0.0117593758411319,0.172436658410662
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36916,0.00569576006463784,0.00417700937417835,-0.00249117830875173,0.0138826984380274,0.17271886683109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37221,-0.00490664634780754,0.00360648540390671,-0.0119753577394647,0.00216206504384962,0.173693754569602
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,37162,-0.00319857786680664,0.00235337896766655,-0.00781120064343308,0.00141404490981981,0.174125486421246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36847,-0.00492271623825627,0.00362475781967087,-0.0120272415648112,0.00218180908829863,0.174462570168014
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39455,-0.0076752612765265,0.00565921898072525,-0.018767330478748,0.00341680792569499,0.175043109176266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36847,-0.00535535381662711,0.00395891749451933,-0.013114832105885,0.00240412447263078,0.176165983656819
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36823,0.00635647040364556,0.0046990942344559,-0.002853754295888,0.0155666951031791,0.176175829604409
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,39194,0.00445013816592474,0.00329422297087838,-0.00200653885699689,0.0109068151888464,0.176750890126439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37162,0.00755780863837089,0.00559717432173462,-0.00341265303222897,0.0185282703089707,0.176947014556471
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36763,0.00485461179622013,0.00360163453155505,-0.00220459188562776,0.011913815478068,0.177718152904786
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,39187,-0.0134730062646282,0.0100005538042628,-0.0330740917209832,0.00612807919172677,0.177928167887676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36880,0.00723241195045272,0.00538039373492688,-0.00331315977000397,0.0177779836709094,0.178903048691959
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,39194,0.00541215119169154,0.00403469971478439,-0.00249586024928587,0.0133201626326689,0.179810879595035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36823,0.00843418742110673,0.00629324170333703,-0.00390056631743384,0.0207689411596473,0.180205725167152
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36861,0.0048265318454887,0.00361163948404386,-0.00225228154323727,0.0119053452342147,0.181448782829817
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39330,-0.00383493219102081,0.00287019414251715,-0.00946051271035442,0.0017906483283128,0.18152953337036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39431,0.00461433096579296,0.00346432178105068,-0.00217573972506638,0.0114044016566523,0.182894269670155
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39601,-0.00287657416186382,0.00215971862849874,-0.00710962267372135,0.0013564743499937,0.182906253492178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,37203,0.00780078278697248,0.00587087529606716,-0.00370613279331915,0.0193076983672641,0.183962265723037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,37269,-0.00262167781605477,0.00197420425922919,-0.00649111816414399,0.00124776253203444,0.18421270559499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39455,0.00599546913368925,0.00451663034088761,-0.00285712633445047,0.014848064601829,0.184389715648845
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36847,0.00539680943676265,0.00406637451304219,-0.00257328460880004,0.0133669034823253,0.184473713340118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37243,0.00389906529912661,0.0029473739316443,-0.00187778760689621,0.00967591820514943,0.185894053268104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36847,-0.0109879584503761,0.00832143168493507,-0.0272979645528488,0.00532204765209665,0.186712248307321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36847,0.00443954143806717,0.00337308077793864,-0.00217169688669257,0.0110507797628269,0.188141954979576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36847,-0.00391285668775073,0.00299074420618138,-0.00977471533186624,0.00194900195636477,0.190788348200839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36880,0.00327729402757898,0.00250661997618369,-0.00163568112574105,0.00819026918089901,0.191082251736713
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37255,0.00288659739282115,0.00221069648326752,-0.0014463677143832,0.00721956250002549,0.191664056507778
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,37196,0.00286724223096157,0.00219729415430356,-0.0014394543114734,0.00717393877339655,0.191951533698072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39123,0.00642672492100345,0.0049270183457573,-0.00323023103668085,0.0160836808786878,0.192123079126333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37221,-0.00592674207552584,0.00455849855121291,-0.0148613992359031,0.00300791508485147,0.193572265168149
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39404,0.00283989979844463,0.00218774752990543,-0.00144808536017002,0.00712788495705927,0.194275395426788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36823,-0.00335686095763791,0.00258609213172105,-0.00842560153581116,0.00171187962053534,0.194296470958663
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,39194,0.00997588206390254,0.00770114587548617,-0.00511836385205035,0.0250701279798554,0.195210723904582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36741,-0.00909036095012039,0.0070196984463206,-0.0228489699049088,0.00466824800466798,0.195351857410964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36742,0.00280762605528993,0.00216998037995268,-0.00144553548941732,0.00706078759999718,0.195742039147937
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39309,-0.0045064123478648,0.00348726249750704,-0.0113414468429786,0.00232862214724901,0.196290939535591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36847,-0.00577026678062699,0.00447935864661659,-0.0145498097279955,0.00300927616674153,0.197703741463201
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,37058,-0.00597918108024059,0.00464302023589186,-0.0150795007425886,0.00312113858210746,0.197846759658262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39462,0.006023000467266,0.00469793640156871,-0.00318495487980867,0.0152309558143407,0.199844078977538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39194,-0.0131191910231267,0.0102472658762183,-0.0332038321405145,0.00696545009426107,0.200472948287079
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39636,0.00664587902512423,0.00519384223905531,-0.00353405176342418,0.0168258098136726,0.200716342985105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36992,0.00838991908199382,0.00656301726913828,-0.00447359476551722,0.0212534329295049,0.201145089481484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,39166,-0.00472178338452541,0.00369574943441752,-0.0119654522759837,0.00252188550693293,0.201401694038503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36992,0.00798152882836667,0.00624986424313469,-0.00426820508817732,0.0202312627449107,0.201600350266468
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36916,-0.0028449030240014,0.00222858322914188,-0.00721292615311948,0.00152312010511668,0.201784138631795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36741,0.00559969631384339,0.00438825654920001,-0.00300128652258863,0.0142006791502754,0.201957004180953
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36823,0.00524711541718396,0.00413580183953383,-0.00285905618830235,0.0133532870226703,0.204569915999974
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37255,0.0149796321606288,0.0118448751069362,-0.0082363230489661,0.0381955873702237,0.206019511998862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36847,-0.00485625536139148,0.0038427225261746,-0.0123879915126937,0.00267548078991074,0.206342159495553
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36763,0.00838831318429547,0.00664033442900844,-0.00462674229656108,0.021403368665152,0.206528102327483
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36916,0.00666410237586392,0.00528148519744757,-0.00368760861113331,0.0170158133628612,0.207049529282484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36847,0.00425603553402242,0.00337461314264441,-0.00235820622556062,0.0108702772936055,0.207263369965804
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36861,-0.00709841227698116,0.0056532579898271,-0.0181787979370423,0.00398197338307996,0.20927302491543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36916,0.0091177204551758,0.00726982428492161,-0.00513113514327056,0.0233665760536222,0.209797497009337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,37203,0.00413821587706752,0.00329975966912394,-0.00232931307441541,0.0106057448285505,0.209830051639605
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,37269,-0.00241607013506165,0.00192930895411516,-0.00619751568512736,0.00136537541500406,0.210484073793624
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39563,0.00322803301948305,0.00258476188931917,-0.00183810028358253,0.00829416632254862,0.211731768711493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36823,-0.00589949379515384,0.00473504984312308,-0.0151801914876751,0.00338120389736739,0.212817322818835
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36823,-0.00641943478828924,0.00516884183251634,-0.0165503647800213,0.00371149520344277,0.214279149021485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39485,0.00676918567919816,0.00545471248897254,-0.00392205079918802,0.0174604221575843,0.214632734243991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36880,-0.00513902990873115,0.00416560393146726,-0.013303613614407,0.00302555379694468,0.217344815070586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36763,-0.00445262542424849,0.00361826092509287,-0.0115444168374305,0.00263916598893352,0.21849668594176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39291,-0.00615434530907885,0.00501278773144617,-0.0159794092627133,0.00367071864455564,0.219568157910202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39583,0.00997606873449805,0.00813087361368863,-0.00596044354833167,0.0259125810173278,0.219865404519036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36847,-0.00623374613756263,0.00510623785375334,-0.0162419723309192,0.00377448005579392,0.22218119619459
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,39187,0.00506904047296062,0.00416177220986018,-0.00308803305836534,0.0132261140042866,0.223243300001347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39187,-0.00335112443442011,0.00275441289989794,-0.00874977371822007,0.00204752484937984,0.223761322448508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36763,0.00924699760434186,0.00763804337287765,-0.00572356740649835,0.0242175626151821,0.226052794453152
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36847,0.00678857671368677,0.00562396820060876,-0.00423440095950641,0.0178115543868799,0.227424564118478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36861,-0.00367608922899349,0.00304550334466689,-0.00964527578454059,0.00229309732655362,0.227434074144588
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38875,-0.00326344276134058,0.00270368864653621,-0.00856267250855155,0.00203578698587038,0.2274390393499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39455,-0.00243819499685917,0.00202434137530688,-0.00640590409246065,0.00152951409874231,0.228439080357802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36916,-0.00701285246308275,0.00582671013469569,-0.0184332043270863,0.00440749940092081,0.228778748789701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36763,0.00727315746021298,0.00607313977861097,-0.00463019650586452,0.0191765114262905,0.231098061380159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36823,0.00356520228218686,0.00298226726527742,-0.00228004155775689,0.00941044612213061,0.231927513411903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37162,-0.00474901290022505,0.00398002030101862,-0.0125498526902215,0.00305182688977144,0.232808144898831
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37243,0.00401394003769834,0.00337119492098661,-0.00259360200743541,0.0106214820828321,0.233809987167949
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39636,0.00379502967628948,0.00319174973420935,-0.00246079980276085,0.0100508591553398,0.234453422808711
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36763,0.0092842294013213,0.00780977821998159,-0.00602293590984261,0.0245913947124852,0.234543069308908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37162,0.00691537275139474,0.00583667947324406,-0.00452451901616363,0.0183552645189531,0.236113610392535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36763,-0.00650748391097619,0.00550372093430954,-0.0172947769422229,0.00427980912027051,0.237078197770987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37164,-0.00508648755072186,0.00432943623429584,-0.0135721825699417,0.00339920746849798,0.240072173713511
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,39068,0.00342325277602823,0.00292343996439315,-0.00230668955418234,0.0091531951062388,0.241630987399585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39582,-0.00292570166759091,0.00250252973039781,-0.00783065993917062,0.00197925660398881,0.242382702361378
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39526,-0.00440846584962131,0.0037774408609666,-0.0118122499371158,0.00299531823787322,0.243208265875934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39396,0.002287261785091,0.00195996303201644,-0.00155426575766123,0.00612878932784323,0.243232096328399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36847,-0.00478586700727144,0.00410151784986736,-0.0128248419930115,0.00325310797846858,0.243292325216951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38979,-0.00861396093721038,0.00738250268366661,-0.0230836661971969,0.00585574432277618,0.243307192006623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,39187,0.00541433224147965,0.00464285612388908,-0.00368566576134294,0.0145143302443022,0.24356696935546
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36763,-0.00301412248215352,0.00258509026096927,-0.00808089939365329,0.00205265442934625,0.24365154158705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36847,0.0084214003022776,0.00722384702529246,-0.00573733986729563,0.0225801404718508,0.243726737584807
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39123,0.00559120918525061,0.00481822742955209,-0.00385251657667148,0.0150349349471727,0.24589320739117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,37255,-0.00493288991694745,0.00426041125385841,-0.0132832959745099,0.00341751614061503,0.246949464578288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36715,0.00346290295779475,0.00299782991706025,-0.00241284367964335,0.00933864959523285,0.24805701330301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39531,-0.00366283504038398,0.00317154535969725,-0.00987906394539058,0.00255339386462263,0.248147446007083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39194,0.00563318855095683,0.00488921050727109,-0.0039496640432945,0.0152160411452082,0.249271008761435
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36847,0.00477025450725466,0.00414088855912974,-0.00334588706863962,0.012886396083149,0.24934816548018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39123,-0.00430950735363923,0.00375218688577778,-0.0116637936497637,0.00304477894248522,0.250767665222179
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36861,0.00600159347174068,0.00523759518151559,-0.00426409308402988,0.0162672800275112,0.251871810642965
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36955,0.00389577898591922,0.00340098851858077,-0.00277015851049909,0.0105617164823375,0.252030515949705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36709,-0.00428371730601871,0.00375776786263104,-0.0116489423167755,0.00308150770473812,0.254323883065301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36763,0.0025749180202255,0.0022672570263004,-0.00186890575132328,0.00701874179177429,0.25610531731855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36992,0.00575075549262643,0.00506563058125333,-0.0041778804466301,0.015679391431883,0.256292417313226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39463,0.00579673738864149,0.00510682326530197,-0.00421263621135038,0.0158061109886334,0.256352997586479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39513,-0.00381670111184405,0.00336393910897885,-0.0104100217654426,0.0027766195417545,0.256564025994364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36847,0.0046181188532874,0.00409608785352003,-0.00341021333961187,0.0126464510461867,0.259575681956313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36823,0.00940788425773374,0.00835912809769513,-0.00697600681374871,0.0257917753292162,0.260414981345803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36880,-0.00333480506514082,0.00297436992055812,-0.00916457010943473,0.0024949599791531,0.262232771547657
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,37076,0.00292146688450749,0.00260806838779623,-0.00219034715557313,0.00803328092458811,0.262664772720168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36992,-0.00525023906977956,0.00469171967004069,-0.0144460096230593,0.00394553148350018,0.263142955397212
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36992,-0.00551297606835482,0.00492971009180815,-0.0151752078482988,0.00414925571158914,0.263453270732319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36916,-0.00276781012586208,0.00247767652713726,-0.00762405611905111,0.00208843586732696,0.263973504242943
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36847,-0.00371645481109619,0.00332801966038967,-0.0102393733454599,0.00280646372326756,0.264137162868662
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39589,-0.00278463523728846,0.00249700807328449,-0.00767877106092606,0.00210950058634914,0.264787263164165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39477,0.0278715067282195,0.0250334805374919,-0.0211941151252646,0.0769371285817036,0.265567699460366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39169,-0.00400646111671754,0.00360075915296165,-0.0110639490565224,0.00305102682308729,0.265867829947371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36880,-0.00436977036087232,0.00392741313292698,-0.0120675001014092,0.00332795937966456,0.265887503160318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36763,0.00348413082583513,0.00314518593265486,-0.0026804336021684,0.00964869525383866,0.267984421641377
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36861,-0.00343968684773425,0.00310568670608822,-0.00952683279166716,0.00264745909619866,0.268079965426553
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36823,0.00471287489772822,0.00425793134486037,-0.00363267053819811,0.0130584203336545,0.268381974812131
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39654,0.00258422444983346,0.00233844924271678,-0.00199913606589144,0.00716758496555835,0.269132973604931
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39601,0.00356904452886494,0.00323266619805104,-0.0027669812193151,0.00990507027704499,0.269586380254303
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39642,0.00514885626256061,0.00469203324829116,-0.00404752890409007,0.0143452414292113,0.272500826946697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36880,-0.00981178995133287,0.00894892480966001,-0.0273516825782665,0.00772810267560074,0.272915780576896
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37164,0.00458289001354888,0.00418096882181364,-0.00361180887720585,0.0127775889043036,0.273042165257278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,37162,-0.00347193031971767,0.00316865214264877,-0.00968248851930926,0.00273862787987392,0.27322557115849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,37162,0.00604475838009079,0.00553779504290253,-0.00480931990399818,0.0168988366641798,0.275053365343423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37162,0.00537750066766007,0.00493296372017863,-0.00429110822389005,0.0150461095592102,0.275682895229548
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36880,0.00479262205704456,0.00440468339905618,-0.00384055740510556,0.0134258015191947,0.276583483196442
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36992,-0.00276206987757286,0.0025406814938058,-0.00774180560543223,0.0022176658502865,0.276996985847814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37255,0.00322580945508317,0.0029823178513167,-0.00261953353349756,0.00907115244366389,0.279430634059473
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36823,0.0100403021162059,0.00928735754759121,-0.00816291867707292,0.0282435229094846,0.279686165007977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36861,0.00644126333043813,0.00596992134704075,-0.00525978250976174,0.018142309170638,0.280629742707156
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39104,0.00376740783989961,0.00350283431270456,-0.00309814741300133,0.0106329630928005,0.282154649389289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39462,0.00300786757399281,0.00280277181942142,-0.00248556519207316,0.00850130034005879,0.283209389559857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,37243,-0.00333362645579553,0.00310702577680075,-0.009423396978325,0.00275614406673394,0.283322002115477
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36763,0.00560422456963658,0.00522526423109288,-0.00463729332330545,0.0158457424625786,0.283505481933552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36880,0.0035980897962581,0.00335672512503761,-0.00298109144881561,0.0101772710413318,0.283783605275756
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,39194,-0.00429000779870948,0.004005255940409,-0.0121403094419111,0.00356029384449216,0.284144454609611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39502,0.0018293418845101,0.00170909336165033,-0.00152048110432455,0.00517916487334476,0.284475327085668
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36847,0.00459166437424064,0.00429925839326871,-0.00383488207656604,0.0130182108250473,0.285535392937462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37247,0.00268919743887421,0.00253312089477742,-0.00227571951488953,0.00765411439263795,0.288430843362353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36880,0.00368837168903332,0.00347513292079017,-0.00312288883571542,0.010499632213782,0.288546349389071
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39485,0.0037847114669392,0.00357336796970728,-0.00321908975368706,0.0107885126875655,0.289551193032963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37221,0.00816814402101278,0.00771381894372329,-0.00695094110868487,0.0232872291507104,0.289666467928531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36861,-0.00358937805630349,0.00339568547569032,-0.0102449215886565,0.00306616547604954,0.290513549388547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36823,0.00454948021547647,0.00431275601786449,-0.00390352157953793,0.0130024820104909,0.291496553451468
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39187,-0.00568526554316041,0.00539291997744164,-0.016255388698946,0.0048848576126252,0.291804460895428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39589,-0.00329204032023203,0.00317590069388609,-0.00951680568024878,0.00293272503978471,0.299953308632594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37203,0.00350479249493154,0.00340588371423376,-0.00317073958496664,0.0101803245748297,0.303480133241739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36955,0.00354146257688625,0.00344284642325183,-0.00320651641268734,0.0102894415664598,0.303666993495629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37203,0.0024777596688891,0.00241065600532914,-0.00224712610155602,0.00720264543933423,0.30404635025148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,37247,-0.00254886833392762,0.00248897700476257,-0.00742726326326226,0.00232952659540701,0.305825054939081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36992,0.00363175235596876,0.00354919740741622,-0.00332467456256703,0.0105881792745045,0.306204587652495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36741,-0.00357126555412692,0.00349192415134577,-0.0104154368907646,0.00327290578251079,0.306459722333301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39433,0.00234820751721999,0.00231265253798056,-0.00218459145722191,0.00688100649166189,0.30994392649686
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39485,0.00726983578842071,0.0071662188129105,-0.00677595308488386,0.0213156246617253,0.310380069346285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36287,-0.00433363409704341,0.00429029503789179,-0.0127426123713113,0.0040753441772245,0.31246724215889
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37162,0.00436786876235935,0.00432432003217332,-0.00410779850070036,0.0128435360254191,0.312480669021854
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,37203,0.00512907165901083,0.00509331426894214,-0.00485382430811576,0.0151119676261374,0.313944052935219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,37162,-0.0039071154383371,0.00388351222047991,-0.0115187993904777,0.00370456851380352,0.31439729867936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,39029,0.00600641626963762,0.00597932862512284,-0.00571306783560314,0.0177259003748784,0.315139789167849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36880,0.00748942801410169,0.00746290445985265,-0.0071378647272095,0.0221167207554129,0.315613149425331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,37203,0.00806187824351906,0.00806035517068518,-0.0077364178910239,0.023860174378062,0.317238051460519
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36763,-0.00488253508399847,0.00488202156721375,-0.0144512973557374,0.00468622718774049,0.317279263532519
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37221,0.00629232183843413,0.0063087837041013,-0.00607289422160442,0.0186575378984727,0.318593831111649
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36763,-0.00550085476912261,0.00552447712911965,-0.0163288299421971,0.00532712040395191,0.319403809179663
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36847,-0.0040559765082165,0.0040770896770288,-0.0120470722751929,0.00393511925875995,0.319842502638082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36916,0.0222847104094291,0.0224162765588256,-0.021651191645869,0.0662206124647271,0.320178502870499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36916,-0.00508064935668871,0.00511402593441751,-0.015104140188147,0.0049428414747696,0.320498533802103
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37162,-0.00513458497366151,0.00516980410833418,-0.0152674010259965,0.00499823107867347,0.320637481431509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39462,-0.0033652972149806,0.00340491522801585,-0.0100389310618917,0.00330833663193047,0.322990116277005
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,37255,-0.0076150606771119,0.00772011557880719,-0.022746487211574,0.00751636585735019,0.323959402167476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37203,-0.00469649988022844,0.00478256713211959,-0.0140703314591828,0.00467733169872595,0.326116527255105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36847,0.00739825554580501,0.00755024827496714,-0.00740023107313059,0.0221967421647406,0.327169825080772
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39104,0.00492063950270898,0.00505322159483928,-0.00498367482317601,0.014824953828594,0.330190374252794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36847,0.00833819813086893,0.00856401460611159,-0.00844727049710979,0.0251236667588477,0.330258322903017
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,37221,0.00246877684532938,0.00254143781376767,-0.00251244126965525,0.00744999496031401,0.331362798105172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,39194,0.00652808549139459,0.0067608543864519,-0.00672318910605113,0.0197793600888403,0.334274689964066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39194,0.00526903661724328,0.00546126425394646,-0.00543504132049179,0.0159731145549783,0.334660008744743
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,37221,0.00312781410492019,0.00324200820346222,-0.00322652197386575,0.00948215018370614,0.334674919540938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36847,-0.00548398004565152,0.00569135162603737,-0.0166390292326848,0.00567106914138172,0.335283492097992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39104,0.0025179047338527,0.00261440321608473,-0.00260632556967338,0.00764213503737878,0.335518418689829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39462,0.00502392362692031,0.00521719716789783,-0.00520178282215943,0.0152496300760001,0.335585856967809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39445,0.00198869674949892,0.00206958753528992,-0.00206769481966932,0.00604508831866715,0.336610636748256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39123,0.00494446456019512,0.00514885418705512,-0.00514728964643292,0.0150362187668232,0.336918132834639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37221,0.00240312291150706,0.0025077304130849,-0.00251202869813934,0.00731827452115346,0.337936711943117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39601,0.00166702121426236,0.00174017723495724,-0.00174372616625384,0.00507776859477856,0.33809791826049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36880,0.00287993662130181,0.00300830119520801,-0.00301633372130588,0.0087762069639095,0.338419400429562
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36880,-0.00228893942996567,0.00239177138965088,-0.00697681135368139,0.00239893249375005,0.338582871645788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36847,-0.00426368842939604,0.00445695283554855,-0.0129993159870712,0.00447193912827912,0.338768887815361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36847,-0.00591166301180533,0.00618102392528448,-0.0180264699053629,0.00620314388175225,0.33887807481046
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36823,-0.00316617631946493,0.00331548649743121,-0.00966452985443011,0.00333217721550024,0.33961363610949
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,39123,0.0116700471814068,0.0122239581105518,-0.0122889107152746,0.0356290050780883,0.339752013452846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,39194,0.00436250775791053,0.00459462163465926,-0.00464295064602162,0.0133679661618427,0.34239139498142
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36847,-0.00380923734877905,0.00401825735089724,-0.0116850217565376,0.00406654705897955,0.343156882532514
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36880,0.00472862732368066,0.00499232389108756,-0.00505632750285097,0.0145135821502123,0.343565686768351
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,39123,0.00455255387400849,0.00481955859389851,-0.0048937809700326,0.0139988887180496,0.344878807142719
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36880,0.00387162253059171,0.00411194767190822,-0.00418779490634839,0.0119310399675318,0.346439112734892
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39636,-0.00206911465271478,0.00219935420831561,-0.00637984890101337,0.00224161959558381,0.346831133330618
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36916,-0.00143398488493303,0.00152792330469187,-0.00442871456212909,0.00156074479226303,0.3479959995518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36992,-0.00363397047478413,0.00388047821581087,-0.0112397077777734,0.00397176682820518,0.349046760703945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36992,0.00504773406281808,0.00539836041996822,-0.00553305236031963,0.0156285204859558,0.34978080939051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36847,0.00325842612080229,0.00348682621755414,-0.00357575326560383,0.0100926055072084,0.350066159602032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36823,0.00376567829949128,0.00403205128277052,-0.00413714221473894,0.0116684988137215,0.350355077557411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39578,0.00507412923825462,0.00543979794327118,-0.00558787473055689,0.0157361332070661,0.350948979064458
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39462,0.00459849543169044,0.00493142707995381,-0.00506710164501903,0.0142640925083999,0.351099503801105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36861,0.00386395777977498,0.00414929468549451,-0.00426865980379426,0.0119965753633442,0.351751461494093
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,39104,0.0030827738076147,0.00331599973562461,-0.00341658567420953,0.00958213328943893,0.352559109813601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36880,-0.00172835675541946,0.00186301190063283,-0.00537986008065981,0.0019231465698209,0.353569913126908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36992,-0.00726329087918575,0.00784886555826895,-0.0226470673733929,0.00812048561502139,0.354778953099597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36880,-0.00272458990220337,0.00296181771134143,-0.00852975261643258,0.00308057281202584,0.35764043998792
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,39194,0.00263110234580906,0.00287011712704958,-0.00299432722320812,0.00825653191482624,0.359302813412886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39391,0.00440494037410502,0.0048253394596945,-0.0050527249668962,0.0138626057151062,0.36132207979419
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36823,-0.00325113395948644,0.00356452492826926,-0.0102376028188942,0.00373533489992131,0.361744074026612
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39104,0.00312552367945705,0.00342869329586194,-0.00359471518043236,0.00984576253934645,0.362005551449125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36763,0.00633011798762595,0.00694524806243854,-0.00728256821475359,0.0199428041900055,0.36208589874204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36992,-0.00662116004554199,0.00726941527870811,-0.0208692139918099,0.00762689390072591,0.362405466746289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36763,-0.00283356124819624,0.00311548895470199,-0.00893991959941214,0.00327279710301965,0.363099991132837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39194,-0.00246568145278596,0.00271199725780987,-0.00778119607809331,0.0028498331725214,0.363272359700359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39636,0.00224466399874161,0.00247308825175178,-0.00260258897469187,0.00709191697217509,0.364084956860648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36823,-0.00358987393487818,0.00395650530721097,-0.0113446243370117,0.00416487646725532,0.3642475857349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,39104,0.00433047182592584,0.00478260442705577,-0.00504343285110348,0.0137043765029551,0.365234989185534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39428,0.0105103955400376,0.0116185237598043,-0.0122619110291788,0.033282702109254,0.365679163549932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37164,0.00368786760710055,0.00409674045076549,-0.00434174367639981,0.0117174788906009,0.368033235697647
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36847,0.00393060872509908,0.00437368344263578,-0.00464181082246706,0.0125030282726652,0.368832441775194
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,39104,0.00407781416095338,0.00453784680098649,-0.00481636556898014,0.0129719938908869,0.368868193382923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36864,0.00527318905143842,0.00587831234717812,-0.00624830314903069,0.0167946812519075,0.369705191830562
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36992,0.00314351032454972,0.00351466504684382,-0.00374523316726416,0.0100322538163636,0.371126005347189
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36482,0.00372859939120958,0.00417294021921966,-0.00445036343846097,0.0119075622208801,0.37159743004723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36861,-0.00281540049811203,0.0031543836472581,-0.00899799244673791,0.00336719145051385,0.372123092133503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39462,-0.00295945885742384,0.00331581549278674,-0.00945845722328586,0.00353953950843818,0.372124188886673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36992,0.00482571866097666,0.00543875862387554,-0.00583424824181939,0.0154856855637727,0.374943513763206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39104,0.00512952483881901,0.00579975592453876,-0.00623799677327696,0.016497046450915,0.376474301423052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36847,-0.00308517578232349,0.00349201906257877,-0.00992953314497788,0.0037591815803309,0.376986884000674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36880,-0.0032436096591348,0.00367688421739387,-0.0104503027252268,0.00396308340695719,0.377705957204548
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36847,0.00255541377208041,0.0029057451158547,-0.0031398466549948,0.00825067419915562,0.379182545053356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36847,-0.00473806414538846,0.00539038110176283,-0.0153032111048436,0.00582708281406669,0.379426446927499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36880,-0.00287502303824425,0.00328365721132095,-0.00931099117243332,0.00356094509594482,0.381288828184504
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36847,-0.00455248359831852,0.00520561268198048,-0.0147554844550003,0.00565051725836322,0.38184463293297
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36916,0.00314597629667026,0.00360653443147036,-0.00392283118901163,0.0102147837823522,0.383062098378126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36880,-0.00317077992902688,0.00364629899946771,-0.0103175259679836,0.00397596610992983,0.384542080814318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37255,-0.00219062144029896,0.00252307329208869,-0.00713584509279279,0.00275460221219487,0.385281776106737
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36763,0.00547316804843735,0.00630841981180345,-0.00689133478269742,0.0178376708795721,0.385631731084019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,39093,-0.00657987034509064,0.00759048976789427,-0.0214572302901634,0.00829748959998214,0.386034488876435
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36880,0.0045749112435394,0.00528593337277983,-0.00578551816710908,0.0149353406541879,0.386787774246145
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36823,0.00368768048076105,0.00426651714618812,-0.00467469312576766,0.0120500540872898,0.387423172062977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39455,-0.00231072986645533,0.00268832462702071,-0.00757984613541592,0.00295838640250527,0.390054894216011
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39187,0.00198518659150078,0.00231228079097056,-0.00254688375880153,0.00651725694180308,0.390608069707249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,37255,-0.00326517319371171,0.00380809311587042,-0.0107290357008177,0.00419868931339431,0.391223347537506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36880,-0.00305328175257028,0.00356974218325219,-0.0100499764317446,0.003943412926604,0.392388976960234
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39187,-0.00152285084635293,0.00178187181407888,-0.00501531960194754,0.00196961790924169,0.392766882222557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36789,-0.00251290714534245,0.00294740860084544,-0.0082898280029995,0.0032640137123146,0.393907769356568
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36538,-0.00505688572063225,0.00593418506076591,-0.0166878884397334,0.00657411699846893,0.394141190209511
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39427,0.00501764173875339,0.00588913088391649,-0.00652505479372294,0.0165603382712297,0.394218083075675
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39079,0.00504906375966689,0.00592844896903136,-0.00657069621963457,0.0166688237389684,0.394412939500052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37164,0.00936412721422472,0.0110068224750166,-0.0122092448368078,0.0309374992652572,0.394920581497775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,39194,-0.00317792340429987,0.00373637554260377,-0.0105012194678033,0.00414537265920353,0.395040745634997
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39526,0.00240745727467915,0.00283690649967539,-0.00315287946468461,0.00796779401404292,0.396105920196634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36861,0.0028416874774267,0.00338554207997367,-0.00379397499932169,0.00947734995417508,0.401283678780789
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36763,-0.00392356138892687,0.00469271471094252,-0.0131212822223742,0.00527415944452047,0.403116959118761
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39428,0.00542299071369489,0.00649476698805289,-0.00730675258288877,0.0181527340102786,0.4037431407151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39187,0.003535531869613,0.00424540957658865,-0.00478547090050075,0.0118565346397268,0.404977041293956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,37255,0.00528691316250409,0.00634956345147186,-0.00715823120238075,0.0177320575273889,0.405062199881758
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36763,-0.00180184751592319,0.00216866657041844,-0.00605243399394334,0.00244873896209696,0.406071646785978
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36992,0.002548420810758,0.00309058154439956,-0.00350911901626513,0.00860596063778112,0.409627770254898
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,37221,-0.0112964256313551,0.0137220599732668,-0.0381916631789581,0.0155988119162479,0.410391997640305
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36763,-0.00481462809916881,0.00585692781325965,-0.0162942066131577,0.00666495041482011,0.411070133482304
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36847,-0.00284636018160844,0.00349024853007466,-0.00968724730055478,0.00399452693733789,0.414791588003588
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36823,-0.00238986900046032,0.00293400324531796,-0.00814051536128351,0.00336077736036288,0.415350175810856
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,39194,-0.00442216332831239,0.00546703617439839,-0.0151375542301332,0.00629322757350846,0.41859858431619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37247,-0.00343075996521269,0.00426254931513989,-0.0117853566228869,0.0049238366924615,0.42091481583504
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36823,-0.00448109386104664,0.00556912875778975,-0.0153965862263145,0.00643439850422127,0.42104808755217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37162,0.00652316098922641,0.00810729709607885,-0.00936714131908814,0.022413463297541,0.42106347387557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39578,0.00205851126048215,0.00256156343242124,-0.00296215306706348,0.00707917558802777,0.421631881313145
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,39213,0.00377308733199432,0.00470104881265442,-0.00544096834080834,0.012987143004797,0.422215747312493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37162,-0.00327076152488111,0.00410783751115352,-0.011322123046742,0.00478059999697979,0.425916337909656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39455,-0.00328249726493038,0.00412674874092741,-0.0113709247971481,0.00480593026728735,0.426381985214705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,39123,-0.0114562265494845,0.0144404844431979,-0.0397595760581523,0.0168471229591834,0.42759207881789
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36916,0.00357767726955171,0.00452244567519273,-0.00528631625382604,0.0124416707929295,0.428904498834618
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36992,0.00512495846299015,0.00648080823514354,-0.00757742567789118,0.0178273426038715,0.429081490785082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36823,-0.00643296493940158,0.00814599347740292,-0.0223991121551113,0.00953318227630815,0.429712828452464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39589,-0.00315292928997233,0.00399347747929942,-0.0109801451493992,0.00467428656945453,0.429820665235067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36955,0.00178958572616091,0.00227728514367804,-0.00267389315544804,0.00625306460776987,0.431975100048926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36861,0.00342649167374904,0.00437566884376578,-0.00514981926003188,0.01200280260753,0.433596029977707
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39428,-0.00300542107601505,0.00384373668176577,-0.010539144972276,0.00452830282024586,0.434285191966364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36763,-0.00385390736619146,0.00494018321689657,-0.0135366664713087,0.00582885173892581,0.435338622416966
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37221,0.00156767600957176,0.00201486425301047,-0.00238145792632876,0.00551680994547228,0.436550770969296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36823,0.00415213418295116,0.00533704884998255,-0.00630848156301464,0.014612749928917,0.436593813299166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36847,-0.00363780388263847,0.00468006748333546,-0.012810736149976,0.00553512838469905,0.436998214015932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36992,0.00469349193141635,0.00604536789110549,-0.0071554291351504,0.0165424129979831,0.437540346686694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36847,-0.00434773848907254,0.00561233194262862,-0.0153479090966246,0.00665243211847955,0.438545952117738
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,39104,-0.00402759265585421,0.00520679136705661,-0.0142329037352852,0.00617771842357674,0.43922315469861
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36880,-0.00607462326570422,0.00788380467964685,-0.0215268804378121,0.00937763390640361,0.441006587609849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36861,-0.00196033312113733,0.00255848926978315,-0.00697497208991231,0.00305430584763765,0.443567548088651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37203,0.00260023667166761,0.00340579590320282,-0.00407512329860992,0.00927559664194514,0.445194879085923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36880,0.00289414289632956,0.00379238332978136,-0.0045389284300419,0.010327214222701,0.445390700022405
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39194,0.00272758902066433,0.00357714770551189,-0.00428362048213898,0.00973879852346764,0.445771525463066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37162,-0.00505242106337515,0.00665330259532887,-0.0180928941502197,0.00798805202346944,0.447636109108796
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,37255,0.00371394950199792,0.00489158257044616,-0.00587355233607655,0.0133014513400724,0.44771511228752
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37162,0.00283550836844825,0.00375335871865805,-0.00452107472012154,0.010192091457018,0.449987664143904
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,37200,0.00150574483206601,0.0019953675644492,-0.00240517559425442,0.00541666525838644,0.450490790949796
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36823,0.00563997373999472,0.00747687291777798,-0.00901469717885012,0.0202946446588396,0.450669931390556
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39450,0.00125298322661465,0.00166602415204137,-0.00201242411138644,0.00451839056461573,0.452014831475576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36847,-0.00306599980204429,0.00408458897064394,-0.0110717941845064,0.00493979458041784,0.452891852861211
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39428,-0.00226850903731381,0.00303008437332641,-0.00820747440903358,0.00367045633440596,0.454072708262979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36880,0.00596698537720486,0.00797064738797028,-0.00965548350321689,0.0215894542576266,0.454100491900151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36916,-0.00329539709394302,0.00440972898402064,-0.0119384659026235,0.00534767171473743,0.454895683340455
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36880,0.00369405067563276,0.00494619703049971,-0.00600049550414667,0.0133885968554122,0.455170261717705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36916,-0.00208774465511258,0.0028036774043223,-0.00758295236758428,0.00340746305735913,0.456500332312709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,39355,-0.00159175834015106,0.00213876252416988,-0.00578373288752402,0.0026002162072219,0.456741409714536
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36916,0.00365791959387016,0.0049441406389675,-0.00603259605850614,0.0133484352462465,0.459405301520266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36992,-0.00491617501806568,0.0066461965246625,-0.0179427202064042,0.00811037017027282,0.45949740634869
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36847,0.00333019085982511,0.00450451409299848,-0.00549865676245191,0.0121590384821021,0.459738365456251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37221,0.00718894173368946,0.00973946526077718,-0.0119004101774338,0.0262782936448127,0.460452124340191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,37164,0.00378881519098005,0.00513731889090178,-0.00628032983518743,0.0138579602171475,0.460826925704669
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36741,0.00560040830101521,0.00761670931125037,-0.00932834194903552,0.0205291585510659,0.46218347512417
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39531,0.00497626233628114,0.00677549544713839,-0.00830370874011011,0.0182562334126724,0.462685970000165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37203,0.00162590514823266,0.00221606079130582,-0.00271757400272674,0.00596938429919206,0.463150219467333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39123,0.00372684484897186,0.00508191753311996,-0.00623371351594325,0.013687403213887,0.463354229555758
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,37164,0.00513376321757625,0.00700799118777785,-0.00860189951046834,0.0188694259456208,0.46384128260676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36861,0.00312059803742758,0.00426666872293217,-0.00524207265951948,0.0114832687343746,0.464554896758066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39104,0.00320324905069226,0.00438588875368974,-0.00539309290653963,0.0117995910079241,0.465185832220507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36763,-0.00495163690594634,0.00679146088543759,-0.018262900241404,0.00835962642951134,0.465955915935469
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36763,0.00361332239689296,0.00496139021049723,-0.00611100241568161,0.0133376472094675,0.466450980527489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39355,-0.00298948428278292,0.00410755389080113,-0.0110402899087531,0.0050613213431873,0.466746480569735
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36861,0.0038047649238482,0.00522911861518045,-0.00644430756190548,0.0140538374096019,0.466865390978383
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36861,0.00432054877480458,0.00594616622733804,-0.00733393703077798,0.0159750345803871,0.467478098105214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36861,-0.00419588279705588,0.00577561478937524,-0.0155160877842314,0.0071243221901196,0.467556763933815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39485,0.00477759931158509,0.0065904289316626,-0.00813964139447361,0.0176948400176438,0.468506289437009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39428,0.0019757584390952,0.00275945089241494,-0.00343276531003808,0.00738428218822848,0.474004392220971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39123,0.00301523596606828,0.00422023051461208,-0.0052564158425714,0.011286887774708,0.474946815154457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37247,-0.00206871498010502,0.00290355373596288,-0.00775968030259227,0.00362225034238224,0.476182499392026
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36823,-0.00332010161201648,0.00466345420787024,-0.0124604718594422,0.0058202686354092,0.476515087737346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39104,0.00488905817935398,0.00691498141381938,-0.008664305391732,0.01844242175044,0.479562774980004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36847,-0.00309443149751374,0.00437903966237285,-0.0116773492357645,0.00548848624073704,0.479799687867525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,37221,-0.00267788141471617,0.00379726251503751,-0.0101205159441897,0.00476475311475734,0.480690142203687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36861,0.00363042238260225,0.0051525424018967,-0.00646856072511527,0.0137294054903198,0.481079548788316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36880,-0.00338944215027577,0.0048186790954552,-0.012834053177368,0.00605516887681643,0.481821845779239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36861,0.00234055571641356,0.00333075217090758,-0.0041877185385653,0.00886882997139241,0.482249141432773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,39187,-0.00640551680138085,0.00914806045872187,-0.0243357153004757,0.011524681697714,0.483810403950541
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,39092,0.00518362084167626,0.0074089146809145,-0.00933785193291616,0.0197050936162687,0.484159243908935
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36880,0.00452423280861965,0.00647255808531904,-0.00816198103860567,0.017210446655845,0.484573346533948
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37162,0.00387728620591443,0.0055507944461559,-0.00700227090855113,0.01475684332038,0.484870998672445
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36880,-0.00156306248246122,0.00223788953648166,-0.00594932597396527,0.00282320100904284,0.484906500725768
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39589,0.00456802699165388,0.006550952517892,-0.00827183994341445,0.0174078939267222,0.485621211901121
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37145,0.00246027831293208,0.00354720211709463,-0.00449223783657339,0.00941279446243756,0.4879565862869
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36992,-0.00206413573015287,0.00300815689389132,-0.00796012324217986,0.00383185178187412,0.492612581046673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,39187,0.00356917080461135,0.00520526967102835,-0.00663315775060421,0.0137714993598269,0.492923104053995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36992,-0.00360172638508131,0.00525553988354125,-0.0139025845568222,0.00669913178665953,0.493154706664022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37164,0.00229741311958964,0.00335960914586853,-0.00428742080631267,0.00888224704549195,0.494092805031371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36992,0.00499447508766411,0.00731950238020666,-0.00935174957754094,0.0193406997528692,0.495029175961039
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39428,-0.00263545702420575,0.00386384746254248,-0.010208598050789,0.00493768400237751,0.4951982690992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36823,0.00437220143953943,0.00641859489904982,-0.00820824456259823,0.0169526474416771,0.495772030621144
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36847,-0.00223836852396924,0.00328993816685451,-0.00868664733100408,0.0042099102830656,0.496284209804342
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39123,-0.00453776459839691,0.00667805809970504,-0.0176267584738188,0.00855122927702496,0.496829540304693
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39571,0.0017219826565657,0.00254715537235225,-0.00327044187324471,0.00671440718637611,0.499024658039254
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36992,0.0025323063141168,0.00375480777393216,-0.00482711692279023,0.00989172955102384,0.500058649827568
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36763,0.00300275342320648,0.00445359124039022,-0.00572628540795835,0.0117317922543713,0.500176531374954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36916,-0.00234108934389431,0.00347562123088754,-0.00915330695643388,0.00447112826864526,0.500594448941611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36823,0.00186765868411067,0.00279126246052712,-0.00360321573852248,0.00733853310674381,0.503438469584008
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,37164,-0.00175258796201819,0.00263689343212281,-0.0069208990889789,0.00341572316494251,0.506292079971136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39526,0.00267981244366737,0.00403754223429796,-0.00523377033555663,0.0105933952228914,0.50687732272923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39194,0.00246648707027017,0.00372014448064089,-0.00482499611178598,0.00975797025232632,0.507335535234549
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39428,0.00134971794819563,0.00204605265625608,-0.00266054525806629,0.00535998115445755,0.509476270884469
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36847,-0.00417967788550797,0.00635363142173721,-0.0166327954721129,0.00827343970109696,0.510652660122416
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39187,0.00190779065030133,0.00290055944785189,-0.00377730586748838,0.00759288716809103,0.510720656482682
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36861,-0.0027866963572462,0.00424180237957728,-0.0111006290212177,0.00552723630672527,0.511218537438531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36880,0.00170938395937766,0.0026045384812437,-0.00339551146386,0.00681427938261532,0.511637006280816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39104,-0.00363487127578691,0.00557141392290013,-0.0145548425646712,0.00728510001309734,0.514144042322268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39531,0.00484112127357871,0.00750776451175959,-0.00987409716947009,0.0195563397166275,0.519056708402672
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37247,-0.00212634150989385,0.00330163240124871,-0.00859754101634132,0.00434485799655363,0.519569253915278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36763,-0.00528380658329725,0.00822402377485577,-0.0214028931820146,0.0108352800154201,0.520570710626086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,39374,-0.002785464066908,0.0043416519164938,-0.0112951018232358,0.00572417368941984,0.521163700270149
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39601,0.0020141880136685,0.00313954612725524,-0.00413932239575177,0.00816769842308876,0.521172589866921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39187,0.00238782791599691,0.00372783913911586,-0.00491873679667018,0.00969439262866401,0.521831931063348
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39104,0.00176993271777378,0.0027743789881879,-0.0036678500990745,0.00720771553462207,0.523512058575832
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36880,-0.00166089005142494,0.00260965825281453,-0.00677582022694141,0.00345404012409153,0.524501608966247
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36847,-0.00204965397945347,0.00322832306249335,-0.00837716718194045,0.0042778592230335,0.525507039545617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37030,-0.00241335513368773,0.00381186352703221,-0.00988460764667086,0.0050578973792954,0.526668832048056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39194,0.00358759788960901,0.00567658601371185,-0.00753851069726622,0.0147137064764842,0.527397192443485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36880,-0.00158858331394972,0.00252100180378666,-0.00652974684937158,0.00335258022147214,0.528614774212453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36847,0.00350905207930384,0.00559590648925364,-0.00745892463963329,0.014477028798241,0.530621738785999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36880,-0.0029935302926985,0.00479517773886004,-0.0123920786608642,0.00640501807546718,0.532455622590255
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37221,0.00257750085585765,0.00413174877256238,-0.00552072673836462,0.0106757284500799,0.532751647808104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36880,-0.0025383995634298,0.00409527074936258,-0.0105651302321804,0.00548833110532085,0.535376594185982
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36823,-0.00375816218313598,0.00608650923051277,-0.015687720274941,0.00817139590866905,0.536944217639644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,37077,-0.00562991978603613,0.0091247007724784,-0.0235143333000938,0.0122544937280215,0.537247340581486
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36763,0.00177771657885326,0.0028965656566493,-0.00389955210817937,0.00745498526588588,0.539403425759326
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36955,0.00218022155078155,0.00355656439206328,-0.00479064465766248,0.00915108775922559,0.539878644381282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,37164,0.00292259477821403,0.00478151201686209,-0.00644916877483567,0.0122943583312637,0.54105947455994
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36916,-0.0035477156000499,0.00580528509714735,-0.0149260743904587,0.00783064319035891,0.541132451130265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39123,0.00212026177926815,0.00347186607440292,-0.00468459572656158,0.00892511928509788,0.541408969538849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36955,0.00162819728807574,0.00268025126649514,-0.00362509519425472,0.00688148977040621,0.543543877400148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39187,0.00453680037403124,0.00748401211706259,-0.0101318633754114,0.0192054641234739,0.544391980452941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36861,-0.00362636256205279,0.00599501165437156,-0.015376585404621,0.00812386028051547,0.545258719307005
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36763,-0.00231717628817494,0.00383380719928088,-0.00983143839876548,0.00519708582241559,0.545584848730683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39516,0.00155025551838451,0.00259564280434597,-0.00353720437813359,0.00663771541490262,0.550347438388503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37221,0.00399596936717931,0.00669546325345032,-0.00912713860958332,0.0171190773439419,0.550639841211219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36847,-0.00284828117886459,0.00478826778483426,-0.0122332860371397,0.00653672367941055,0.551957380399321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36823,-0.00161349189028059,0.00271481168321693,-0.00693452278938576,0.00370753900882459,0.55230281203915
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39549,-0.00372701186356665,0.00627600984628191,-0.0160279911622792,0.0085739674351459,0.552620976995605
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39123,0.00451471670012581,0.00760656200115075,-0.0103941448221297,0.0194235782223813,0.552836193737477
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36916,-0.0018485207736313,0.00311676283423585,-0.00795737592873356,0.00426033438147097,0.553131704018175
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39123,0.00163890309988209,0.00277193502233743,-0.00379408954389927,0.00707189574366345,0.554362876292108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36763,-0.00165054650259965,0.00279165848517506,-0.00712219713354277,0.00382110412834348,0.55436895868116
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36847,-0.00101948202924882,0.0017269319527093,-0.00440426865655904,0.00236530459806141,0.554971541185485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36847,-0.00316458168480469,0.00536263795616051,-0.0136753520788793,0.00734618870926991,0.55512323713434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39455,0.00146057291802947,0.00247687744676119,-0.00339410687762247,0.00631525271368141,0.555411967654884
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,39194,0.00246260042864881,0.00418153989759299,-0.00573321777063345,0.0106584186279311,0.555922688348951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36880,-0.0021124582463948,0.00358901429026931,-0.00914692625532265,0.00492200976253305,0.556146979471585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39355,0.00348477604527638,0.00595559395292592,-0.00818818810245842,0.0151577401930112,0.558471497766676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36823,0.00354597091674573,0.00608182923740556,-0.00837441438856917,0.0154663562220606,0.559874654519307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39187,0.00164073169387519,0.00282142500729994,-0.00388926132043269,0.00717072470818308,0.560894968647202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,39251,-0.00135541803673044,0.00234933871097439,-0.00596012191024024,0.00324928583677937,0.563991477906737
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,39351,0.0035424022257747,0.00617217982160735,-0.0085550702245757,0.0156398746761251,0.566023499258796
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,39330,0.00152331458963116,0.002657590721852,-0.00368556322519876,0.00673219240446107,0.566522128272533
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36823,-0.00242938894830072,0.00424602950492349,-0.0107516067779508,0.00589282888134931,0.567227058242015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36741,-0.00172221856856389,0.00301329938225964,-0.00762828535779278,0.00418384822066499,0.567644682442004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36880,-0.00213414700216427,0.00373421940281757,-0.0094532170316867,0.00518492302735816,0.567663725251125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36847,-0.00253534238611971,0.00445629049320268,-0.011269671752797,0.00619898698055754,0.56941014089904
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39428,-0.000926467980308787,0.00162863560096403,-0.00411859375819829,0.00226565779758072,0.569458711182188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36847,0.0019596156173418,0.00344910928703506,-0.00480063858524692,0.00871986981993052,0.569942588879608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36992,0.00332426940088366,0.00593804416227117,-0.00831429715716783,0.0149628359589351,0.575608369228746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,39194,0.00253085207452931,0.00452760637288309,-0.00634325641632154,0.0114049605653802,0.576182253119704
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36861,-0.00258119079371706,0.00462939949385274,-0.0116548138016684,0.0064924322142343,0.577151568871347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39123,0.00219907565121158,0.0039575307221485,-0.00555768456419947,0.00995583586662263,0.578445882577615
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39531,-0.00187633776118648,0.00340247723935666,-0.00854519315032553,0.00479251762795257,0.581325007769441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36992,0.00212702130803148,0.00386653882563534,-0.00545139479021378,0.00970543740627674,0.582253790872496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39479,-0.00272043172069999,0.00496475817861999,-0.0124513577507952,0.0070104943093952,0.583735414885485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37221,0.00172569545569105,0.00315477025593589,-0.0044576542459433,0.00790904515732539,0.584380424234992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39187,-0.0015682391054123,0.00287149748304128,-0.00719637417217322,0.00405989596134861,0.584978101224279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37221,0.00153195178786036,0.00280524629494982,-0.00396633095024129,0.00703023452596202,0.585005077787282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37162,-0.00209623844880037,0.00389738215386455,-0.00973510747037489,0.00554263057277415,0.590684454328906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36847,-0.00188298664884461,0.00350221264185263,-0.00874732342687577,0.00498135012918654,0.590824014833216
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,37237,0.00153898188274696,0.00286596798040394,-0.00407831535884476,0.00715627912433867,0.591287303758733
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36763,-0.00228743299265424,0.00426820011119754,-0.0106531052106014,0.00607823922529293,0.592020416143228
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36992,-0.00341957804717024,0.00638149534312625,-0.0159273089196977,0.00908815282535721,0.592065903237138
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37243,-0.00214523401836987,0.00402120982013226,-0.0100268052658291,0.00573633722908936,0.593710793023242
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39654,0.00140954353301734,0.00265116908306635,-0.00378674786979272,0.00660583493582739,0.594963265364108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36835,-0.00310708370714626,0.00587707551223331,-0.0146261517111235,0.00841198429683101,0.597037940998614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36916,-0.00128263262393426,0.00243174146444403,-0.00604884589424455,0.00348358064637603,0.597887494860314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,37203,0.00104161472919097,0.00198000438173196,-0.00283919385900367,0.00492242331738561,0.598850888042207
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36880,-0.00226397020906585,0.00432412048551557,-0.0107392463606764,0.00621130594254466,0.600588524400765
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36847,0.00426512696980072,0.00825324309893032,-0.0119112295041027,0.0204414834437041,0.605317609640822
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39274,-0.00129653931039344,0.00251612437915368,-0.00622814309353465,0.00363506447274777,0.60635652143677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39541,-0.00122409391978496,0.00237599548798814,-0.0058810450762417,0.00343285723667179,0.60642639058023
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36823,-0.00193352437723363,0.00378128674286927,-0.0093448463932574,0.00547779763879014,0.609121901724899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36847,-0.00269886733454646,0.00531764037129387,-0.0131214424622824,0.00772370779318952,0.611791321063271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36763,-0.00372012077343948,0.00735134533880441,-0.0181287576374961,0.0106885160906172,0.612833240180269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36847,0.00207386241507766,0.00410154182292727,-0.00596515955785978,0.0101128843880151,0.613125438695756
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36861,0.00183756212506294,0.00363587158028227,-0.0052887461722903,0.00896387042241619,0.613288318897114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36823,-0.00281585727034096,0.00559350697071154,-0.0137791309329356,0.00814741639225365,0.614681244784955
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39462,0.00239273191181441,0.00476166322097539,-0.00694012800129735,0.0117255918249262,0.615323793887867
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39462,-0.00251710732683566,0.00504412876442949,-0.0124035997051175,0.00736938505144615,0.617774536267411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37162,0.00191863017130243,0.00385692694101409,-0.00564094663308518,0.00947820697569004,0.618880018370085
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39531,0.00116747240318155,0.0023477364768069,-0.00343409109135999,0.00576903589772308,0.619001864788453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39123,0.00245650873123938,0.00498819904204042,-0.00732036139115983,0.0122333788536386,0.622398695349171
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39589,-0.00125650698743563,0.00255580414551908,-0.00626588311265302,0.00375286913778175,0.622988891357566
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36763,-0.0017700904350341,0.00360826171097252,-0.00884228338854024,0.00530210251847205,0.62374219760422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36823,-0.00193161614614696,0.00394026355646593,-0.00965453271682018,0.00579130042452627,0.623983306181522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36880,-0.00392293992321174,0.00803172860061924,-0.0196651279804255,0.011819248134002,0.625253674286127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36992,-0.00184560408137684,0.00378258898211569,-0.00925947848632359,0.00556827032356992,0.625614426601019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39654,0.00104856442083937,0.00215210154981103,-0.00316955461679024,0.00526668345846898,0.626103695701703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36763,0.00174532656327632,0.00359150939832475,-0.00529403185744018,0.00878468498399282,0.627004835814267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37243,-0.00592079674588548,0.012327665580167,-0.0300830212830128,0.0182414277912418,0.631032742820201
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39477,-0.000946890804203045,0.00198547700796289,-0.0048384257398103,0.00294464413140421,0.633434235576996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36861,-0.00203729456332514,0.00430124876918983,-0.0104677421509372,0.00639315302428693,0.635756506247647
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36763,0.00252714186474784,0.00537154362823989,-0.00800108364660235,0.013055367376098,0.638028696660016
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36763,-0.00174558768425218,0.0037333227888499,-0.00906290035039798,0.00557172498189362,0.640100791941847
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39485,-0.00173985838368153,0.00374885191478691,-0.00908760813666387,0.00560789136930081,0.642579724281072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36823,0.00361436028070033,0.00780511493211236,-0.0116836649862399,0.0189123855476406,0.643318140998428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36823,0.0022642024784228,0.00491467037964399,-0.00736855146567941,0.011896956422525,0.645019933446741
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,39194,-0.00161906107553963,0.00352633225019185,-0.00853067228591566,0.00529255013483641,0.64614429549456
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,39194,0.00116686016378911,0.00254709592377134,-0.00382544784680272,0.00615916817438094,0.646877332662864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,39136,-0.00186760844402715,0.00407962290090149,-0.00986366932979406,0.00612845244173976,0.647110468542799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36880,0.00306014114035626,0.00669252849491871,-0.0100572147096844,0.0161774969903969,0.647501236803163
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36992,-0.00250568182765985,0.00552186947565003,-0.0133285459999339,0.00831718234461421,0.649999217633438
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36861,-0.00190527595789208,0.00420432604313166,-0.0101457550024301,0.00633520308664598,0.650433995449925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36992,-0.00162628327800363,0.00360058672021098,-0.00868343324961715,0.00543086669360988,0.651513289344385
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36847,0.00136431573744391,0.00303691949579907,-0.00458804647432228,0.00731667794921009,0.653264009233419
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36992,-0.00195051659037603,0.00436493924182496,-0.010505797504353,0.0066047643236009,0.654983889975739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36916,0.00162079650116909,0.00364533932433871,-0.00552406857453479,0.00876566157687296,0.656600975429496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39428,-0.0021117755710848,0.00475585979674022,-0.0114332607726956,0.00720970963052604,0.657022575270624
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38957,0.000994848122018507,0.00224655171828906,-0.00340839324582804,0.00539808948986506,0.657892850823518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36861,0.00238645479664411,0.00548421744764009,-0.00836261140073046,0.0131355209940187,0.663461441455057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37221,-0.00176042428195564,0.00404762020210983,-0.00969375987809092,0.00617291131417963,0.663621874635646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36823,-0.00233074666395535,0.00541448350670294,-0.0129431343370931,0.00828164100918242,0.666864783121513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,37221,0.00173893010874979,0.00407900854544124,-0.00625592664031504,0.00973378685781462,0.669887733779603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37164,-0.00250107874186503,0.0058852694761152,-0.0140362069150508,0.00903404943132075,0.670863783656069
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36763,-0.000956236770601406,0.00225143967040326,-0.00536905852459179,0.00345658498338898,0.671046503939843
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,39194,0.00525338251845611,0.0123910798186455,-0.0190331339260891,0.0295398989630013,0.671597621034052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36847,-0.00116411939923892,0.00276324002149841,-0.0065800698413758,0.00425183104289796,0.673552219119521
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39541,0.000735194790766498,0.00174624809135677,-0.00268745146829277,0.00415784104982576,0.67375089839279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36808,0.00339583877755736,0.0081779052376015,-0.0126328554881416,0.0194245330432563,0.677969365388773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36861,0.00328029559944694,0.00794531172455125,-0.0122925153806735,0.0188531065795674,0.67971685679226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36847,-0.00255425311841676,0.00619791861599256,-0.0147021736057622,0.00959366736892866,0.680262511279051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36992,-0.00100231008607507,0.00248604950944628,-0.00587496712458978,0.00387034695243964,0.686827228693606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36861,-0.00208354619377206,0.00518894764788882,-0.0122538835836341,0.00808679119609004,0.68803289166064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39104,0.00170239007015978,0.00423993559003744,-0.0066078836863136,0.0100126638266332,0.688048183768921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36763,-0.00215244880579907,0.00536507195233049,-0.0126679898323668,0.00836309222076869,0.688282322234204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39194,0.00187356902754598,0.00467057862929509,-0.0072807650858724,0.0110279031409644,0.688320799026789
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39462,0.00142019622174431,0.00354298075298961,-0.00552404605411532,0.00836443849760395,0.688537851689722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37162,0.00196083087141611,0.00491688903813123,-0.0076762716433211,0.0115979333861533,0.690050944926504
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36992,0.00149491429446875,0.00380779024730041,-0.00596835459024004,0.00895818317917755,0.694626298674547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36823,-0.00245401986099932,0.00630888258575498,-0.0148194297290791,0.00991139000708045,0.697298724979665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36823,-0.00204013014910711,0.00526234269673077,-0.0123543218346994,0.0082740615364852,0.698255993388264
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36763,0.0013688868425077,0.00353579412390579,-0.00556126964034764,0.00829904332536304,0.69865098740214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39526,-0.00153026575647173,0.00395633760950752,-0.00928468747110648,0.00622415595816302,0.698918276327981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36823,-0.00110395056968363,0.00286098461386081,-0.00671148041285083,0.00450357927348356,0.699604131613838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36880,0.0020490184594006,0.00532021565500096,-0.00837860422440129,0.0124766411432025,0.700141593437149
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36916,0.000864806950251299,0.00227474826762135,-0.00359369965428655,0.00532331355478914,0.703820516332907
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36861,-0.00258876018876805,0.0068094143657817,-0.0159352123457002,0.0107576919681641,0.703822994433084
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36861,0.000880317521223212,0.00233301142076149,-0.00369238486346931,0.00545301990591573,0.705934093687007
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36763,0.00179555755364607,0.00475925692449664,-0.00753258601836735,0.0111237011256595,0.705974362986025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37247,0.00201658321228634,0.00540505286206576,-0.00857732039736255,0.0126104868219352,0.709085983758679
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,39079,-0.00114155840663915,0.00306339411995488,-0.00714581088175072,0.00486269406847241,0.7094180985095
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36823,-0.00195082369437944,0.00529046322798168,-0.0123201316212235,0.00841848423246464,0.712325264659486
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36992,-0.00260566094194173,0.00708541130257555,-0.0164930670949898,0.0112817452111063,0.713065762558476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37247,-0.000856155529815349,0.00235763707429126,-0.00547712419542622,0.00376481313579552,0.716505289706559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39355,0.00186221490948152,0.00517622376655102,-0.00828318367295847,0.0120076134919215,0.719029310820786
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36880,0.00112848221612074,0.00314334434858331,-0.00503247270710254,0.00728943713934403,0.719596048585356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36861,0.00128204857633625,0.0035730663225132,-0.00572116141578963,0.00828525856846212,0.719744037222189
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36823,0.00178662144739242,0.00501088236306023,-0.00803470798420564,0.0116079508789905,0.721436089075237
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39123,0.00383487432116236,0.0108442266061757,-0.017419809826942,0.0250895584692667,0.723619164244956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39654,0.000867600217871403,0.00246496540377396,-0.00396373197352557,0.00569893240926837,0.724863709556488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36880,0.000997041941637257,0.00283494710924251,-0.00455945439247805,0.00655353827575257,0.725071592731471
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39434,0.00256562814597201,0.00747172853310839,-0.0120789597789204,0.0172102160708645,0.731318830943884
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39541,0.00224134788552866,0.00653577326336303,-0.0105687677106629,0.0150514634817202,0.731651852029626
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36847,0.00204185924918623,0.00598278879092915,-0.00968440678103491,0.0137681252794074,0.732891908066269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36847,0.0013933540205151,0.00410189790458914,-0.00664636587247962,0.00943307391350982,0.734099361886883
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36823,-0.00126631533729422,0.00372836610465745,-0.00857391290242282,0.00604128222783439,0.734130776079486
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,39187,0.00079865550826847,0.00236268182317725,-0.00383220086515894,0.00542951188169588,0.735345979177297
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36763,0.000841698986956132,0.00249811497296316,-0.00405460636005166,0.00573800433396392,0.736172664099449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36823,0.0024765265622428,0.00735027582024138,-0.0119300140454303,0.0168830671699159,0.73617557680885
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36823,0.00282818510111402,0.00845216779965407,-0.013738063786208,0.019394433988436,0.737924505970868
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36992,0.00107231044994223,0.00322399560738068,-0.00524672094052391,0.00739134184040837,0.739439575907737
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36823,-0.000790695157911826,0.00238620198936844,-0.00546765105707396,0.00388626074125031,0.740377153936749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39654,0.000646286152821296,0.00195065477034409,-0.00317699719705311,0.0044695695026957,0.740409205639879
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36823,-0.00222784084421937,0.00675206665358965,-0.0154618914852551,0.0110062097968163,0.74144372628753
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36861,0.00148297027661249,0.00450481076812309,-0.00734645882890877,0.0103123993821337,0.742012331685106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39455,0.00100610524157882,0.00307035782912244,-0.00501179610350115,0.0070240065866588,0.743155640742739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,39355,-0.000340891541730487,0.00104326642664055,-0.00238569373794596,0.00170391065448499,0.743858496436212
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37203,-0.00179486119593415,0.00557807154702174,-0.0127278814280968,0.00913815903622846,0.747631522984334
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36823,-0.00078005234774343,0.00244692482205793,-0.00557602499897698,0.00401592030349012,0.749892016586461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36880,0.00119385363358444,0.00379483074414726,-0.0062440146249442,0.00863172189211308,0.753070684025766
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36880,-0.000859137588879931,0.00273479312396843,-0.00621933211185806,0.00450105693409819,0.75341174203253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36763,-0.00161493699838971,0.00514639234243899,-0.0117018659895701,0.00847199199279072,0.753678396649839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36763,-0.00111384819129925,0.00356780318521526,-0.00810674243432115,0.00587904605172265,0.754898071496633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36880,0.000967100212679644,0.00310308177335893,-0.00511494006310386,0.00704914048846315,0.755305689532094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39312,-0.0017534617287663,0.00565001104782971,-0.0128274833825125,0.00932055992497993,0.756301748614276
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36861,0.00176573219578072,0.00568987789728894,-0.0093864284829056,0.012917892874467,0.756316248752524
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36847,0.00127759359559733,0.00412956570023579,-0.00681635517686481,0.00937154236805947,0.757039789840913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36763,0.00149233606855123,0.00485406915769935,-0.00802163948053949,0.011006311617642,0.75851352219012
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39526,0.000717942439218175,0.00235473683173489,-0.0038973417509822,0.00533322662941855,0.760451965825325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39123,0.000930942795927783,0.00307242461198238,-0.00509100944355769,0.00695289503541325,0.761894619369597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,39330,0.00135990131657527,0.00450296670094417,-0.00746591341727529,0.0101857160504258,0.76265537461866
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36880,-0.00057814685073591,0.00192694264139149,-0.00435495442786323,0.00319866072639141,0.764156816413389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36823,0.00146637613584735,0.00490791991484148,-0.00815314689724196,0.0110858991689367,0.765114823522199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36992,0.00136671848261554,0.00457889843760585,-0.00760792245509193,0.010341359420323,0.765340304629087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36763,0.00141208605612871,0.00475623345732589,-0.00791013152023003,0.0107343036324875,0.76655423078291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39303,-0.0006663523710817,0.00225281170271334,-0.00508186330839985,0.00374915856623644,0.767396901925908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39601,-0.000740301041900939,0.0025085283684382,-0.00565701664403981,0.00417641456023793,0.767911082853097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36763,-0.00152096304323521,0.00524905117408832,-0.0118091033444483,0.0087671772579779,0.772005025931102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37221,0.000833528834316961,0.00289544588392441,-0.00484154509817488,0.0065086027668088,0.773446474929876
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36880,-0.000868876725171267,0.00302460743989651,-0.00679710730736843,0.00505935385702589,0.773910951510118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,37143,-0.00125298459918879,0.00436620358041662,-0.00981074361680536,0.00730477441842778,0.774137317862774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39194,-0.00148162540005758,0.00522366267401663,-0.0117200042411302,0.00875675344101502,0.776692358277141
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36967,-0.00126961508648983,0.00448430469178163,-0.0100588522823818,0.00751962210940217,0.777086329795783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39578,-0.000967511703407419,0.0034557602573038,-0.00774080180772287,0.00580577840090803,0.779503793807485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36880,0.00116200508375567,0.00416032939056931,-0.00699224052176018,0.00931625068927151,0.780014627127996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,37031,0.000780891464207694,0.00281261700360484,-0.0047318378628578,0.00629362079127319,0.781294246935361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37221,-0.00102503408562318,0.00370848341235006,-0.0082936615738293,0.00624359340258294,0.782243410388669
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36823,-0.00187014671139672,0.00677075559993109,-0.0151408276872617,0.0114005342644682,0.782391809843015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39258,-0.00410892158869257,0.0149158054201771,-0.0333439002122397,0.0251260570348545,0.782955684742473
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36861,0.00101430021985612,0.00368554346154973,-0.00620936496478135,0.00823796540449358,0.78315911072665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,37162,0.000829717659183134,0.00302279992998024,-0.00509497020357814,0.00675440552194441,0.783715266792042
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37164,0.000767844164309773,0.00280282278627964,-0.00472568849679832,0.00626137682541786,0.784124519269392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35538,-0.00244536499908052,0.00893640802946217,-0.0199607247368264,0.0150699947386653,0.78436584669053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,37269,0.000711931267375122,0.00260560568522565,-0.00439505587566716,0.0058189184104174,0.784680342964678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37162,0.00198955794132147,0.00730642664725207,-0.0123310382872926,0.0163101541699355,0.785393889043082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36992,-0.00156205597953838,0.00574432920698527,-0.0128209412252295,0.00969682926615276,0.785680248122125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37255,-0.000574765709116621,0.00213428346782911,-0.00475796130606167,0.00360842988782843,0.787702028574242
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36861,0.00134143498151498,0.00498807238161961,-0.00843518688645946,0.0111180568494894,0.787989151315608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39526,-0.0010450935599878,0.00389930574365706,-0.00868773281755563,0.00659754569758003,0.788687268604335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,37221,0.00081731715558951,0.00313889941910654,-0.0053349257058593,0.00696956001703833,0.794572281107397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39102,-0.00104266113870569,0.00400888937571585,-0.00890008431510876,0.00681476203769738,0.794800103549543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36861,0.0022198691241419,0.00875178943954008,-0.0149336381773567,0.0193733764256405,0.79977213310378
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37164,-0.00112422168844338,0.00443326103241755,-0.00981341331198179,0.00756496993509502,0.799817988517918
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36861,-0.00149782575352772,0.00599540422046182,-0.0132488180256329,0.0102531665185774,0.802723738684984
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36861,0.000631149861650594,0.00252940205001798,-0.00432647815638465,0.00558877787968584,0.802958586042696
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36763,-0.000794780209092114,0.00320992606810623,-0.00708623530258033,0.0054966748843961,0.804447433704958
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36823,-0.000773698631297179,0.00312619193825076,-0.00690103483026868,0.00535363756767432,0.80453378328651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,39123,0.00196899495463011,0.00796876354470293,-0.0136497815929876,0.0175877715022478,0.80484269334921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37162,0.000743023045708001,0.00302483386286864,-0.00518565132551454,0.00667169741693054,0.805964157510693
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36861,0.00139042041155504,0.00572822081039208,-0.00983689237681344,0.0126177331999235,0.808217309603258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36823,-0.0015184914094565,0.00626903280572724,-0.0138057957086819,0.0107688128897689,0.808612937231834
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36823,-0.00123246248778766,0.00516896567730643,-0.0113636352153083,0.00889871023973295,0.811547649709684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37162,-0.000785970517355445,0.00330615662986688,-0.00726603751189454,0.00569409647718365,0.812094838168144
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39194,0.00120401196650993,0.00507580235306696,-0.00874456064550131,0.0111525845785212,0.812500095503526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36763,0.000628506971104224,0.00266275882126836,-0.00459050031858177,0.00584751426079022,0.813408653107483
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36880,0.000947571096504545,0.0040877257538406,-0.00706437138102303,0.00895951357403212,0.816690282307139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,39123,0.00211156407248202,0.00917621910214566,-0.0158738253677235,0.0200969535126875,0.818007445473004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36847,0.000738682871834688,0.00325199140811698,-0.00563522028807459,0.00711258603174396,0.820312519891876
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37221,-0.000713317776523297,0.00314094687276478,-0.00686957364714227,0.00544293809409568,0.82034745560213
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36763,-0.00080319731807402,0.0035373953376293,-0.00773649217982746,0.00613009754367942,0.820381663360762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36880,-0.000555072673726887,0.00246391230439914,-0.0053843407903492,0.00427419544289543,0.821764369171162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39499,-0.000631776867073499,0.00286289862493608,-0.00624305817194822,0.00497950443780122,0.825346666856388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36880,0.000532680665725399,0.00241844633564676,-0.00420747415214225,0.00527283548359304,0.825674324781554
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,39187,-0.00134209574053516,0.00618157653992028,-0.0134579857587789,0.0107737942777086,0.828123905055983
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36847,-0.00109081538277543,0.00513597492514551,-0.0111573262360606,0.00897569547050978,0.831808455851296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36880,0.00122715484793468,0.00592049784781981,-0.0103770209337921,0.0128313306296615,0.835800648929089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37164,-0.000753396090572193,0.00371759278947779,-0.00803987795794866,0.00653308577680428,0.839406401416983
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36861,-0.00102745096342723,0.00508866047995846,-0.0110012255041458,0.00894632357729136,0.839990466817846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36847,0.000805294951826569,0.00399570358434337,-0.00702628407348643,0.00863687397713956,0.840279496171197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36880,0.00110514722323847,0.00551343727185859,-0.00970118982960437,0.0119114842760813,0.841134956422433
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36763,-0.00123975576780217,0.00618638291495228,-0.0133650662811086,0.0108855547455043,0.841170484252813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39104,0.000898766542481713,0.0044867464910979,-0.00789525658007017,0.00969278966503359,0.841236329035343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38999,-0.00112721507569705,0.00567074473492491,-0.0122418747561499,0.00998744460475578,0.842439766256452
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36861,-0.000595915272330897,0.00300442017038183,-0.00648457880627928,0.00529274826161748,0.842777469940192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,39355,-0.000714020552315761,0.00367982060220706,-0.00792646893264159,0.00649842782801007,0.846149725010828
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36823,-0.00105953567790512,0.00557421300183443,-0.0119849931615006,0.00986592180569037,0.849251069043117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36992,-0.00275371169559213,0.0146330141611845,-0.0314344194515137,0.0259269960603295,0.850734786801381
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36847,0.000759932051218015,0.00403841276573921,-0.00715535696963084,0.00867522107206687,0.850741826139063
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37269,-0.00029575452322797,0.00162995883030879,-0.0034904738306332,0.00289896478417725,0.856017970476133
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36955,-0.000563657896416498,0.00311448998925707,-0.00666805827536036,0.00554074248252736,0.856386838410954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39123,0.0005144109726286,0.00284573860394702,-0.00506323669110756,0.00609205863636476,0.856554248148697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39485,0.0010791302055151,0.00597652351531175,-0.0106348558844959,0.0127931162955261,0.856714191246984
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39194,-0.000943757675968232,0.00523869042476171,-0.0112115909085012,0.00932407555656472,0.857036148230202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,37243,-0.000344017586218137,0.00191225738284378,-0.00409204205659195,0.00340400688415568,0.857232905563643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,37221,-0.000968386459696018,0.00539958586968513,-0.0115515747642789,0.00961480184488684,0.857669990109088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36992,0.000813211891993818,0.00453449638794421,-0.00807440102837683,0.00970082481236446,0.85767445007301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39187,-0.00124226015160842,0.0071974377800326,-0.0153492382004723,0.0128647178972555,0.862970145641324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37128,0.000454350775633784,0.00267146428500885,-0.00478171922298356,0.00569042077425113,0.864953430500721
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36916,-0.000337254696253958,0.00199880687527762,-0.00425491617179809,0.00358040677929017,0.86601332774275
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,37247,0.000355867659627592,0.00212925541825521,-0.00381747296015262,0.0045292082794078,0.867268480437704
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36880,-0.000968334706607187,0.00582337817238308,-0.012382155924478,0.0104454865112636,0.867936149653261
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39601,0.000648547821598381,0.00390866997319891,-0.00701244532587148,0.00830954096906824,0.868217833653978
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36847,-0.00068543473568156,0.00418215643291038,-0.00888246134418589,0.00751159187282278,0.86981643654274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36847,0.000355847325216541,0.00219203203778793,-0.0039405354688478,0.00465223011928088,0.871043333740166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37162,0.000560687838265173,0.00351147440643154,-0.00632180199834065,0.007443177674871,0.873141166500443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39428,-0.000734095820077868,0.0046848792647326,-0.00991645917895377,0.00844826753879804,0.87548756484834
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36992,-0.000721301856960992,0.00466303819053722,-0.00986085671041395,0.00841825299649197,0.87707218009658
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37126,-0.000704302746798028,0.00456476432647421,-0.00965124082668747,0.00824263533309141,0.877382630112378
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36861,-0.00031117102942382,0.00201857827919982,-0.00426758445665547,0.00364524239780783,0.87749116442941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36880,0.000569704555506424,0.00372536762054142,-0.00673201598075476,0.0078714250917676,0.87845932917444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36847,0.000530622938670564,0.00348107227713671,-0.00629227872451739,0.00735352460185852,0.878849577589572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39104,0.000708905981771467,0.00475974853915837,-0.00862020115497894,0.0100380131185219,0.88160484541327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39104,-0.000837752728953686,0.0056348738929763,-0.0118821055591872,0.0102066001012799,0.88181383616708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36916,0.00104350116299561,0.00706698492893684,-0.0128077892977206,0.0148947916237118,0.882614587281165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38915,0.000822482368263497,0.00557350763021813,-0.010101592586964,0.011746557323491,0.882684211036241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36880,-0.000337141753211566,0.00232616653645861,-0.00489642816467045,0.00422214465824732,0.884764947607093
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,37162,0.000625464220833644,0.00432603530911295,-0.00785356498502773,0.00910449342669502,0.885043679711653
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36823,-0.000622109282426813,0.00430748204370843,-0.00906477408809534,0.00782055552324171,0.885167011403288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36880,0.000345653181452589,0.00241396212470611,-0.00438571258297139,0.00507701894587657,0.886143121035021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,37162,-0.000534235510928986,0.00382145136816388,-0.00802428019253018,0.00695580917067221,0.88882092940132
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37230,-0.000873122160754975,0.00625744692398344,-0.0131377181317625,0.0113914738102526,0.889030950116529
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36861,0.000830036385006605,0.00622601168769578,-0.0113729465228771,0.0130330192928903,0.893944440827938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39415,-0.00080161656335833,0.0060251345935042,-0.0126108803666266,0.0110076472399099,0.894159248794159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36763,-0.000538260127970064,0.00409835478343734,-0.00857103550350726,0.00749451524756713,0.895511930048927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36861,-0.000420836585249691,0.00320714233582427,-0.00670683556346525,0.00586516239296587,0.895604544748668
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36823,-0.000476256679079977,0.00365089911368622,-0.00763201894190498,0.00667950558374502,0.896213205239814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36763,-0.0006863143418054,0.00533949061034387,-0.0111517159380794,0.00977908725446859,0.897727269342146
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36916,-0.000316394513738066,0.00251012801643013,-0.00523624542594112,0.00460345639846499,0.89969662510467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36880,0.000927876057675755,0.0075837548746884,-0.0139362834967135,0.015792035612065,0.902623432368202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36847,-0.000474803166232839,0.00390417086475424,-0.00812697806115114,0.00717737172868546,0.903206426868536
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39599,0.000219763485002824,0.00186195322634465,-0.00342966483863268,0.00386919180863833,0.906046667112159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36992,-0.000432177459817039,0.00366326178188087,-0.00761217055230354,0.00674781563266946,0.906088458294525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39496,-0.000281409676681688,0.00241981692417613,-0.0050242508480669,0.00446143149470352,0.907421260837164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39330,-0.000388108651127683,0.00338760978154083,-0.0070278238229477,0.00625160652069234,0.908789799063603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39194,0.000360549166063718,0.00319615810239939,-0.00590392071463908,0.00662501904676652,0.910185065108235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36847,-0.000617019627249593,0.00567225597100341,-0.0117346413304163,0.0105006020759171,0.913379919597428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36861,-0.000454683898114779,0.00419387452832112,-0.00867467797362417,0.00776531017739461,0.913667311884556
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36861,0.000804161864334692,0.00747200311866209,-0.013840964248243,0.0154492879769124,0.914296229008176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36847,-0.000387351188572883,0.00364377591620163,-0.00752915198432807,0.00675444960718231,0.91534217427971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36992,0.000490078571640535,0.0046454482043344,-0.00861499990885488,0.00959515705213595,0.915983526730977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36861,-0.000746769730718346,0.00737375804723652,-0.0151993355033019,0.0137057960418652,0.919334617298027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36819,0.000746105942402306,0.00753742060306221,-0.0140272384395996,0.0155194503244042,0.921150271122065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,39321,0.000396843609203683,0.0040112485883901,-0.00746520362404091,0.00825889084244828,0.92119304776692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36847,-0.000307049665465756,0.00312811892314236,-0.00643816275482478,0.00582406342389327,0.921808478517147
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36880,0.000482067588422478,0.00497169534502415,-0.00926245528782485,0.0102265904646698,0.922757805575722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36916,-0.000450721910779211,0.00486079121960157,-0.00997787270119828,0.00907642887963986,0.926122701174329
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36847,-0.000317372282271304,0.00344914476176765,-0.00707769601533589,0.00644295145079329,0.926687786928588
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39460,0.000749208425244695,0.00828079654645246,-0.0154811528058021,0.0169795696562915,0.92791064475552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39589,-0.000177469497139541,0.00196449460063691,-0.00402787891438788,0.0036729399201088,0.928019421238282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36880,0.000207449249848628,0.00232108817499949,-0.00434188357315038,0.00475678207284763,0.928784648445776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37164,0.000414780440938494,0.00468160110914237,-0.00876115773298055,0.00959071861485754,0.929402802445257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36861,0.000249565383738181,0.00299484380139513,-0.00562032846699628,0.00611945923447264,0.933589150144609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36763,0.000996544701060745,0.0121408708426976,-0.0227995621506266,0.0247926515527481,0.934582989115298
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36823,0.000392732942701621,0.00484623580258161,-0.00910588923035834,0.00989135511576158,0.935412438342664
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39485,-0.00038815687287419,0.00483321362445684,-0.00986125557680959,0.00908494183106121,0.935991529456299
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36861,0.000391136639792635,0.00488417310577515,-0.00918184264752666,0.00996411592711193,0.93617295732128
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36861,-0.00021758212042115,0.00283964245886618,-0.00578328133979887,0.00534811709895657,0.938924641673814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36763,0.000353219248820446,0.0046405286088099,-0.00874221682444696,0.00944865532208785,0.939327915175962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36992,0.000354007457262252,0.004809664009526,-0.00907293400140871,0.00978094891593321,0.941327167189928
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37162,0.000273382051490654,0.00379849004053825,-0.00717165842796432,0.00771842253094563,0.942625925302086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,37164,0.00157668071562148,0.0221871597058809,-0.041910152307905,0.045063513739148,0.943348927519203
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36968,0.000309166161920583,0.00435162566497533,-0.00822002014143107,0.00883835246527223,0.943362177053178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36763,0.000340167941015736,0.00482381779504375,-0.00911451493727002,0.00979485081930149,0.943782196674088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36861,0.000260628235305828,0.00369691568059033,-0.00698532649865121,0.00750658296926287,0.943797766679617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39654,-0.000176605718598799,0.00252088882159668,-0.0051175478089283,0.0047643363717307,0.94414927293623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36992,-0.000344282539683361,0.00516877380076224,-0.0104750791891773,0.00978651410981062,0.946894707074626
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36823,0.000223582643924375,0.00344962547084364,-0.00653768327892915,0.0069848485667779,0.948323460567716
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36861,-0.000247577749534785,0.00395140049674746,-0.00799232272315982,0.00749716722409024,0.950041686389846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,37162,0.000576606549115796,0.00925681228417346,-0.0175667455278642,0.0187199586260958,0.950332896101089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39462,0.000200769946556016,0.00330580918645123,-0.00627861605888839,0.00668015595200042,0.951573083219015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36763,-0.000254988960430314,0.00420818675861854,-0.00850303500732264,0.00799305708646202,0.951683896719605
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36976,0.000515697097667682,0.00861314620129375,-0.0163660694568681,0.0173974636522034,0.952257536501112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36847,-0.000171626402037445,0.00291343325986453,-0.00588195559137192,0.00553870278729702,0.953025822921656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39654,-0.000343065274557067,0.0059852988813331,-0.0120742510819699,0.0113881205328558,0.954292646856688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36906,-0.000137328854554871,0.00239752704875652,-0.00483648187011764,0.0045618241610079,0.954323567440045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39187,0.00028103909490376,0.00519122400332517,-0.00989375995161357,0.0104558381414211,0.956826471244335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39485,-0.000297393296857866,0.00565525147865074,-0.0113816861950133,0.0107868996012976,0.958061591111956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,39187,0.000570812515958954,0.0109434254465205,-0.0208783013592212,0.0220199263911391,0.958401661148159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36847,0.000493494608974061,0.0102520824049147,-0.0196005869046587,0.0205875761226068,0.961608602343381
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36992,-0.000158336665741449,0.00340579411381216,-0.00683369312881329,0.00651701979733039,0.962920141002232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39601,-0.000240116874482929,0.00521687040008106,-0.0104651828586418,0.00998494910967594,0.963289339475119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39123,-0.000198189270485286,0.00439687793297334,-0.00881607001911302,0.00841969147814245,0.964048142167197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39654,0.000105495080559743,0.00249751212094636,-0.00478962867649511,0.0050006188376146,0.966307876543065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,39104,0.0001600015860642,0.00413539590903333,-0.00794537439564113,0.00826537756776954,0.969137472203258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38967,-0.000233317893141855,0.00662638201008139,-0.0132210266329014,0.0127543908466177,0.971912413592708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36880,0.000162711614794959,0.0046917407742813,-0.00903310030279638,0.0093585235323863,0.972335118452681
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36847,0.000126887150102269,0.00377467802007767,-0.00727148176924996,0.0075252560694545,0.97318441715215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38959,0.000101021519571639,0.00301806987904657,-0.00581439544335963,0.00601643848250291,0.973298473694867
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36847,-0.000192379108256918,0.00607813338610202,-0.0121055205450169,0.011720762328503,0.974750866998795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36861,0.000105767710653872,0.00385779352940604,-0.00745550760698197,0.00766704302828971,0.978127872633159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37221,-8.05595058501763e-05,0.00296583144401678,-0.00589358913612305,0.0057324701244227,0.978330520418822
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36992,0.000153078233745952,0.00582219989406861,-0.0112584335586285,0.0115645900261204,0.979024723435945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36847,0.000110370229275342,0.00422308261102034,-0.00816687168832453,0.00838761214687522,0.979150087919082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36861,-0.000165160382809038,0.00673599039908082,-0.0133677015650074,0.0130373807993894,0.980438947613194
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39123,-0.000107294866446587,0.00459202002808532,-0.00910765412149382,0.00889306438860064,0.981359038363233
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,37255,0.000170662691954157,0.00774455530212501,-0.0150086657002109,0.0153499910841192,0.982419203918735
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,39104,-0.000126545845278534,0.00584346699005948,-0.0115797411457951,0.0113266494552381,0.982722694992932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37255,-7.13008502359491e-05,0.00330365761922619,-0.00654646978391929,0.00640386808344739,0.982781411763593
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39485,-0.000129638663604455,0.00839287051840203,-0.0165796648796724,0.0163203875524635,0.987676343317579
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39187,3.81083171778771e-05,0.00258519286670205,-0.00502886970155815,0.0051050863359139,0.988239012562995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36847,-4.02236229679058e-05,0.00328889039055702,-0.00648644878845967,0.00640600154252386,0.990242192193454
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,37162,5.96431440024553e-05,0.00497547142201744,-0.00969228084315173,0.00981156713115664,0.990435827298291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39319,-2.10335509184672e-05,0.00202174198982759,-0.00398364785098055,0.00394158074914362,0.991699355970525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36861,-6.49343998350122e-05,0.00672158705007801,-0.0132392450179879,0.0131093762183179,0.992292251071089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36823,4.05605940999787e-05,0.00435537108492754,-0.00849596673235799,0.00857708792055795,0.992569737602282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39187,6.13483349638425e-05,0.00684843816086345,-0.0133615904603285,0.0134842871302562,0.992852763946122
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36861,-1.45133156365094e-05,0.00273605657916686,-0.00537718421080355,0.00534815757953053,0.995767754600677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37164,-2.32180357024516e-05,0.00672705969417313,-0.0132082550362818,0.0131618189648769,0.997246209792195
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36847,9.72493306752077e-06,0.00368016249583364,-0.00720339355876642,0.00722284342490146,0.997891612550645
